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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
INDICATIONS 
FOR CHOLECYSTECTOMY
Cholecystectomy has become one of the 
commonest general surgical procedures 
carried out in North American hospitals. 
This trend has probably resulted from more 
extensive investigation of patients with 
abdominal complaints and more specific 
radiographic procedures. It undoubtedly 
represents a by-product of third-party 
coverage in the health insurance field.
Acute cholecystitis, recurrent biliary 
colic and the rare injuries to the gallbladder 
are established indications for cholecystec­
tomy. Recurrent pancreatitis is also in­
cluded among the indications, if biliary cal­
culi are present, since the cholecystitis may 
be an aggravating factor. The demonstration 
of stones, radiologically or surgically, in the 
absence of definite symptoms is a relative 
indication for cholecystectomy.
The trend has been to remove the gall­
bladder in the early phase of cholecystitis if 
the diagnosis has been previously estab­
lished or is confirmed by oral cholecysto- 
gram or intravenous cholangiogram. Earlier 
operation lessens time in hospital and re­
duces the total morbidity for the patient. 
With improved anesthesia and supportive 
care using intravenous fluids and anti­
biotics, the risk of early intervention is ac­
ceptable. Cholecystostomy is reserved for 
high-risk situations. Delayed cholecystec­
tomy is usually recommended for the acute 
attack which has passed the period of 
greatest inflammation (considered to last 
for three or four days); when the gallbladder 
has previously been drained for treatment 
of acute cholecystitis; and for the treatment 
of gallstone ileus.
In this issue (page 20), Drs. G. E. 
Mylne and P. N. Karnauchow have re­
viewed the results from a smaller Canadian 
city in 1,001 patients subjected to cholecys­
tectomy over a period of five years. They 
note that the trend is towards earlier diag­
nosis and operation at a time when symp- 
tcms are minimal or absent. The mortality 
rate in this series was 1% which is about 
average, and the complication rate was 
12.9%, which seems high, although minor 
complications such as paralytic ileus were 
included. While 10% of the gallbladders 
contained no stones, only 0.6% were re­
ported as normal. The incidence of 
adenocarcinoma was 0.4%. In a compa­
nion article by the same authors (page 25), 
the incidence of gallstones was reviewed 
in 2,066 autopsies in the same city over 14 
years. There were 1,525 autopsies in pa­
tients over the age of 10 years with intact 
gallbladders. The incidence of gallstones in 
this group was 19.7%. Obviously some of 
these may have been symptomatic. Six of the 
deaths were attributed to cholecystitis, in­
cluding three in patients without gallstones. 
The authors feel that this mortality com­
pares favourably with the mortality rate 
of 1% in their surgical series. There were 
only five cases of adenocarcinoma of the 
gallbladder (0.3%) in the autopsy series, 
three with associated gallstones. In ad­
dition, four cases of carcinoma of the com­
mon bile duct were found, two of these 
having stones in the duct. The authors are 
of the opinion that the carcinoma may 
have caused the stones rather than vice 
versa. They point out that the risk of car­
cinoma is low and probably does not 
constitute an adequate reason for cholecys­
tectomy for asymptomatic gallstones. Carci­
noma of the gallbladder is an uncommon 
condition and its cure is rare.
The question remains whether a young, 
healthy patient who has radiologically 
demonstrated gallstones should be advised 
to have a cholecystectomy if symptoms are 
equivocal or absent. The above authors 
point out that the combined mortality from
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carcinoma of the biliary system and pan­
creatitis is less than the operative mortality. 
While there are other factors such as 
eventual development of biliary cirrhosis or 
cholangitis and the higher mortality rate 
from operation in older patients, the death 
rates in these reports do not give clear sup­
port to operative intervention. On the other 
hand, Briele, Long and Parks1 found 23 
cases of carcinoma of the gallbladder in 
1,500 cholecystectomies with 27 early 
postoperative deaths. The prognosis in car­
cinoma of the gallbladder is so poor that 
this should be considered a point in favour 
of early cholecystectomy.
With respect to morbidity, balancing the 
operative complications and discomfort 
against the risk of developing symptoms 
from the gallstones over a long expectation 
of life, most surgeons would probably feel 
that the combined morbidity from a surgical 
attack is less than the cumulative morbidity 
of biliary colic and possible jaundice. Per­
haps individual surgeons are swayed by 
dramatic personal experiences such as dis­
covering a geriatric patient dead with per­
foration of the gallbladder or seeing a 
younger patient die within 24 hours from 
acute cholangitis and septic shock. The non­
aggressive physician, on the other hand, 
would probably be inclined to accept the 
complications or at least wait until signifi­
cant symptoms develop. Lund2 has reported 
a series of 535 patients with gallstones of 
whom one-third developed complications 
and one-half developed symptoms over a 
period of years. The magnitude of the risk 
of developing symptoms or complications is 
not established since in many cases the con­
dition is not diagnosed. At the present time 
it seems that the only way of dealing with 
this problem is to discuss the risks of mor­
bidity and mortality with the patient and 
come to a decision for each case on its own 
merits.
S. E. C arroll
St. Joseph’s Hospital,
London, Ont.
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R E V IE W  A R T IC L E
EXTRAPULM ONARY RESPIRATION: A REVIEW*
IOHN A. AWAD, M.D., D.Sc.,f 
Quebec City, Que.
Summary: Various methods have been devised 
either to replace or assist diseased lungs: (1) 
intravascular injection of oxygenated blood. (2) 
intravascular injection of oxygen, (3 ) pervas- 
cular oxygenation, (4) donor or cross-circula­
tion, (5) intravascular injection of hydrogen 
peroxide, (6) intraperitoneal injection of oxy­
gen, (7) intraperitoneal injection of hydrogen 
peroxide, (8) biologic gas exchangers— either 
homologous or heterologous lungs, (9) direct- 
exposure oxygenators (bubble, screen or disc), 
(10) membrane (indirect exposure) gas exchan­
gers, (11) liquid interface oxygenators. Each of 
these methods has certain disadvantages. Direct 
gas-blood interface oxygenators, although re­
latively efficient, have been shown to damage 
lungs and other organs, traumatize the red cells, 
denaturize proteins, increase blood viscosity and 
form gas, fibrin and fat emboli. The most prom­
ising approach to respiratory assistance appears 
to lie in the use of membrane gas exchangers. 
Although numerous improvements have made 
these devices safe and practical for clinical ap­
plication, very long perfusions and intracorporeal 
pulmonary prostheses await the development of 
antithrombogenic membranes and oxygenators 
with better performances.
Resume: Parmi les diverses methodes qui ont 
ete conpues pour remplacer ou aider dans leur 
fonction les poumons malades, on peut rap- 
peler: (1) I'injection intravasculaire de sang 
oxygene; (2 ) I'injection intravasculaire d'oxyge- 
ne; (3 ) I'oxygenation pervasculaire; (4) le re- 
cours a un donneur ou la circulation croisee; 
(5) I'injection intravasculaire de peroxide d'hy- 
drogene; (6) I'injection intraperitoneale d'oxy- 
gene; (7) I'injection intraperitoneale de peroxide 
d'hydrogene; (8) les echangeurs gazeux biolo- 
giques (poumons homologues ou heterologues); 
(9 ) oxygenateurs par contact direct (barbotage, 
treillis ou disque): (10) echangeurs gazeux a 
travers une membrane (contact indirect); (11) 
oxygenateurs liquide "interface". Toutes ces me-
*From the Department of Surgery, Laboratory of 
Experimental Surgery and the Research Group on 
Artificial Organs, Laval University, Quebec City, 
Que.
Supported by Medical Research Council of Can­
ada Grants MA-4167 and MA-4502.
-(-Associate Professor of Surgery, Laval University.
thodes presentent certains inconvenients. Sans 
doute les oxygenateurs par contact direct oxyge- 
ne-sang sont-ils relativement efficaces, mais 
il a ete demontre qu'ils lesent les poumons et 
d'autres organes, traumatisent les erythrocytes, 
denaturent les proteines, augmentent la viscosite 
sanguine et forment des emboles (gaz, fibrine et 
lipide). II semble que la methode la plus pro- 
metteuse d'assistance respiratoire soit I'emploi 
d'echangeurs gazeux a travers une membrane. 
Bien que de nombreuses ameliorations aient 
rendu ces appareils plus surs et plus pratiques 
en clinique il faudra encore attendre le develop- 
pement de membranes antithrombogeniques et 
d'oxygenateurs d'un meilleur rendement pour 
pouvoir proceder a de tres longues perfusions 
et a des protheses pulmonaires intra-corporelles.
Since the discovery of the function of the 
lung numerous attempts have been made to 
duplicate or complement the gas-exchange 
performance of this organ, either to main­
tain its vitality or to assist/patients suffering 
from respiratory distress.
The task of adequate! replacing the aver­
age human lung presen s a formidable chal­
lenge. Depending on the state of activity of 
the individual four to 30 1/min of blood 
must be oxygenated. According to the meta­
bolic needs of the organism, from 250 to 
5,000 ml of oxygen might have to be ab­
sorbed and about the same quantity of car­
bon dioxide removed. This transfer is per­
formed by exposing to the alveolar gases a 
relatively steady blood volume, 700 to 900 
ml, spread over a surface area of 50 to 100 
sq m. Under normal conditions this is car­
ried out with a pulmonary pressure of less 
than 30 mm Hg, a process made possible 
because blood passes through a system with 
a very low resistance.
The various methods of extrapulmonary 
artificial respiration or oxygenation that have 
been devised may be classified as follows:
(1) Intravascular injection of oxygen­
ated blood: (a) controlled perfusion of vital 
organs; (b) reservoir perfusion.
(2) Intravascular injection of oxygen.
(3) Pervascular oxygenation.
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(4) Donor or cross-circulation.
(5) Intravascular injection of hydrogen 
peroxide.
(6) Intraperitoneal injection of oxygen.
(7) Intraperitoneal injection of hydrogen 
peroxide.
(8) Biologic gas exchangers: (a) homolog­
ous and heterologous; (b) autologous.
(9) Artificial gas exchangers: (a) direct- 
exposure gas exchangers, e.g. bubble, screen 
and disc oxygenators; (b) membrane (in­
direct exposure) gas exchangers—wettable 
membranes (e.g. cellophane), non-wettable 
membranes (e.g. Teflon and silicone rubber) 
and porous membranes; (c) liquid-interface 
gas exchangers (e.g. fluorocarbon oxygen­
ators).
Intravascular Injection of
Oxygenated Blood
Controlled Perfusion of Vital Organs
Because most tissues, except the brain and 
heart, can tolerate temporary arrest of the 
circulation relatively well, it was deduced 
that death could be delayed for some time by 
perfusing these organs. In 1813 LeGallois 
first envisioned the indefinite artificial sup­
port of the circulation through a continuous 
perfusion of oxygenated blood and physiol­
ogists showed that they could re-establish 
the irritability of dying muscle by injecting 
venous blood. In the mid-nineteenth centu­
ry Brown-Sequard maintained the reflex 
nervous activity in isolated mammalian 
heads by perfusing them with “red incoag­
ulable blood” obtained by the whipping of 
black blood. He demonstrated that the limbs 
of guillotined criminals, at the stage of rigor 
mortis, could be reactivated by perfusing 
them with oxygenated blood while the un­
perfused part of the body decayed. In 1849 
Loebell suggested the use of stored oxygen­
ated blood and this idea was mentioned much 
later by Lillehei et al.1 In 1868 Ludwig and 
Schmidt devised a method of extracorporeal 
artificial oxygenation of blood by shaking 
venous blood in a glass flask and then in­
fusing it under constant pressure from a re­
servoir. In 1910 Laewen and Sievers main­
tained life for five minutes in rabbits’ heads 
which had been cannulated, isolated and 
perfused with oxygenated Ringer’s solution 
or blood. Tuffier suggested in 1920 that the
injection of oxygenated Ringer's solution into 
the carotid artery would maintain the cere­
bral circulation during cardiac surgery. In 
1939 O’Shaughnessy2 prolonged circulatory 
arrest up to 10 minutes by perfusing the 
brain with an oxygenated hemoglobin solu­
tion. In 1954 Parkins, Jensen and Vars pre­
vented brain damage in dogs during circula­
tory arrest by perfusing the carotid arteries 
with cold blood. Between 1948 and 1958 
Kunlin,3 Burstein and Binet, and Massimo 
and Boffi attempted to extend the period of 
suspended systemic circulation by artificial 
coronary perfusion combined with artificial 
oxygenation of the brain. Between 1956 and 
1960 Kimoto, Sugie and Asano4 and Saka- 
kibara successfully used controlled perfu­
sion of vital organs in hypothermic patients. 
This method, besides requiring multiple can- 
nulations, is hazardous and its usefulness is 
limited by the progressive ischemia of the 
spinal cord. Furthermore, circulatory arrest 
produces an anaerobic environment in most 
of the body tissues and although the viability 
of the cells may be preserved their specific 
function is eventually disturbed.
Reservoir Perfusion
This is the simplest method of providing 
oxygenated blood during cardiac operations. 
Oxygenated blood is injected into the ar­
terial system in a continuous flow while 
venous blood is simultaneously removed to 
maintain a constant body volume. Many in­
vestigators contributed to the development 
of this technique.5' 10 Warden et al1 used 
two mechanical pumps for reservoir perfu­
sion while Callaghan et als infused the blood 
and collected it by gravity. Warden et al,9 
for intracardiac operations in humans, used 
arterialized venous blood from an extremity 
heated to 45° C to promote arteriovenous 
shunts. Brown et a/10 and Button, Bernhard 
and Walter used blood oxygenated in vitro 
for open cardiac operations. Brown et al10 
also devised a technique of intermittent ex­
tracorporeal oxygenation which consisted of 
the injection of oxygenated blood while 
venous blood was collected from the patient. 
This blood was then oxygenated and reused 
for arterial transfusion.
The limiting factor in reservoir perfusion 
is the initial amount of blood available. 
These techniques failed to gain acceptance
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because of the development of the more 
convenient and safer pump oxygenators.
Intravascular Injection of Oxygen
This method of extrapulmonary oxygena­
tion was so temptingly simple that a number 
of investigators employed it both experi­
mentally and clinically. Nysten in 1811 in­
jected up to 200 ml of oxygen intravenously 
in dogs breathing pure nitrogen and noted 
that, when injected very slowly, the oxygen 
did not appear to be harmful. Smith11 was 
one of the first to draw attention to the toxic 
effects of oxygen—the Lorraine-Smith ef­
fect. Gaertner showed that continuous in­
travenous injection of pure, electrolytically 
prepared oxygen was perfectly compatible 
with life and suggested this method for com­
plementary oxygenation. Intravenous oxygen 
was shown to be relatively safe in animals 
when injected in quantities of 0.5 ml/kg/ 
min, since the normal requirement was much 
higher (6 to 7 ml/kg/min). Theoretically 
the injection of 1 ml/kg/min should raise 
the oxygen content of venous blood by ap­
proximately 1 vo l% .12 Mariani13 was ap­
parently the first to administer oxygen intra­
venously to a living human being. Stuertz 
stressed the importance of intermittent in­
jections and recommended that they should 
be made at a distance from the heart. Bourne 
and Smith14 found that, instead of allevia­
ting hypoxemia, intravenous oxygen pro­
voked signs of pulmonary embolism, cardiac 
irregularity, systemic hypotension and finally 
right-heart failure, and that hypoxemia wor­
sened under this treatment. Dick15 found 
that the arterial oxygen saturation tended to 
decrease immediately when oxygen was in­
jected intravenously. Singh found that at 
two atmospheric pressures (1,520 mm Hg) 
30% to 40% of the oxygen requirement of 
the cat could be given intravenously without 
harmful effects. Singh and Shah found that 
oxygen administered intravenously brought 
clinical improvement to critically ill patients. 
Singh16 employed hypothermia to increase 
the oxygen solubility in blood while simul­
taneously decreasing the body’s oxygen re­
quirements. With the aid of a wetting agent 
and heparin, Lary17 produced minute oxy­
gen bubbles by passing oxygen through a 
porous filter connected to an artificial ar­
teriovenous shunt. The small bubbles were
absorbed more easily, thus decreasing the 
risk of obstruction to the pulmonary vascular 
bed. He was able to keep dogs breathing 
pure nitrogen alive for up to one hour. Con­
nolly et alis  devised a method of total heart- 
lung bypass by bubbling oxygen into the 
central veins and injecting the oxygenated 
blood, after defoaming over silicone-coated 
surfaces, into the arterial system. However, 
this technique was impractical because the 
foam impaired the venous return and drain­
age. Cole19 also suggested the use of intra­
venous oxygen to provide extrapulmonary 
oxygenation and noted that small amounts 
of this gas have remarkable “antishock” 
properties. More recently intra-arterial oxy­
gen delivered by a special apparatus has been 
used to treat peripheral arterial insufficiency.
In summary, the technique of intravascu­
lar oxygenation has fallen into disuse, main­
ly because of the danger of gas embolism.
Pervascular Oxygenation
This term has been used to describe the 
technique by which blood is removed from 
the vascular system and the organ perfused 
with moist gaseous oxygen. Since (for emer­
gency) most tissues can use reserves of glyco­
gen and fat, the administration of oxygen 
alone meets their immediate needs.
The method was first described by 
Magnus. Bunzl et al used it to support the 
spinal cord, while Burns, Robson and Smith 
used it to oxygenate the muscle. Sabiston 
et al20 adapted it to the isolated heart which 
was kept beating for eight hours. They used 
this technique to perfuse the coronary arte­
ries in cardiac operations, later reverting to 
blood and re-establishing the circulation.
D onor or Cross-circulation
These terms are applied when blood is 
continuously exchanged between two anim­
als or humans by linking their circulatory 
systems. In cross-circulation, the vascular 
bed of one organism is perfused with blood 
from another, while blood from the first 
perfuses the second. In donor circulation, 
the arterial blood of one organism fully sup­
plies the vascular system of another. Sim­
ultaneously the venous blood of the recipient 
returns to the venous system of the donor. 
In such cases, the donor acts as an oxygen­
ator and is of a larger size.
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Fredericq in 1890 was the first to intro­
duce the technique. In 1919 Bazett and 
Quinby used the entire cardiac output of 
one animal to perfuse another and noted 
that the animal in better condition tended 
to bleed into the other. They employed scales 
to control these shifts of blood. In 1931 
Firor21 kept two animals alive for more 
than two days by cross-circulation. Duncan, 
Tocantins and Cuttle, in 1940, used cross­
circulation to detoxify the blood of sick 
patients. In the experimental laboratory, 
Kerr et al22 developed donor circulation 
for open-heart operations. In 1955 Lille- 
hei23 used this method successfully for 
open-heart surgery in man.
Because of the dangers to which the 
donor is exposed clinical use of this method 
has been discarded, especially since the suc­
cessful application of the heart-lung ma­
chines.
Intravascular Injection  of
Hydrogen Peroxide
Supersaturation of liquids with gases at 
atmospheric pressure has been observed un­
der a variety of experimental conditions. 
Kendrick et al saturated liquids with gases 
at 100 atmospheres absolute, then reduced 
the pressure to one atmosphere without bub­
ble formation. The separation of hydrogen 
and oxygen at metal electrodes in “quiet 
water” during electrolysis may proceed so 
rapidly that dissolved gases cannot diffuse 
away quickly enough, producing a local gas 
tension equivalent to many atmospheres.24 
Similarly, hydrogen peroxide under the in­
fluence of catalase rapidly decomposes to 
oxygen and water producing extremely high 
oxygen tensions. One millilitre of a 30% 
solution of hydrogen peroxide contains 
enough oxygen to saturate more than 1.5 1 
of venous blood. On a few occasions intra­
vascular hydrogen peroxide has been used 
to increase oxygen concentrations in man. 
In 1910 Laewen and Sievers used sodium 
peroxide solutions for artificial oxygenation 
of the brain during circulatory arrest. Oliver 
and Murphy,23 in 1920, treated 24 patients 
who had severe influenzal pneumonia with 
intravenous hydrogen peroxide. Siderova, in 
1944, described the use of intravenous 
peroxide in animals as an antidote to potas­
sium cyanide. In 1958 Abeatici, Laugeri and
De Nunno tested clinically intravenous 
oxygenation by hydrogen peroxide. Later 
they used an aerosol of hydrogen peroxide 
to oxygenate stored human blood flowing 
over a spiral plastic tube.26 Lorincz, Jacoby 
and Livingstone27 studied the effect of hy­
drogen peroxide on the blood of various 
animals and made quantitative determina­
tions of blood catalase activity. Cat’s and 
rabbit’s blood was found to be very rich in 
catalase. Paniker and Iyer noted that human 
blood was also rich in catalase and in gluta­
thione peroxidase. Dog’s and fowl’s blood 
are poor in these enzymes. Hydrogen per­
oxide injected in these animals oxidized 
hemoglobin to methemoglobin. In 1964 
Balia et al injected hydrogen peroxide into 
an artery to promote wound healing and as 
an adjunct to external irradiation therapy 
in the treatment of advanced malignant di­
seases in humans.28 Dritsas and Flotte20 
used this agent as a source of oxygenation in 
the perfusion of isolated organs.
Three complications of this method of 
oxygenation have blocked its wide accept­
ance in the treatment of respiratory insuf­
ficiency: (1) Water accumulates in the in­
travascular compartment. In the presence 
of the enzyme, catalase, hydrogen peroxide 
dissociates into oxygen and water. The water 
overloads the circulation and causes hemoly­
sis of erythrocytes. (2) Embolic phenomena 
occur owing to the rapid release of oxygen 
into the circulation. (3) This method does 
not extract carbon dioxide from the blood.
Intraperitoneal Injection of
Oxygen
Numerous complications from oxygen em­
bolism, and pulmonary and cardiac dam­
age is, so have seriously limited the use of 
intravenous gas injections. However, com­
pared with membrane oxygenators, the peri­
toneum offers a relatively large surface area, 
approximately equal to that of the skin— 2 
sq m in adult men. Furthermore, it is richly 
supplied with blood vessels, especially in the 
greater omentum. It is also highly permeable 
and one of the largest absorptive and exud­
ative surfaces of the body. On this basis, we 
attempted to evaluate the effect of intra­
peritoneal oxygen injections in hypoxic 
dogs.31 Although the technique increased 
arterial oxygen tension slightly, it did not
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extract carbon dioxide from the blood. The 
usefulness of this technique in relieving 
hypoxia seems limited.
INTRAPERITONEAL INJECTION OF
Hydrogen Peroxide
Theoretically, by injecting the peroxide 
intraperitoneally some of the disadvantages 
of intravenous administration could be 
avoided while the large surface area and the 
good vascular supply should, it was assumed, 
provide a sufficient oxygenating surface. 
Therefore we performed a series of experi­
ments to determine the efficacy of this tech­
nique of oxygenation.32 In a group of six 
rabbits a dilute hydrogen peroxide solution 
was slowly dripped into the peritoneum. In 
a group of five cats a hydrogen peroxide ae­
rosol was insufflated into the peritoneum. 
In both groups a satisfactory increase in 
blood oxygenation was obtained. However, 
because the surface area of the blood ex­
posed to hydrogen peroxide was limited, the 
very high concentration used (about 9% ) 
resulted in the formation of gas emboli. Car­
bon dioxide elimination was negligible also 
and this may prove to be the limiting factor 
in the clinical application of this technique.
B iologic Gas Exchangers
Homologous and Heterologous
Oxygenation
The well-ventilated and perfused isolated 
lung was among the first oxygenating devices 
proposed. As far as efficiency of gas ex­
change and gentleness of blood handling are 
concerned, it is also the standard against 
which mechanical devices are compared.
Jacobj in 1895 used an excised lung to 
oxygenate the blood passing through a per­
fused organ. In 1929 Brukhonenko33 per­
fected a method for total-body perfusion in 
dogs at flows up to 2.5 1/min. In the 1930s 
Hemingway, and Beland, Moe and Visscher, 
stressed the filtering capacity of an excised 
lung inserted in a perfusion circuit.
Terebinskii, Tosatti, Potts et al,34 Weso- 
lowski and Welch, and Mustard suggested 
and performed cardiac operations in anim­
als using biologic oxygenation. Mustard,35 
Campbell, Crisp and Brown36 and others 
used dog or monkey lungs for oxygenation. 
Campbell, Crisp and Brown resected a lobe
from the patient and used it for extracor­
poreal bypass.
The main difficulties of homologous and 
heterologous oxygenation are a marked 
diminution in performance within one hour 
mainly because of edema, the danger of in­
fection from micro-organisms present in 
animal lungs, and the difficulties in cannula- 
tion.
Autologous Lung Oxygenation
Right-heart bypass.—This uses the pa­
tient’s own lungs for gas exchange by in­
jecting the blood into the pulmonary artery. 
The venous blood is diverted around the 
right-heart cavities and infused with a pump 
into the pulmonary artery. Dusser de Ba- 
renne in 1919 was the first to describe this 
technique. Sewell and Glenn, and Leeds et 
al were the first to apply it in animals. In 
1953 Dodrill et al37 reported the first clin­
ical application of this technique in the 
correction of congenital pulmonary steno­
sis.
Left-heart bypass.—Blood already oxy­
genated by the patient’s own lung is drained 
from the pulmonary veins or left atrium and 
injected into a peripheral artery.
Autologous lung oxygenation.—This is a 
combination of both the above procedures. 
Blood is drained from the caval veins and 
infused back into the pulmonary arterial bed 
through a pump. After arterialization in the 
lungs the blood is drained from the left 
atrium and infused, by a second pump, into 
the systemic arterial tree. The large number 
of cannulations and the unpredictability of 
pulmonary vasomotor reactions diminish the 
usefulness of this technique.
A rtificial Gas Exchangers
Whereas gas-exchange devices vary great­
ly in their mode of construction and in their 
method of oxygenation, they also differ from 
the lung in certain important respects: (1) 
The natural lung exposes a monocorpuscular 
film of blood to the air while oxygenators 
offer a relatively thick layer, 0.1 to 0.3 mm, 
to the oxygen. (2) In the alveoli blood is 
exposed to a partial pressure of oxygen of 
100 mm Hg while in the artificial organ it 
is usually exposed to pure atmospheric oxy­
gen with a partial pressure of 700 mm Hg. 
Where hyperbaric oxygen is used the par-
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tial pressure may be even higher. (3) In 
the human lung the surface exposed to 
oxygen varies from 50 to 100 sq m depend­
ing on the needs of the individual, while in 
oxygenators the surface does not exceed 
10 sq m. (4) The flow in the natural organ 
is pulsatile. (5) The resistance in the natural 
lung is low and the drop of pressure between 
the pulmonary artery and left atrium does 
not exceed 30 mm Hg at rest. (6) There is 
no trauma to red cells in the natural lung, 
the flow being smooth and laminar.
In the average human lung the blood ves­
sels end in numerous short capillaries, whose 
diameter is only slightly larger than that of 
a red blood cell. The blood film therefore 
is so thin that only a single layer of red cells 
is exposed to the alveolar gases at one time. 
In the normal pulmonary circulation most 
of the resistance is concentrated in the ar­
terioles and capillaries. The venous system 
offers little resistance and the pressure dif­
ference between the end of the capillaries 
and the left atrium is believed to be less than 
1 mm Hg.
The lungs have a large reserve oxygenating 
capacity. Depending on the individual’s state 
of activity and his metabolic needs, his lungs 
can introduce from 250 to 5,000 ml of oxy­
gen into the blood and remove approxim­
ately the same amount of carbon dioxide.
It should be noted that the artificial lung, 
whether used for total cardiopulmonary by­
pass or for pulmonary support, does not need 
to be as efficient as the natural organ. For 
cardiac operations it needs to provide only 
about 250 to 300 ml of oxygen for the basal 
needs because it is perfusing the resting 
organism. If extrapulmonary oxygenation is 
limited to providing only additional assist­
ance to lungs still functioning, the problem 
is further simplified because any additional 
gas exchange will be beneficial.
The Ideal A rtificial Lung
Artificial heart-lung machines do not 
provide normal organ perfusion. In cardiac 
operations artificial oxygenators are used 
for only relatively short periods (a reason­
able limit of perhaps three hours), and as 
long as organ derangement is reversible 
their use is accepted as a calculated risk.
If gas exchangers are used for the relief of 
pulmonary insufficiency, the perfusions will
have to be maintained much longer or even 
indefinitely. In such cases the deleterious 
effects of oxygenators with direct gas-blood 
interface from trauma to the blood,38 de- 
naturation of proteins,30 or damage to vital 
organs40"43 would be cumulative and would 
aggravate the patient’s difficulties instead 
of relieving them.
The ideal oxygenator has been defined 
chiefly in terms of cardiac surgery. However, 
when the gas exchanger is to be used spe­
cifically for pulmonary assistance, it should 
fulfil certain characteristics which can be 
summarized as follows: (1) It should be 
safe enough for long periods of use. It 
should not cause trauma to the blood, de- 
naturation of plasma proteins, or deleterious 
changes in the lungs and other organs. The 
danger of gas and other types of emboli 
should be eliminated. (2) Although a highly 
efficient device is not an absolute requisite, 
it should be capable of meeting at least the 
patient’s normal basic metabolic demands. 
(3) It should have a constant blood volume 
and operate with minimal changes in flow 
and pressure. (4) The resistance to blood 
flow through the circuit should be low. (5) 
It should be compact and have a small prim­
ing volume. (6) It should be of dependable 
construction, relatively cheap and prefer­
ably sterile and disposable. (7) It should be 
designed so that it can be connected to the 
patient easily and rapidly in case of an 
emergency, and the temperature of blood in 
it should be controlled effectively. (8) Its 
gas-exchange efficiency should not deterior­
ate with time. (9) It should be possible to 
produce this unit or artificial lungs in various 
sizes to meet the gas-exchange requirements 
of various individuals. (10) It should have 
antithrombotic properties in order to elimin­
ate the need for heparinization.
Extracorporeal Bypass
Total bypass.— In this method practically 
all the blood is diverted from the heart into 
the extracorporeal system. In addition to a 
gas exchanger it requires one or more 
pumps. Furthermore, during prolonged per­
fusion the blood suffers greater trauma 
because all the elements pass more fre­
quently through the extracorporeal system. 
The techniques most frequently used are: 
(1) Complete bypass— all the blood is re-
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moved from both venae cavae or the right 
atrium and reinjected into the aorta. (2) 
Right-heart bypass—the venous blood is di­
verted around the heart cavities and infused 
with a pump into the pulmonary artery. (3) 
Left-heart bypass—blood is removed from 
the left atrium and infused into the aorta 
or one of its branches. (4) Right- and left- 
heart bypass or autogenous lung oxygen­
ation—a combination of both 2 and 3.
Partial bypass.—In this case only part of 
the cardiac output is diverted to the extra­
corporeal circulation. The four techniques 
used are as follows: (1) Venoarterial bypass. 
This is frequently used in cardiac opera­
tions before and after institution of complete 
bypass. Part of the blood going to the right 
atrium is removed and reinjected into the 
aorta. It has also been used between peri­
pheral vessels (e.g. femoral vein to femoral 
artery) for prolonged support of the cardio­
respiratory system. (2) Arterioarterial by­
pass. Blood is removed from the arterial 
system, usually during systole, and reinjected 
during diastole. This method is used mainly 
for cardiac assistance. (3) Venovenous by­
pass. This method requires a pump and 
consists of cannulation of the inferior vena 
cava through the femoral vein and collection 
of this blood by gravity into a reservoir. 
From there the blood is pumped into the 
oxygenator and then into the jugular vein. 
In cases where insufficient blood is obtained 
by gravity, drainage can be improved by can- 
nulating both femoral veins. (4) Arterio­
venous bypass. The femoral vessels are can- 
nulated and connected directly to the oxy­
genator. This method does not require a 
pump because the blood is driven by the 
head of pressure in the artery into the oxy­
genator and returned to the vein. Thus the 
priming volume is smaller and the trauma
inflicted on the blood greatly reduced. Usu­
ally from one-third to one-quarter of the 
cardiac output is passed through the oxygen­
ator. Rashkind et al44 found that during 
short perfusions this type of oxygenation did 
not increase the cardiac work in hypoxic 
puppies.
Direct-Exposure Gas Exchangers
Gas exchangers, which use the direct gas- 
blood interface principle, have been de­
veloped to a high state of efficiency. For this 
reason disc, bubble and screen oxygenators 
are widely used in cardiac surgery. Perfu­
sions are generally carried out for short 
periods rarely exceeding three hours. In spite 
of this restriction many workers have de­
scribed a variety of lesions attributable to the 
device, ranging from destruction of red blood 
cells,43 denaturation of proteins,39 coagu­
lation defects,46 and changes in lungs,47 
the brain,43 the kidney41 and the liver.42 
These exchangers have also been known 
to produce emboli.48 Use of these oxygen­
ators for long periods, as is required in pul­
monary assistance, has been associated with 
a high morbidity and mortality.49 Therefore 
these devices have been abandoned as gas 
exchangers for prolonged respiratory as­
sistance.
Membrane Gas Exchangers
For prolonged respiratory support the 
most promising approach appears to be the 
use of membrane oxygenators with high gas 
permeability, even though the relative gas- 
exchange capacity of these oxygenators is 
lower than that of the direct types. The in­
creased safety and low trauma to the blood 
make possible the prolonged perfusions ne­
cessary in pulmonary assistance (Table I). 
In nature, respiratory gases are exchanged
TABLE I.—Comparison of Blood Alterations P roduced by Blood-Gas Interface and M embrane
Oxygenators
Test
Viscosity......................................
Solubility, % change denatured
protein salted out........................
Electrophoresis..............................
Turbidity, % light transmission. 
Cellular changes..........................
Biological signs............................
Blood-gas interface
Increased by 100%
Albumin 89%
Globulin 183%
10% increase in globulin 
10% to 40% of control 
Coating of 75% to 100% 
red blood cells
Shock 25%
Death 16%
Decerebrate signs 48%
Membrane oxygenator
Increased by 14%
Albumin 10%
Globulin 8%
2% to 6% increase in globulin 
90% to 98% of control
Shock 0%
Death 0%
Decerebrate signs 0%
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across a semipermeable membrane separat­
ing the blood in the vessels from the gases 
in the alveoli. The gas transfer occurs by a 
process of molecular diffusion.
Barrer and Skirrow,30 in 1948, noted that 
both natural and synthetic elastomers (Teflon 
and silicone rubber) were permeable to gas 
and postulated that the passage of gases 
through plastic or rubber membranes was 
due to three phenomena: (1) absorption of 
the gas into the membrane at one surface; 
(2) diffusion of the gas through the mem­
brane; (3) dissolution and freeing of the 
gas from the opposite surface. Brubaker and 
Kammermeyer, after comparing the per­
meability of different membranes, noted that 
polyethylene permitted the diffusion of more 
oxygen and carbon dioxide than any other 
membrane. Michaels and Parker showed 
that the fabrication process is important. 
Thus, depending on the degree of crystallin­
ity and density of the product, the gas per­
meability of polyethylene may vary by a fac­
tor of 10. In 1955 Kolff and Balzer51 built 
an artificial lung made of thin polyethylene 
tubing and demonstrated that it could sup­
port the circulation of dogs. Clowes and 
Neville52 devised an artificial lung of two 
sheets of ethylcellulose held by grooved 
supports. Teflon was later substituted for 
ethylcellulose because it was stronger and 
more permeable to oxygen and carbon 
dioxide. Thomas53 used a film of silicone 
on a nylon cloth. McCaughan et al54 sug­
gested the use of microporous membranes 
which have extremely high gas-permeation 
coefficients. However, if the pores are too 
large gas embolism can occur and unfor­
tunately blood oozes through when pressure 
in the liquid phase reaches high levels.
A great advantage of membrane oxygen­
ators is that they can be included in a closed, 
constant-volume system. The membrane used 
can be of three types: (1) Wettable mem­
branes—since they are moist, they are sim­
ilar to the natural ones and are thought to 
be best.55 A good example of this type is 
cellophane. (2) Non-wettable membranes— 
the ones presently available diffuse gases 
better than the wettable membranes. How­
ever, their effect on the blood and other 
organs has not been studied sufficiently. The 
driving force for gas transfer, as described 
by Barrer, can be represented by the follow­
ing equation
N _ PrA(Pi-Pg) 
t
where N =  flow in ml/sec at 250 C and 760 
mm Hg, t =  membrane thickness in cen­
timetres, Pr =  permeability, A =  area cm2 
and (P, - P2) = partial pressure across the 
membrane in mm Hg. (3) Porous mem­
branes—in this type gas or vapour passes 
through by a simple diffusion process. Per­
meability depends more on pore size and 
percentage porosity than on the type of plas­
tic used.54
Although a large number of materials 
have been used in the construction of mem­
brane oxygenators, only those made of sili­
cone rubber have achieved wide acceptance 
because of their good gas transmission rates 
(Table II).
Wettable cellophane membranes are em­
ployed mostly in artificial kidneys for 
hemodialysis. Their gas transfer capabil­
ities were investigated by Firme et alr,i> who 
used an oxygenator made of 40 flat tubes 
of regenerated cellulose, with a wall thick­
ness of 0.0015 inches, arranged in parallel. 
Although their device did not provide enough 
oxygen to perfuse an adult patient, these 
membranes had great facility in extracting 
carbon dioxide from the blood. More recent­
ly Chamberlain, Lee and Ames57 evaluated 
a cellophane minicoil oxygenator-dialyzer 
and suggested that it be used in the treatment 
of newborn infants suffering from respiratory 
distress syndrome. We have evaluated ex­
perimentally the membrane dialyzer (Ultra­
flow 145 dialyzer, Travenol Laboratories, 
Morton Grove, 111.) as a partial venoarterial 
bypass for pulmonary and cardiac assistance 
during hemodialysis58 and as an “artificial 
gill” for the treatment of acute respiratory 
distress.59 Although oxygenation was un­
satisfactory, good carbon dioxide extraction 
was obtained.
One of the advantages of this system of 
perfusion is its great versatility. Besides its 
application for support of the heart, for gas 
exchange and for hemodialysis it can also be 
used concomitantly: (1) to control the tem­
perature of the patient by varying the tem­
perature of the dialyzing fluid; (2) to main­
tain blood electrolyte homeostasis; (3) to 
regulate acid-base balance and (4) to pro­
vide for the nutrition of the patient. For
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TABLE II.—Permeation Coefficients of the D ifferent M aterials Used to M anufacture Semi-
permeable M embranes*
Material
Z)'02 D'H20
ml cm/ cm2/ sec/ cm Hg X
D 'C 02
D '02
Polyvinylidene chloride....................................... 0.051 0.012 0.82
(Saran).................................................................... 0.062
Monochlorotrifluoroethylene (Trithene A ) . . .  . 0.092 0.022 10.72
Polyester (M ylar)................................................. 0.221
0.672 0.092 1.8
Nylon 6 ................................................................... 0.381 — —
Cellulose acetate.................................................... 6.62
6.03 5.42 5.1
7.81
Polypropylene........................................................ 11.22 0.042 3.42
Butyl rubber.......................................................... 13.01 — —
Polystyrene............................................................ 18.62 0.432 4.92
Polyethylene.......................................................... 354
4.1 3
551 0.01 —0.072
3.8—31.05 4-55
8.5—34.42 2 .6 - 4 .6 2
T etrafluoroethylene.............................................. 662 0.022 2.72
(Teflon)................................................................... 1053 2 .6 -4 .0
Ethylcellulose........................................................ 962
(Ethocel)................................................................. 1003 4.52 4.12
2651 4 4.33
Natural rubber...................................................... 2301 4 — 53
3273 5.65
Silicone rubber (Silastic 50)................................ 2.6004 10.22 4 —54
(Silastic S 2000)........................ 5,8902
6.5003
Microporous polyethylene................................... 130,000
(Permax)................................................................. 400,0003
Blood plasma......................................................... 6.5 —10.16 3 2 -1 5
*After Galetti PM, Brecher GA.12
fVolume of gas (in ml STPD) diffused per unit thickness per unit area per unit time per cm difference of 
pressure of the gas between the two sides of the membrane.
these reasons cellophane membranes have 
been used for the construction of artificial 
placentas.56* 57 One of its disadvantages 
is that if fluid is not used on both sides the 
cellophane rapidly becomes coated with a 
dried deposit.60
Various investigators have constructed 
oxygenators made of polyethylene and 
Teflon.61 Gas transfer through polyethylene 
is so low that this material has been aban­
doned for the construction of membrane 
oxygenators. Teflon in thick, strong layers 
has a tendency to retain carbon dioxide.55 
At present the materials most widely used 
for artificial lungs are dimethyl silicone elas­
tomer (silicone rubber) and silicone polycar­
bonate copolymer.
Designs of membrane oxygenators have 
varied widely.60’ 61 In general two types 
can be detected: (1) membrane oxygenators 
made of sheets separating the blood from 
the gases. Some of the designs use molds 
to form capillary channels to improve gas 
exchange. A great drawback of this type of
oxygenator is its great resistance to the flow 
of blood; (2) membrane oxygenators made 
of capillary tubes or hollow fibres. In one 
design the blood is passed through the tubes. 
The main disadvantage of this is the high 
resistance to flow and the risk of blood clog­
ging the tubes. In another design oxygen is 
passed into the tubes while the blood is 
made to circulate around them. A third de­
sign combines both methods in a bag through 
which oxygen is circulated.62 By having 
blood and oxygen flowing at countercurrents, 
gas exchange is improved.
Of the various designs, four appear to 
have progressed far enough to permit clinic­
al trials. These are the Bramson membrane 
oxygenator, the General Electric Peirce, the 
Travenol membrane and the Lande-Ed wards 
oxygenators.
A major barrier to improved gas exchange 
has been the thickness of the blood film in 
these devices. In laminar-flow gas exchan­
gers the blood layer in contact with the 
membrane becomes well oxygenated and
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offers a resistance to the passage of oxygen 
to the inner layers. The corrective method 
proposed has consisted in the production of 
a turbulent flow or agitation: (1) by intro­
ducing a screen in the bloodstream to im­
prove mixing (Travenol membrane oxygen­
ator); (2) by agitation as in the Waters med­
ical monitors oxygenator and Katsuara 
swing-type oxygenator. If agitation is ex­
cessive the possibility of trauma to the 
blood63 is consequently increased; and (3) 
by induction of secondary currents,64- 65 as 
in the Drinker66 or Melrose67 membrane 
oxygenators. Furthermore, recent develop­
ments in the production of microporous 
membranes have greatly improved permea­
bility to respiratory gases.68
It can therefore be stated that although 
improvements in the design of these devices 
remain to be made, membrane gas exchan­
gers appear at present to come nearest to 
the concept of the ideal artificial lung.
Liquid-Interface Devices
Another method of preventing the direct 
contact between gases and the blood was 
proposed by Howlett, Dundas and Sa- 
biston.69- 70 These authors developed a 
liquid-liquid oxygenator utilizing fluorocar­
bon FX-80 and perfused dogs for up to 12 
hours. Later Geyer, Monroe and Taylor 
showed a higher toxicity of FX-80 in compa­
rison with that of FC-43 and suggested that 
all further work be done with FC-43. Other 
investigators71- 72 employing the same prin­
ciple demonstrated the effectiveness of this 
oxygenator, although much work remains to 
be done before it can be used clinically.
Discussion
From the beginning extracorporeal per­
fusions have produced various disturbances 
in the body.
In constructing a safe artificial lung one 
of the main difficulties to be overcome is the 
destruction of the formed elements of the 
blood brought about by contact with a for­
eign material.
Plasma proteins become denatured and 
tend to coagulate at the gas-liquid interfaces. 
The mechanism might, at least partially, be 
associated with the oxidation of sulfhydryl 
groups. Under these conditions the protein 
molecule, which normally has a helical
arrangement, tends to straighten out or be­
come randomly coiled. This decreases its 
solubility, reduces its crystallizing ability, in­
creases its reactivity and alters the protein’s 
normal biological activity. Concurrently fat 
globules are liberated into the blood stream.
Hemolysis and disturbances of the coa­
gulation mechanisms increase. Gas, fibrin 
or fat emboli form.
Biochemical and enzymatic changes have 
been noted.
The viscosity of the blood increases and 
has a deleterious effect on the microcircula­
tion and cellular perfusion.
Host defense mechanisms are depressed 
as shown by a generalized depression of the 
phagocytic function of the Kupffer cells.
There is derangement of the blood elec­
trolytes, acid-base balance and the body 
fluid compartments.
Physiological disturbances during bypass 
are also frequently encountered.
There are changes in the lungs, the heart, 
the liver, the brain, the kidneys, the pan­
creas, the intestines and endocrine glands.
This extensive review demonstrates that 
the various artificial gas exchange devices 
are still far from equalling the natural lung 
in efficiency. It will be many years before 
an artificial lung will be considered safe 
enough for intracorporeal use in replacement 
of the destroyed organ. Still, with materials 
and technology presently available, a suf­
ficiently safe and reliable lung might be de­
veloped to act as temporary pulmonary sup­
port for patients suffering from temporary 
and reversible pulmonary distress.
In general, membrane gas exchangers 
have produced far fewer deleterious effects. 
However, even these oxygenators pose a 
number of problems that will have to be 
solved before they can be used clinically for 
periods longer than a few weeks. Most of 
these oxygenators are now made of perm­
selective membranes (dimethylsiloxane and 
silicone polycarbonate copolymer) which 
allow a good diffusion of respiratory gases.
The design of these oxygenators remains 
a major problem. Since, unlike the situation 
in the natural lung, the blood film is re­
latively thick, the oxygenated blood at the 
boundary layer offers resistance to the oxy­
genation of the deeper layers. Various forms 
of blood mixing have been proposed to cor-
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rect this defect, namely external agitation, 
production of a turbulent blood flow, crea­
tion of secondary currents and production 
of thinner blood films (although this last 
technique tends further to increase the re­
sistance to the blood flow).
Another major barrier to the use of a per­
manently installed intracorporeal lung has 
been the necessity for heparinization of the 
patient. The development of antithrombo- 
genic membranes would greatly facilitate the 
production of artificial lungs for prolonged 
pulmonary assistance, or for intracorporeal 
pulmonary replacement. Since these mem­
branes would eliminate the need for hepar­
inization, the perfusions would become safer 
and less complicated. To date four tech­
niques have been investigated: (1) treat­
ment of the surface with graphite, benzal- 
konium and heparin.73' 74 This produces 
only retardation of clotting and does not 
prevent platelet deposition; (2) multiple 
coating and polishing of surfaces;75’ 76 (3) 
permanent chemical bonding of heparin77 
and other materials;76 and (4) production 
of a negative charge on a plastic surface by 
internal polarization; such plastics are known 
as “Electret”.78
There are also other fields that need fur­
ther investigation. Good manifolding, espe­
cially at the inlet, is necessary for an ideal 
distribution of the blood to the various 
areas of the device if adequate gas exchange 
is to be realized. When studies of the oxy­
genators are made using small models, 
values lower than the theoretically calcul­
ated ones are obtained from the larger-scale 
prototypes. Whether this is owing to inade­
quate manifolding or to formation of prefer­
ential channels by the blood needs to be 
clarified. Optimization of the flow distribu­
tion and the reduction of resistance to blood 
flow are areas for further improvement.
As stressed by Galletti and Brecher,12 the 
logistics problems of the membrane lung 
can be summarized in the statement that car­
bon dioxide elimination depends upon the 
membrane area available, whereas oxygen 
uptake depends upon the design of the blood 
distributing system. One of the greatest bar­
riers to the accurate evaluation of the vari­
ous methods of extrapulmonary respiration 
has been the difficulty of devising an ade­
quate experimental model, which would sim­
ulate various diseases affecting the human 
lung and which would give results that could 
easily and accurately be reproduced for a 
reliable comparison.
In spite of the difficulties a number of 
membrane lungs are being developed and 
some have even been used clinically for pro­
longed pulmonary assistance.79'82 There­
fore, with the rapid progress that can be 
made with adequate financial assistance, it is 
not unrealistic to look forward to a time 
when a patient with irreparably damaged 
lungs may be provided with a pair of good 
artificial ones.
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USE OF AUTOGENOUS PERICARDIUM AND HOMOGRAFT AORTIC 
VALVES IN PULMONARY VALVE RECONSTRUCTION:
AN EXPERIMENTAL STUDY*
G. A. TRUSLER, M.D., E. ISHIZAWA, M.D., and E. ECHEVARRE, M.D.,
T o ro n to , O ut.
Summary: Homograft aortic and autogenous 
pericardial valves were implanted in the pul­
monary valve area in calves and the animals 
followed up to 24 months. The homograft aortic 
wall narrowed in all calves, frequently with some 
calcification. Most homograft arotic valve leaf­
lets degenerated and shrivelled although a few 
leaflets appeared relatively normal.
Triple-leaflet valves of autogenous pericardium 
became thick and short. If mounted in a frame 
the leaflets projected into the lumen to produce 
stenosis. Single pericardial leaflets mounted on 
a pericardial patch disappeared.
We conclude that autogenous pericardium is 
unsatisfactory for use as a pulmonary valve sub­
stitute. Aortic homograft valves may also fail 
over the long term. A better substitute for the 
pulmonary valve must be sought.
Resume: Des valvules aortiques homogreffes et 
des valvules pericardiques autogenes furent im- 
plantees dans la region de la valvule pulmonaire 
chez des veaux, et les animaux observes pen­
dant 24 mois.
La paroi aortique ayant re?u I'homogreffe 
s'est retrecie chez tous les veaux, souvent avec 
apparition de calcifications. La plupart des val­
vules aortiques homogreffes, degenererent et se 
recroquevillerent, bien que quelques valvules 
aient semble relativement normales.
Les valvules a triple feuillet, faites a partir 
d'un pericarde autogene, devinrent epaisses et 
courtes. Une fois montees dans un cadre, les 
valvules se projectaient dans la lumiere pour 
produire une stenose. Des feuillets pericardiques 
simples, montes sur un morceau de pericarde, 
disparurent.
Nous concluons, que le pericarde autogene 
n'est pas satisfaisant pour etre employe comme 
substitut de la valvule pulmonaire. Des valvules 
aortiques homogreffes peuvent aussi faire de- 
faut a long terme. Un meilleur substitut pour la 
valvule pulmonaire doit etre recherche.
‘ From the Department of Surgery, University of 
Toronto, and the Division of Cardiovascular Sur­
gery, The Research Institute, The Hospital for 
Sick Children, Toronto, Ont.
Supported by Medical Research Council of Canada 
Grant 3622.
Reprints requests to: Dr. G. A. Trusler, The Hos­
pital for Sick Children. 555 University Avenue, 
Toronto, Ont. M5G 1X8.
A pu l m o n a r y  valve substitute is often ne­
cessary in the extensive reconstruction of the 
right ventricular outflow tract which is re­
quired in severe tetralogy of Fallot, truncus 
arteriosus and some complex cases of trans­
position of the great arteries with pulmonary 
stenosis. Prosthetic tubes without valves or 
with prosthetic valves have been unsatisfac­
tory1 but outflow-tract reconstruction has 
been successful when homograft valves have 
been used either in prosthetic tubes,2’ 3 or 
in a length of homograft artery.4' 8 A triple­
leaflet graft of autogenous fascia lata has 
also been employed.9- 10 While early experi­
ence has been encouraging, late results must 
be examined carefully before wide use of 
such grafts can be recommended.
The need for outflow-tract reconstruction 
may arise suddenly when construction of a 
fascia lata valve is inconvenient and no 
homograft aortic valve is available. At such 
a time, an appropriate tissue for valve con­
struction would seem to be autogenous peri­
cardium.11 We investigated the fate of auto­
genous pericardial valves and homograft 
aortic valves in the right ventricular outflow 
tract of calves.
M ethod
The pulmonary valve was replaced, par­
tially or completely, by either homograft aor­
tic valves or valves of autogenous pericar­
dium in calves 2 to 5 weeks old and weigh­
ing between 100 and 140 lbs. The anesthetic 
technique and conduct of the operation and 
postoperative course have already been de­
scribed.12- 13 A rotating disc oxygenator 
primed with homologous blood drawn 48 
hours previously was employed for cardio­
pulmonary bypass.
All homograft aortic valves were taken 
24 to 48 hours before the experiment and 
kept at 4° C in Ringer’s lactate solution con­
taining three million units of penicillin G. 
Before insertion, the homograft aortic wall 
was trimmed to a short cylinder extending 
several millimetres beyond the valve leaf­
lets. We incised the recipient’s right ventri-
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cle and pulmonary artery longitudinally, re­
moved the pulmonary valve leaflets and 
sutured the aortic valve graft into the base 
of the pulmonary artery, using two rows of 
00 synthetic suture. The cardiac incision 
-  was sutured to compress the aortic valve 
graft slightly and any residual defects were 
closed with pericardium.
replaced by a homograft aortic valve. One 
calf died on the farm 15 months after oper­
ation and the heart was lost. The other five 
died or were sacrificed 12 to 24 months 
after operation (Table I ) . The valve-ring 
area was narrowed and stenotic in all five 
of these animals and the homograft wall was 
obviously calcified in four. All five valves
TABLE I.—Aortic Valve H omograft
Time to
Calj necropsy Died or
no. (months) sacrificed Graft wall Valve leaflets
186
214
216
224
229
12
18
19
18
24
D Narrowed Partial obstruction by thrombosis caused death
S Narrowed, calcified All three leaflets thin and pliable but slightly shrivelled
S Narrowed, calcified One good leaflet. Two leaflets shrivelled
S Narrowed, calcified One good leaflet. Two leaflets thin and short
S Narrowed, calcified All three leaflets thin and partly shrivelled
In calves receiving autogenous pericardial 
leaflets either one or all three pulmonary 
leaflets were replaced. In the latter case the 
pericardium was either sutured in free or 
supported on a cloth-covered frame as de­
scribed by Edwards et al.1 * In six calves 
only the anterior leaflet of the pulmonary 
valve was excised along with the respective 
portion of the pulmonary artery and right 
ventricular outflow tract. The defect was 
closed with an elliptical patch of pericardium 
bearing a single cusp fashioned from peri­
cardium and positioned to meet the two 
original pulmonary valve leaflets and to 
maintain competence. After cardiopulmon­
ary bypass, right ventricular and pulmonary 
artery pressures were recorded. The sur­
viving calves were observed until they died 
or were sacrificed at which time the condi­
tion of valves was assessed by gross and 
microscopic examination.
R esu lt s
The pulmonary valve was replaced in 40 
calves. Ten died within 48 hours of opera­
tion. Another 17 died within the next two 
months chiefly from infection, either gastro­
intestinal, pulmonary, cardiac or mediastinal. 
Thirteen calves survived beyond two months 
and were available for long-term study of the 
valve substitute.
Homo graft Aortic Valve
In six of the calves surviving more than 
two months the pulmonary valve had been
Fig. 1.—Right ventricular outflow tract 
opened to show homograft aortic valve. Two 
leaflets are shrivelled and incompetent. One is 
relatively normal and competent. Fistulas 
around the homograft appear top centre.
were insufficient, the size of some of the 
valve leaflets being reduced by degeneration 
and shrivelling (Fig. 1). In two calves one 
aortic homograft leaflet appeared relatively 
normal.
Autogenous Pericardial Valve
In three of the calves surviving more than 
two months all the pulmonary leaflets had 
been replaced by autogenous pericardium 
(Table II). In one, the pericardial leaflets 
were sutured to the site of attachment of the 
original pulmonary valve. Seventeen months 
later the pericardial leaflets were greatly 
thickened and shortened but still pliable. 
The original valve ring had grown moder­
ately and there was mild insufficiency (Fig. 
2). In the other two calves the pericardial
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TABLE II.—Pericardial Leaflets
Time to
Calf
no. Type o) valve
necropsy 
(months)
Died or 
sacrificed Valve ring Leaflets
185 3 cusps — free 17 S Ring slightly enlarged Thick, short and incompetent
245 3 cusps on frame 18 S Relative stenosis Thick, short and incompetent
395 3 cusps on frame 12 S Relative stenosis Thick, short and incompetent
235 Single cusp on patch 18 S Dilated Leaflet disappeared
233 Single cusp on patch 10 D Valve thrombosed —
236 Single cusp on patch 16 S Dilated Leaflet disappeared
237 Single cusp on patch 22 S Dilated Leaflet disappeared
leaflets had been mounted on a cloth-cover­
ed frame. Again, the leaflets were thick, 
short and insufficient and within the rigid 
frame had produced severe stenosis (Fig. 3).
In four long-surviving calves one pul­
monary leaflet and the adjacent portion of 
heart wall had been replaced by a single peri­
cardial cusp mounted on an elliptical patch 
of pericardium. One calf died at 10 months 
with bacterial endocarditis and massive 
thrombotic obstruction of the main pulmon­
ary artery. In the other three calves, sacri­
ficed between 16 and 22 months after oper­
ation, the pericardial cusp had disappeared 
and the patch was dilated.
D iscussion
Homograft aortic valves transplanted to 
the aortic area in humans have given general­
M
Fig. 2.—Pericardial valve without frame showing 
thickening and shortening of the valve leaflets with 
incompetence. A section has been removed from 
one leaflet.
ly satisfactory results both early and late. 
The use of such valves in the low oxygen 
saturation, low pressure pulmonary area is 
more recent and as yet no comprehensive 
long-term studies have been reported. In 
this investigation, when homograft aortic 
valves were implanted in the pulmonary area 
in calves, degenerative changes occurred but 
were not uniform. In each of two animals 
one leaflet remained relatively normal and 
competent, suggesting that some of the de­
generative changes were due to the tech­
nique of implantation of the valve. Of more 
significance was the narrowing and calcifi­
cation that occurred in the homograft aortic 
wall. This caused moderate stenosis and an 
unsatisfactory right ventricular outflow. If 
the same response were to occur in humans 
one would expect poor late results. We have
Fig. 3.—Pericardial valve on frame. The thick­
ened pericardial leaflets cause stenosis as well as 
insufficiency.
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encountered this problem in one child when 
the aortic homograft valve became severely 
calcified and stenotic four years after im­
plantation in the pulmonary artery. Possibly 
the tendency to stenosis could be reduced 
by trimming away most of the homograft 
aortic wall and the degeneration of the leaf­
lets could be eliminated by the use of a sup­
porting frame. In a brief experience (two 
calves) with the use of heterograft (porcine) 
aortic valves in the pulmonary area we found 
a striking tendency to narrowing and stenosis 
of the graft wall.
In searching for a more available valve 
substitute autogenous tissues have been em­
ployed. Fascia lata was used in the aortic 
area, originally by Senning13 and more re­
cently by Ionescu and Ross. 16  Ionescu de­
scribed a method for reconstruction of the 
right ventricular outflow tract with a tube 
and valve of fascia lata. 10 Although early 
results were satisfactory, Ross and Somer­
ville17 and Breckenridge et a lis  have re­
cently reported significant late thickening 
and contraction of the fascia lata pulmonary 
valves.
Because it is readily available autogenous 
pericardium would be particularly conve­
nient if right ventricular outflow reconstruc­
tion was suddenly and unexpectedly neces­
sary during cardiac surgery. Unfortunately, 
we found that valves fashioned from peri­
cardium became greatly thickened and short­
ened causing insufficiency and, if the valves 
were mounted on and enclosed within a 
frame, stenosis. Other investigators1 9 ' 21 
have had similar experiences with pericar­
dium used in the aortic and mitral areas. It 
appears that pericardium, like fascia lata, is 
not a satisfactory pulmonary valve substi­
tute.
Where a single large cusp of pericardium 
was mounted on a pericardial patch and in­
serted in the right ventricular outflow tract 
of calves the patch became thick and dilated 
while the cusp disappeared. Although care­
fully positioned and apparently functioning 
at the time of operation, it is likely that the 
pulmonary valve was never completely com­
petent. Perhaps the disappearance of the 
cusp was related to this incompetence since 
it did not occur in the originally competent 
tri-leaflet pericardial valves. We have found 
a single percardial cusp useful in avoiding
excessive early postoperative pulmonary in­
competence in children with tetralogy of 
Fallot when it is necessary to place a large 
outflow patch across the pulmonary valve 
ring. This study suggests that these peri­
cardial cusps will ultimately fail.
A better substitute for the pulmonary 
valve must be sought. At present aortic 
homograft valves hold most promise but this 
study with calves indicates that long-term 
results may be unfavourable. Recent in­
vestigations by Pierce et a l21 and Imamura, 
Tatsuno and Sakakibara22  suggest that pul­
monary valves, either homograft or hetero­
graft, may be more suitable and merit fur­
ther long-term study.
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CHOLECYSTECTOMY AND RELATED PROCEDURES IN 
TWO COMMUNITY HOSPITALS*
G. E. MYLNE, M.B., B.S., D.M.R.D. (Edin.), F.R.C.PJC] and P. N. K.ARNAUCHOW, M.D.,
North Bay, Out.
Summary: Analysis of cholecystectomies and 
related operations performed on 1,001 patients 
during a five-year period in two community hos­
pitals disclosed a mortality rate of 1%. Overall 
complication rate was 12.9%. Histologically 
"normal" gallbladders were removed in 0.6% of 
patients. Ten per cent of gallbladders contained 
no stones. The number of cholecystectomies 
doubled over the study period. Nearly half of 
the patients were explored on the basis of non­
specific gastrointestinal symptoms and abnormal 
cholecystograms. There was a significant trend 
towards early or "preventive" cholecystectomy.
Resume: L'analyse des cholecystectomies et des 
operations connexes pratiquees sur 1,001 pa­
tients durant une periode de cinq ans dans deux 
hdpitaux a revele que ces interventions etaient 
frappees d'un taux de mortalite de 1%. Le 
taux global des complications a ete de 12.9%. 
Des vesicu.'es considerees comme "normales" au 
point de vue histologique ont ete enlevees chez 
0.6% des maiades. Dans 10% des cas, la vesi- 
cule ne contenait pas de calculs. Le nombre de 
cholecystectomies a double durant la periode 
couverte par I'etude. Pres de la moitie des ma­
iades ont ete observes a cause de symptomes 
digestifs non specifiques et cholecystogrammes 
anormaux. On a constate une tendance remar- 
quable vers la pratique de cholecystectomies 
precoces ou "preventives".
O n l y  one study of cholecystectomy has 
been reported in Canada in the past 10 years. 
This was from a large university centre.1 
Series reported from smaller institutions are 
found only in American2'6 and European7’ 8 
literature.
The object of this report is to present an 
analysis of the performance of cholecystec­
tomy and related procedures in two commu­
nity hospitals. It should be noted that these 
have a common medical staff, including sur­
geons, radiologists and pathologists.
M a ter ia ls  and  M eth o d s
The hospital records of 1,001 patients un­
dergoing cholecystectomy and related proce­
dures in the years 1966 to 1970 inclusive at
*From St. Joseph’s General and North Bay Civic 
Hospitals, North Bay, Ont.
TABLE I.- Incidence of Biliary T ract 
Operations
Year No. of operations
1959 .......................................  57
1960 ....................................... 66
1961 ......................................  81
1962 .........................................  85
1963 ....................................... 83
1964 ....................................... 109
1965 ....................................... 116
1966 .......................................  148
1967 ....................................... 181
1968 ....................................... 219
1969 ....................................... 185
1970 .........................................  268
the St. Joseph’s General and North Bay 
Civic Hospitals were examined. Data were 
tabulated according to age, sex, history, 
physical signs, radiological findings, type of 
operation, pathological findings, complica­
tions, cause of death and length of pre­
operative and postoperative hospital stay.
R esu l t s
The frequency of cholecystectomy and re­
lated operations in the two hospitals is in­
dicated in Table I. There was a fivefold in­
crease in the annual number of these proce­
dures in the years between 1959 and 1970, 
while the corresponding increase in the area 
population was one-third. During the five- 
year period of the review the rate doubled. 
As a percentage of major surgical proce­
dures, cholecystectomies increased from 
14.3% in 1966 to 21.1% in 1970. There 
was a female preponderance of approxim-
TABLE II.—Symptoms of Gallbladder D isease
Symptom No. of patients
Non-prandial pain .................... 935
Postprandial pain...................... 489
Gaseous distension.................... 375
Back pain................................... 470
Fat-food intolerance................. 46o
Nausea........................................ 463
Vomiting.................................... 372
Jaundice..................................... 78
Eructation.................................. 67
Anorexia..................................... 48
Clay stools.................................. 13
No history.................................. 9
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ately 4:1 with a peak age incidence at 45 
years in both sexes.
Pain not specifically related to meals was 
present in over 90% of the patients, while a 
component relationship to food was seen 
in less than 50%. Gas, back pain, fat-food 
intolerance and nausea were experienced by 
less than half of the patients. Jaundice had 
been present at some stage in the patient’s 
history in 8 %. Anorexia was experienced by 
5% (Table II).
An indication of the duration of symp­
toms was obtained in 64% of the patients 
while in 36% neither the duration nor the 
number of attacks was recorded by the at­
tending physician (Table III). This apparent 
deficiency in eliciting long-term histories 
contrasted strongly with the high percent-
cystograms and in these no pathologic fea­
tures were evident in three, chronic cystitis 
alone was present in another three, and 
stones were found in two. No stones were 
found in 13 patients explored on the basis 
of radiologically reported cholelithiasis. One 
normal gallbladder was removed following 
a report of non-function. In 86 patients the 
cholecystogram was either not done, done 
elsewhere and the results not recorded, or the 
records were lost. In a few instances the 
stones were diagnosed during the perform­
ance of other surgical procedures. The in­
cidence of false-positive radiographic exam­
inations in the series was 1.3%.
With respect to operative cholangio­
graphy, 57 of the 80 patients subjected to 
exploration of the duct system had one or
TABLE III.—D uration of Attacks
Duration Years Months Days 24 hours
No. of patients..............................  322 229 46 42
Total numbers stated...................  639
Total not stated ............................  362
TABLE IV.—N umber of Attacks
Number 0 1 2 3 4 5 6 7  8 9 10
No. of patients..................  4 119 43 32 8 5 2 2  1 0  1
Total numbers sta ted . . . 217
Total not stated ................ 784
age of patients (90%) in whom pain was 
recorded as the presenting symptom at the 
time of admission. In those patients whose 
history of pain was adequately documented, 
the majority had experienced only one attack 
prior to operation (Table IV).
On physical examination the most com­
mon sign, recorded in 70% of the patients, 
was tenderness in the right upper abdominal 
quadrant. Pain, as opposed to tenderness, 
was experienced on palpation in 3.5%. 
There were no physical signs related to the 
right upper quadrant or gallbladder in 26%. 
A mass was suspected in the upper ab­
domen in 3.8% (Table V).
Of the 915 patients in whom cholecysto- 
grams were performed and the results re­
corded prior to operation, 71.9% showed 
evidence of stones and 44% demonstrated 
non-function (Table VI). Eight patients 
were operated on in spite of normal chole-
TABLE V.—Physical Signs
Sign No. of patients
Hypochondrial tenderness....... 699
Hypochondrial pain ................. 35
No pain, no tenderness, no
statement regarding either. . . . 267
Hypochondrial m ass................ 45
Jaundice..................................... 38
No physical examination re-
corded......................................... 9
TABLE VI.—R adiological F indings in 915
Patients
No. of
Finding patients %
Cholelithiasis............................. 658 71.9
Non-functioning gallbladder . . 406 44.3
Papilloma of gallbladder.......... 5 0.5
Erroneously reported lithiasis. 13 1.4
Normal cholecystogram........... 6 0.7
Cholecystogram not done or
not recorded.............................. 86 9.4
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more intraoperative cholangiograms. Of par­
ticular interest is the fact that of five pa­
tients who had positive findings, four subse­
quently presented with residual postoperative 
duct calculi. The frequency of residual duct 
stones following the combined procedure 
was 9% (five patients), half the rate follow­
ing exploration without cholangiography 
(17% ).
Less than half the patients operated on 
were subjected to biochemical screening for 
liver function. Of the 404 patients thus ex­
amined, 71 (18% ) showed some evi­
dence of hepatic impairment. A surprisingly 
large number of these tests were performed 
in patients who were not jaundiced at the 
time of admission and had no clinical 
evidence or history of liver dysfunction.
Cholecystectomy was performed in 981 
patients, concomitant exploration of the 
common bile duct in 80 (8.2% ), and chole- 
cystostomy in 20. All gallbladders removed 
were examined by a member of the pathol­
ogy staff. Of the total series, only six were 
normal while changes of chronic chole­
cystitis were present in over 97%. His­
tologic changes of acute or mixed (acute 
and chronic) cholecystitis were found in 
only 6% of the cases. Chronic cholecystitis 
without lithiasis was present in 4.2%. In 
3.7% the presence or absence of stones was 
not determined; in some cases they had been 
given to the patients as souvenirs. The in-
TABLE VII. — Pathological F indings in 981 
Patients
Finding
No. of 
patients %
Normal gallbladder.................. 6 0.6
No stones present..................... 95 9.6
No information regarding pre­
sence or absence of stones . . . . 37 3.7
Stones without cholecystitis... 32 3.2
Chronic cholecystitis (total) .. 953 97.1
Chronic cholecystitis without 
stones...................................... 42 4.2
Chronic and acute cholecystitis 
without stones...............  . . 36 3.6
Chronic and acute cholecystitis 
with stones............................. 4 0.4
Acute cholecystitis with stones 15 1.5
Acute cholecystitis without 
stones.................................... 4 0.4
Adenomyoma............... 10 1.0
Papilloma....................... 7 0.7
Carcinoma...................... 4 0.4
Ectopic pancreas...................... 1 0.1
TABLE VIII.—Complications in 1,001 Patients 
Undergoing Biliary T ract Operations
Complication No. of patients
Wound infection........................ 49
Peritonitis..................................  10
Pyrexia.......................................  10
Atelectasis..................................  10
Paralytic ileus............................ 7
Dehiscence.................................  6
Pneumonia.................................  6
Urinary infection......................  6
Hemorrhage...............................  4
Vomiting....................................  3
Pulmonary embolism...............  3
Influenza....................................  3
Bile peritonitis........................... 2
Phlebitis.....................................  2
Obstructive jaundice................  2
Aggravation of asthm a............  2
Cardiac arrest............................  1
Cardiac arrhythmia..................  1
Cerebrovascular accident........  1
Aggravation of atherosclerotic
heart disease..............................  1
T otal...........................................  129
cidence of adenomyoma was 1.0%, papillo­
ma 0.7% and carcinoma 0.4% (Table VII).
The commonest complication experienced 
was wound infection, which occurred in 
4.8% of the total. Peritonitis, pyrexia of un­
known origin and postoperative atelectasis 
each developed in 1.0% of the patients. 
Obstructive jaundice due to residual stones 
in the common duct occurred in 0.2%. The 
total incidence of complications was 12.9% 
(Table VIII). A sharp increase in the fre­
quency of complications was encountered in 
the seventh decade, where the incidence was 
21% . In the fifth decade when most chole­
cystectomies were performed the incidence 
was 10% (Table IX).
TABLE IX.—Age of Patients, M ortality Rate 
and Complication Rate
Age No. of No. of Percentage of
(years) patients deaths (%) complications
10 - 19 22 0 (0) 13.6
20 - 29 161 0 (0) 11.8
30 - 39 179 0 (0) 10.0
40 -49 206 1 (0.4) 9.7
50 - 59 177 2 (1.1) 11.8
60 - 69 165 2 (1.2) 21.2
70 - 79 79 3 (3.8) 15.1
80 - 89 12 3 (25.0) 8.3
Total 1,001 11 (1.1) 12.9
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TABLE X.—Comparison of M ortality and Complication Rates
Mortality (%)
Authors
No. of 
cases
Chronic
cholecystectomy
Acute
cholecystectomy
Exploration of 
common bile duct
Total
Total complications
>- Arnold2.......................
Briele, Long and
28,621 1.5 3.5 — 1.8 4.0
Parks3......................... 1,500 — — — 1.8 7.4
Bruce and Harrison1. 
Deysine, Adiga and
581 0.6 4.4 — 1.2 10.0
V Wilder4........................ 531 1.7 5.8 7.6 2.25 12.9
Guthrie and Nolan5.. 
Haff, Butcher and
573 1.0 3.3 — 1.4 11.5
Ballinger15.................. 1,000 — — — 2.9 18.2
Harnisch7...................
Holm, Edmunds and
393 — — — 5.3 9.1
Baker14....................... 1.467 — — — 0.9 7.0
MacVicar et al16........
Magee and
2,043 — — — 3.8
MacDuffee6................
Mylne and Karnau-
1,000 — — 2.2 1.8
chow............................ 1,001 0.8 1.6 2.5 1.1 12.9
Nine patients were discharged with radio­
logical evidence of calculi in the extrahepa- 
tic bile ducts but without clinical problems. 
Twenty-one patients (2%) subsequently re­
turned for repair of their incisional hernias.
Hospital stay was subdivided into pre-
* operative and postoperative days. The mean 
preoperative stay was 5.3 days, the post­
operative stay 12.7 and the total 18 days.
The total number of deaths reported in 
the series was 11, yielding an overall rate of
* 1% (Table IX). The death rate in cases 
with chronic cholecystitis was 0.8%. The 
mortality increased to 1.6% in the presence
^  of acute histological changes and to 2.5% 
with exploration of the common duct (Table 
X).
In two patients there were no stones in 
the gallbladder at operation, one having 
histologically acute and the other chronic
v cholecystitis. Two of the patients were sub­
jected to exploration of the common bile 
duct in addition to cholecystectomy. Causes 
of death included peritonitis in six, lower
* respiratory tract infection in two and hemor­
rhage, pulmonary embolus and renal failure 
in one each. Presenting symptoms included
n  obstructive jaundice in two patients, aged 
61 and 77 years. Of the other nine who died, 
only one, an 84-year-old woman, had the
t  unquestionable features of acute cholecys­
titis. On admission she was vomiting, com­
plaining of abdominal pain and exhibiting 
the clinical features of abdominal rigidity, 
rebound tenderness and Murphy’s sign.
Discussion
The annual rate of cholecystectomy and 
related procedures has doubled over the five- 
year period of the study (1965 to 1970). 
There are clear indications that this increase 
is not a local phenomenon but the reflection 
of a universal surgical trend.7- 911 No at­
tempt is made to explore the reasons for 
the “cholecystectomy explosion” in this 
paper. We have confined ourselves to the 
comparison of our surgical performance in 
this small centre with that of others else­
where.
From the analysis of the history and phy­
sical signs of each patient it was evident that 
in nearly half of them neither the duration of 
symptoms nor the number of attacks experi­
enced was recorded. The patients were 
explored on the basis of non-specific and 
poorly documented upper gastrointestinal 
symptoms, reinforced by the radiographic 
demonstration of biliary calculi or non-func­
tion.
While interest in the detailed description 
of the pain appears to have waned, numer­
ous other conventional symptoms have been 
inquired into. A firm relationship between 
cholecystitis and such familiar complaints as 
gas, “dyspepsia”, fat-food intolerance and 
nausea was not demonstrated in our series. 
The unreliability of such symptoms has been 
reported elsewhere.12 Non-acute hypochon- 
drial tenderness was the commonest physical 
sign, being present in 70%. Absence of phy-
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TABLE X I.—Comparison of Some Pathological F indings, F igures are Percentages
Authors
Arnold2 ...................................
Briele, Long and Parks3........
Bruce and Harrison1..............
Guthrie and Nolan5................
Haff, Butcher and Ballinger15
Hamisch7.................................
Holm, Edmunds and Baker14.
Magee and MacDuffee8.........
Mylne and Karnauchow........
Normal
gallbladder No stones
Carcinoma of 
gallbladder
Associated acute 
pancreatitis
— 32.0 0.25 0.52
2.1 14.0 1.5 0.1--- — 2.4 —
— 7.6 — ___
2.3 4.4 -- - 0.3
— 6.1 4.3 1.2
— — --- 0.4
1.5 20.2 1.1
0.6 9.5 0.4 0.09
sical signs relating to the biliary tract was 
reported in 27 %.
From these findings we deduce that at 
least half the procedures were performed 
purely on a “preventive” basis. This conclu­
sion is supported by the pathological find­
ings, viz. evidence of either acute or mixed 
cholecystitis was present in only 6% of the 
gallbladders removed.
In our series the extrahepatic ducts were 
explored in 8.2% of cases compared with 
19.9% in the series of Harridge and 
Helsby13 and in 56% in that of Holm, Ed­
munds and Baker.14 Exploration of the 
ducts, when supplemented by operative 
cholangiography, resulted in a 50% reduc­
tion in the number of postoperative calculi.
Our rate of histologically normal gall­
bladders (0.6%) compares favourably with 
the figures of 1.5%6 and 2.1% 3 of others 
(Table XI). It is of interest that almost 10% 
of the gallbladders contained no stones. The 
incidence of adenocarcinoma in our series 
was 0.4% while the range reported is 
0.25%2 to 4.3%.7
Complication rates have proved difficult 
to compare. Parameters vary widely from 
report to report. Our overall rate of 12.9% 
lies near the middle of the range (Table X). 
Of all the complications in our series, wound 
infection was the only one that occurred in 
over 1% of the patients. Peritonitis, con­
stituting 1 %, was second in order of fre­
quency. Our patients’ average hospital stay 
exceeded the provincial average by 3.3 days.
Our mortality rate of 1 % compares 
favourably with those of other authors 
(Table X). It would appear to indicate good 
selection of cases and surgical technique. It 
should be noted, however, that in eight of 
the 11 patients who died following the oper­
ation, the procedure was an elective one and
the patients were in no immediate danger 
prior to its performance.
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WHITHER CHOLECYSTECTOMY?*
F. N. KAR NA UC H OW , M.D. and G. E. M YLNE, M.B., B.S., D .M .R.D. (Edin.), F .R .C .P.[C ],
North Bay, Ont
Summary: Data on cholecystic disease in 1,525 
autopsies is compared with those from a pre­
viously reported surgical series. The total mor­
tality due to cholecystic disease is greater in 
the surgical series (1% ) than in the autopsy 
material (0 .4% ). Death rate in surgically treated 
acute cholecystitis without and with gallstones 
was 3.3% and 0.8% respectively. The corres­
ponding rates in autopsy material were 0.2% 
and 0.9%. "Silent" gallstones were found in 
19% of autopsies. The loose inidcations for 
cholecystectomy and the so-called prophylactic 
cholecystectomy do not appear justifiable. They 
do not alter the total mortality resulting from 
biliary tract disease and contribute avoidable 
mortality in patients under 60 years of age.
Resume: Nous avons compare les donnees des 
protocoles de 1,525 autopsies relatives a la 
cholfccystite a celles d'une etude chirurgicale 
sur la meme pathologie et publiee anterieure- 
ment. La mortalite globale attribuable & la ma- 
ladie cholecystique est plus forte dans la serie 
chirurgicale (1% ) que dans la serie d'autop- 
sies (0.4% ). La mortalite survenue dans les cas 
operes de cholecystite aigue, avec ou sans cal- 
culs, a ete de 3.3% et de 0.8% respectivement. 
Les taux correspondants decouverts au cours 
des autopsies etaient de 0.2% et de 0.9%. L'au- 
topsie a permis de decouvrir des calculs "silen- 
cieux" ou asymptomatiques dans 19% des cas. 
Les vagues indications plaidant en faveur de la 
cholecystectomie et la cholecystectomie dite 
prophylactique ne nous semblent pas justifi- 
ables. L'operation ne diminue pas la mortalite 
relevant d'une pathologie des voies biliaires 
mais contribute a provoquer des deces qui 
auraient pu etre evitables chez les personnes 
de moins de 60 ans.
A lthough  cholecystectomy has been per­
formed continuously since it was introduced 
by Langenbuch in 1822,1 there is still disa­
greement concerning the indications for 
operation. In recent years, an aggressive ap­
proach to cholelithiasis has become evident. 
Some advocate prophylactic cholecystectomy 
in individuals with nothing more than radio- 
logically demonstrable gallstones.2'7 The 
literature abounds with argument for and
•From St. Joseph’s General and North Bay Civic 
Hospitals, North Bay, Ont.
against such attitudes, but displays a sur­
prising dearth of data concerning the natural 
mortality of cholelithiasis and cholecystitis. 
Without such information, discussion of this 
subject is incomplete. In this study we have 
analyzed our own autopsy material, com­
pared the findings with those of our previ­
ously reported surgical series and examined 
the entire subject in the light of these results.
M aterials a nd  M ethods
Two thousand and sixty-six autopsies per­
formed in the two North Bay hospitals from 
1957 to 1970 constitute the basis of this 
study. We excluded 448 from the group 
because they represented stillbirths, infants, 
and children up to and including the ninth 
year of age, and 93 were not included be­
cause of previous cholecystectomy.
The total number of subjects with intact 
gallbladders dying of causes other than 
cholecystic disease was 1,525 (441 females 
and 1,084 males). The incidence of gall­
stones was tabulated according to age and 
sex. Death rates within this series for chole­
cystitis with and without gallstones were cal­
culated. Also used were data previously ob­
tained from the analysis of 1,001 patients on 
whom an operation was performed for biliary 
tract disease.8
R e su lts
In the group of 1,525 patients who died 
with their gallbladders in situ, 19.7% had 
gallstones. The incidence of gallstones in 
both sexes rose abruptly at the age of 60 
years and continued to rise until age 90 in 
women and 80 in men (Table I). The gall­
stones formed in girls in their teens and 
men in their thirties.
The series yielded 24 instances of gall­
stones in the common bile duct. Associated 
stones in the gallbladder were present in 21 
of these; in the other three the gallbladder 
had been removed several years earlier.
There were three deaths (0.2%) result­
ing from acute acalculous cholecystitis in 
1,224 autopsies. These occurred in men 
aged 69, 78 and 85 years. Three deaths
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TABLE I.—Autopsy Series of Subjects W ith Gallstones: Age D istribution (Percentage).
Adapted F rom Lieber8
TOTAL % 10-19 20-29
Age groups (years) 
30-39 40-49 50-59 60-69 70-79 80-89
Over
90
Women:
Hansen (1922) 542 31.2 0 12.5 19.6 28.2 36.2 32.8 39.3 0 0
Gross (1929) 3,400 12.4 0.3 2.5 5.5 14.2 24.2 35.4 40.7 21.0 0
Crump (1931) 550 37.8 0 14.5 12.0 25.0 37.0 48.0 51.0 0 0
Ludlow (1937) 1,387 10.45 1.51 4.92 7.39 16.66 22.62 24.76 26.83 50.0 0
Lopis (1947) 684 19.7 0 8.43 16.66 14.87 26.27 26.01 33.3 40.0 0
Lieber (1952) 
Mylne and
7,761 21.7 0 4.2 8.6 12.1 23.3 27.5 30.6 34.9 44.4
Karnauchow 441 31.0 0.7 1.4 1.4 8.0 10.9 27.7 32.1 16.0 1.4
Men:
Hansen (1922) 649 19.0 0 1.8 6.7 12.8 14.0 25.1 34.8 0 0
Gross (1929) 6,131 6.2 0 1.0 1.7 5.0 10.3 15.0 19.0 19.6 34.0Crump (1931) 450 26.2 0 0 6.1 24.0 14.0 35.0 54.0 53.0 0
Ludlow (1937) 2,392 5.77 0.88 2.52 2.4 10.66 15.09 13.73 6.3 0 0
Lopis (1947) 1,182 9.3 3.3 0 0 5.4 9.3 14.06 16.12 33.0 0.8
Lieber (1952) 
Mylne and
12,397 9.67 0 0.86 2.1 4.2 7.6 12.5 16.4 21.4 25.0
Karnauchow 1,084 15.1 0 0 1.8 5.4 9.1 27.4 39.6 16.4 0
from acute cholecystitis with cholelithiasis 
(0.9% ) were encountered in a group of 301 
patients with gallstones. These were in two 
men aged 84 and 88 years and in an 83-year- 
old woman. In none had an operation been 
performed. The total death rate from chole­
cystitis and cholelithiasis for all cases was 
0.4% .
There were five adenocarcinomas of the 
gallbladder (0.3% ), three of which were 
associated with gallstones (60% ). Adeno­
carcinoma of the common bile duct was 
found in four cases. In two of these, gall­
stones were present in the ducts (50% ). 
Table II lists the liver lesions encountered 
in the patients with gallbladder stones. In 
the entire series of autopsies (1,618) there 
were 10 instances of acute pancreatitis 
(0.6% ). In four of these, calculi were found 
in the biliary tree. Chronic pancreatitis was 
seen in nine cases and in seven of these 
(77% ) there were stones in the gallbladder.
Causes of death in 301 patients with 
cholelithiasis are summarized in Table III. 
No attempt has been made to correlate the 
incidence of gallstones with any other di­
sease.
D iscussio n
There are wide variations in both the total 
incidence of gallstones reported and in their 
occurrence by age and sex. The ranges, in­
cluding our own, are shown in Table I.
TABLE II.—Liver Lesions in 301 Patients With 
Gallstones at the T ime of Death
Lesion No. of patients
Portal cirrhosis.............................. 15
Obstructive biliary cirrhosis........ 4
Post-necrotic cirrhosis.................. 3
Acute cholangitis........................... 2
Acute yellow atrophy of liver . . . 1
TABLE III.—Causes of D eath Found at
Autopsy in Patients With Gallstones
Cause No. of patients
Heart diseases................................ 85
Lung diseases................................. 61
Neoplastic diseases........................ 61
Miscellaneous diseases.................. 52
Gastrointestinal tract diseases.. 24
Metabolic diseases........................ 10
Liver diseases................................. 8
301
Lieber9 noted the difference in the incidence 
of gallstones in white and black races, and 
Newman and Northup10 between various 
countries and continents. Enderlin,11 in his 
series of 1,000 autopsies on patients with 
gallstones, stated that 8.6% died directly as 
a result of cholelithiasis. However, he in­
cluded 102 cases in which cholecystectomy 
had been previously performed. Also he may 
have included deaths due to carcinoma of 
the biliary tract and pancreatitis—entities 
that should have been excluded.
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TABLE IV.—Comparative M ortality D ue to Cholecystitis in  Autopsy and
Surgical Series*
Age
(years)
Female Male Total
Autopsy Surgical Autopsy Surgical Autopsy Surgical
10 — 19 0 — 17 0 0 — 33 0 0 — 50 0
20 — 29 0 — 12 0 — 7 0 — 42 0 0 — 54 0 — 7
30 — 39 0 — 28 0 — 12 0 — 58 0 0 — 86 0 — 12
40 — 49 0 — 34 0 — 7 0 134 1 — 4 0 — 168 1 — 11
50 — 59 0 — 54 0 — 6 0 — 180 0 10 0 — 234 0 — 16
60 — 69 0 — 56 1 — 5 1 — 214 0 — 3 1 — 270 1 — 8
70 — 79 0 — 74 0 — 3 1 — 192 0 — 1 1 — 266 0 — 4
80 — 89 0 — 28 0 — 1 1 — 63 0 1 — 91 0 — 1
90 - 99 0 — 1 0 0 — 4 0 0 — 5 0
Total 0 — 304 1 — 41 3 — 920 1 — 18 3 — 1,224 2 — 59
(2.4%) (0.3%) (5.5%) (0.2%) (3.3%)
*Reported elsewhere.
TABLE V.—Comparative M ortality D ue to Cholelithiasis in Autopsy and
Surgical Series*
Age
(years)
Female Male Total
Autopsy Surgery Autopsy Surgery Autopsy Surgery
10 — 19 0 - 1 0 — 21 0 — 0 0 — 1 0 — 1 0 — 22
20 — 29 0 — 2 0 — 155 0 — 0 0 — 6 0 — 2 0 — 161
30 — 39 0 — 2 0 — 151 0 — 3 0 — 28 0 — 5 0 — 179
40 — 49 0 — 11 0 — 159 0 — 9 0 — 47 0 — 20 0 — 206
50 — 59 0 — 15 1 — 135 0 — 15 1 — 42 0 — 30 2 — 177
60 — 69 0 - 38 1 — 123 0 — 45 1 — 42 0 — 83 2 — 165
70 — 79 0 — 44 2 — 56 0 — 65 1 — 23 0 — 109 3 — 79
80 — 89 1 — 22 1 — 10 2 — 27 1 — 2 3 — 49 2 — 12
90 — 99 0 — 2 0 — 0 0 — 0 0 — 0 0 — 2 0 — 0
Total 1 — 137 5 — 810 2 — 164 4 — 191 3 — 301 9 — 1,001
(0.7%) (0.6%) (1.2%) (2.0%) (0.9%) (0.8%)
’Reported elsewhere.
Death rates in this autopsy series and in 
our previously reported 1,001 operations 
on the biliary tract8 are compared in Tables 
IV and V. These show that the “natural” 
mortality is lower for cholecystitis in the 
autopsy series and virtually identical for 
cholelithiasis. The total mortality in the sur­
gical series (1%) was greater than in the 
autopsy material (0.4%). In the 70 years- 
and-older age group the death rates in both 
series are similar, but in the surgical series 
there were three deaths in the under-60 age 
group. It might be argued that the surgical 
mortality was weighed unrealistically by 
those who would have died without oper­
ation and presumably would have appeared 
in the autopsy series. However, analysis of 
the clinical, histological and autopsy find­
ings in these fatalities (Table VI) shows 
that only one patient (case 10) had acute 
cholecystitis and two (cases 4 and 11) had 
obstruction of the common bile duct. The 
remaining eight patients in the group were
in no evident danger of death before opera­
tion.
The work by Lund12 is often quoted to 
support radicalism such as “prophylactic” 
cholecystectomy. However, if his confusing 
figures and calculations are accepted at their 
face value, the only conclusions that can be 
drawn are that: (1) one-third or one-half of 
his patients developed severe symptoms of 
gallstone disease, (2) about 20% of the 
above underwent cholecystectomy during 
the follow-up period, (3) the total surgical 
mortality was 2.7%, and (4) patients over 
60 had a greater operative mortality.
In the Framingham study, Friedman, 
Kannel and Dawber13 concerned themselves 
with that portion (8.1% ) of the total popu­
lation under observation who had gallstones. 
Of these, 56.4% underwent operation dur­
ing a 10-year period of study.
In the series reported by Comfort, Gray 
and Wilson,14 18.7% of patients with 
known cholelithiasis experienced painful
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TABLE VI.—F ost-cholecystectomy D eaths
Symptoms Signs Pathology
Acute Chronic
Case Age Tender- Rebound cholecys- cholecys- Li-
no. (years) Pain Vcmiting ness Pain pain Rigidity Jaundice tectomy tecicmy thiasis
1 40 + — + —
2 53 + + + —
3 66 — + + —
4 77 + 4" 4 - _
5 77 N S N S N S N S
6 86 + — + —
7 56 + — + —
8 74 + + + —
9 80 — + + —
10 84 + + +
11 61 + — +
seizures within the prospective period of 10 
to 20 years. Fifty-four per cent experienced 
few, if any, symptoms. Newman and 
Northup10 in their autopsy series found that 
77% of those who had gallstones at the time 
of death had not experienced symptoms 
severe enough to warrant a visit to a doctor. 
Likewise, 75% of cases in Martensson’s 
series15 had no symptoms.
The purported indications for “prophy­
lactic” cholecystectomy such as the threat 
of carcinoma of the gallbladder16'18 and 
acute pancreatitis19- 20 are unacceptable in 
the light of present knowledge. The belief 
that gallstones as chronic irritants could be 
precancerous was understandable in 193116 
but is hardly credible now. The proposal that 
cholesterol might be a carcinogen because 
of its close relationship to methylcholan- 
threne is not supported experimentally.21 
The epidemiologic argument17 is based on 
the fact that the association of gallstones 
with primary carcinoma of the gallbladder 
is frequent22 while with secondary neo­
plasms it is rare.16 This interpretation, how­
ever, appears to be unreasonable. On the 
one hand primary carcinoma of the gall­
bladder originates in the mucosa where its 
exfoliated, neoplastic cells might well serve 
as nidi for calculi. On the other hand, 
secondary tumours develop intramurally and 
by the time they invade the mucosa, the in­
dividual usually has no time remaining in 
which to form the gallstones. It would appear 
more logical to propose that primary carci­
noma of the gallbladder is responsible for 
the formation of gallstones rather than the 
reverse.
Similar confusion exists regarding the
~ — — — + —
— — — — + +
■ — — — -L +
— — + — + +
N S N S N S — + +
— — — — + +
— — — — + +
— — — — + +
- — — — + +
+ + — +
— — + — + +
etiology and pathogenesis of acute pancrea­
titis. According to Peterson, Collins and Wil­
son,23 acute pancreatitis is associated with 
biliary tract disease in 39% (40% in our 
series) while in 61 % it is associated with al­
coholism, surgical operations, drugs, trauma, 
hyperparathyroidism or as yet unknown fac­
tors. According to McCutcheon,24 incom­
petence of the sphincter of Oddi and regur­
gitation of succus duodenalis may be more 
important than obstruction, and he believes 
that pancreatitis and cholecystitis may have 
the same pathogenesis, i.e. reflux of succus 
duodenalis. He quotes experimental and 
clinical evidence showing that acute pan­
creatitis occurs as a complication in dogs 
with a blind duodenal loop, in patients with 
Polya’s anastomosis complicated by obstruc­
tion of the afferent loop and in patients on 
whom the long-arm T-tube of Catell was 
used to drain the common bile duct. In all 
instances the duodenal juice had free access 
to the pancreatic duct system.
We note that acute pancreatitis occurs 
rarely after operative cholangiography, in 
spite of the frequent reflux of bile-contrast 
medium mixture into the pancreatic ducts. 
Obstruction of the pancreatic ducts as a 
cause of pancreatitis cannot be considered 
seriously since the deliberate ligation of ducts 
merely produces atrophy of the pancreatic 
acinar tissue. Furthermore, pancreatitis is 
not a usual finding in cases of obstructive 
pancreatic tumours.
In our autopsy series the mortality due 
to adenocarcinoma of the gallbladder was 
0.3% and that due to acute pancreatitis 
0.6% (a total of 0.9% ), a figure similar 
to that for our surgical mortality.
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The threat of possible obstruction of the 
common bile duct is real enough. It should 
be pointed out, however, that cholecystec­
tomy as performed now cannot remove 
this threat in all individuals. In our autopsy 
material there were three (3%) instances 
where gallstones had either formed de novo 
or had not been removed by operation. In 
our surgical series nine (0.9%) patients were 
discharged following operation with gall­
stones in the common bile duct. The inci­
dence of residual gallstones in the series of 
Schofield and Macleod25 was 1.4%.
Failure of cholecystectomy to afford relief 
is well documented,7- 25-33 in 4% 25 to 
56% 32 of cases depending on the authors’ 
criteria. Twenty per cent of Schofield and 
Macleod’s patients experienced symptoms 
after cholecystectomy identical to those 
complained of before operation. Of Domellof 
and Schersten’s patients 8.5% actually be­
came worse.28 According to Goldsmith34 
dyspepsia is almost an incurable symptom; 
only 23 of his 114 patients were free from 
it after operation. Dyspeptic symptoms such 
as fatty food intolerance, flatulence, eructa­
tion, heartburn and nausea do not necessarily 
indicate gallbladder disease and the effect 
on symptoms of cholecystectomy in individ­
ual patients is not at all predictable. Not 
only will the results of operation sometimes 
be unsatisfactory from the symptomatic 
point of view, other complications may de­
velop. In our surgical series 21 (2%) re­
turned for repair of a ventral hernia.
There is no evidence that cholelithiasis 
always gets worse35 or that all calculous 
gallbladders must be removed upon dis­
covery.4- 36’ 37 In some patients gallstones 
disappear spontaneously.38 Many other di­
seases produce symptoms suggestive of 
cholelithiasis. These include gastritis, peptic 
ulcer, hiatus hernia, diverticulitis, arthritis 
of the spine, and cardiac ischemia. Undue 
reliance upon cholecystography for diagnosis 
of any kind of abdominal pain may be the 
cause of the “in spite-of cholecystectomy 
syndrome”.39
In the province of Ontario, the total an­
nual mortality due to cholecystitis and chole­
lithiasis varied only slightly in the years be­
tween 1960 and 1970 although the num­
ber of cholecystectomies performed here and 
presumably elsewhere increased fourfold
during the same period. It appears that the 
deaths which would have occurred “natural­
ly” may have been prevented, but only 
at the expense of an operative toll which 
maintained the overall death rate at a steady 
level. In the Framingham study, the age- 
specific death rates failed to reveal excess 
mortality in those with biliary tract disease 
as compared to the general population. The 
shift to “prophylactic” cholecystectomy in 
patients with mild symptoms in our series 
has resulted only in an otherwise avoidable 
mortality in the under-60 age group.
There is no doubt that cholecystectomy is 
a useful operation, but in order to lower 
the death rates we should improve our 
clinical skills rather than engage in meaning­
less prophylaxis.
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PEER REVIEW OF ACUTE CHOLECYSTITIS*
J. E. DEVITT, M.D., C.M., M.Sc., F.R.C.S.[Edin. & C] and M. 0. IYPE, M.B., B.S.,
Ottawa, Ont.
Summary: From a peer review of 447 patients 
with acute cholecystitis were calculated the 
individual surgeon's performance and his pa­
tients' outcome as measured by complication 
rate and length of stay. Wide variations occur­
red in the parameters subjected to inquiry, 
which included mean preoperative and post­
operative stay, complication rate and use of 
cholecystography, operative cholangiography^ 
biochemistry and antibiotics. Delay in operation 
beyond the third day after admission and in­
creased number of requests for blood biochem­
istry tests did not result in shorter postopera­
tive stays or lower complication rates. It is 
concluded that earlier operation and discharge 
and less utilization of some diagnostic services 
and antibiotics are indicated.
Resume: Apres avoir passe en revue 447 cas de 
cholecystite aigue, nous avons evalue le travail 
personnel du chirurgien et Tissue de ('interven­
tion pour le patient, en nous basant sur la fre­
quence des complications et sur la duree de 
I'hospitalisation. Les parametres qui ont joue un 
role dans I'enquete etaient nombreux et tres va­
riables. Y  figuraient la duree moyenne de I'hos- 
pitalisation pre- et post-operatoire, la frequence 
des complications et le recours a la cholecysto- 
graphie, a la cholangiographie peroperatoire, aux 
epreuves biochimiques et aux antibiotiques. 
Retarder Toperation plus de trois jours apres 
Tentree du patient a Thdpital et recourir a de 
nombreuses requisitions pour des epreuves du 
chimisme sanguin sont des decisions qui ne 
sont traduites ni par un racourcissement du se- 
jour a Thdpital apres Toperation, ni par une 
moindre frequence des complications. Nous 
croyons pouvoir conclure qu'il serait indique 
d'operer prdcocement de donner conge au pa­
tient sans delai indu et de faire appel moins 
souvent a certaines epreuves diagnostiques et 
aux antibiotiques.
Acute cholecystitis is probably the most 
common surgical abdominal emergency 
suffered by adult Canadians. Alteration in 
the management of acute cholecystitis 
should have a significant impact, not only
‘ From the Department of Surgery, Ottawa 
Civic Hospital, and the Office of Continuing 
Medical Education, Ottawa, Ont.
Reprint requests to: Dr. J. E. Devitt, Director, 
Continuing Medical Education, University of 
Ottawa, Ottawa Civic Hospital, 1053 Carling 
Avenue, Ottawa, Ont. K1Y 4E9.
benefiting the patients suffering from it but 
on the utilization of health resources re­
quired to deal with it. Consequently a peer 
review was conducted at the Ottawa Civic 
Hospital in which parameters of care were 
calculated for each individual surgeon. It 
was hoped that if each surgeon was aware 
of where he ranked among his peers in 
each of the available parameters of care, 
he might become motivated to emulate the 
practice of those of his colleagues with the 
better performances. It was also hoped that 
such a study would identify ways of im­
proving the management of acute cholecys­
titis.
Material and Method
The authors reviewed the complete chart 
of every patient in whom a histological 
diagnosis of acute cholecystitis following 
cholecystectomy was made in the years 
1968 to 1970 inclusive. A histological diag­
nosis was insisted on to eliminate the dis­
tortion of individuals’ profiles that would 
have resulted from accepting some surgeons’ 
generous criteria for the recognition of acute 
cholecystitis at operation. In this way any 
error on the part of the pathologist would 
have been evenly distributed among all 
surgeons. Also, to ensure that all complica­
tions were recognized, the authors reviewed 
all temperature, order, and intake and out­
put sheets, and the nurses’ notes as well as 
the surgeon’s and consultant’s notes.
Observations
A total of 447 patients met the criteria. 
Thirty-one surgeons performed these oper­
ations. Individual parameters were calcu­
lated only for the 21 surgeons who per­
formed at least seven cholecystectomies 
during the study period.
There was a remarkable spread am ong 
the 21 surgeons in the time that elapsed 
between admission and the day of operation 
(Table I). One surgeon operated on 44% 
of his patients on the day of admission and 
five others operated on 20% to 25% im­
mediately. On the other hand, eight surgeons 
never operated on the day of admission.
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TABLE I.—M ean Preoperative Stay (Days) for 
E ach Surgeon’s Patients and Frequency of 
Cholecystography*
1.6 (25) 3.8 (63) 4.7 (28)
2.6 (33) 3.8 (50) 4.8 (72)
2.8 (30) 3.9 (43) 4.9 (40)
2.9 (34) 4.1 (47) 4.9 (82)
3.1 (26) 4.6 (15) 4.6 (73)
3.2 (60) 4.7 (35) 5.7 (59)
3.8 (57) 4.7 (46) 7.4 (86)
•Number in brackets is the percentage of the sur­
geon’s patients having cholecystography.
In general, surgeons of patients with the 
longer preoperative stays were most likely 
to have ordered cholecystography (Table 
I). Indeed, 76% of patients whose opera­
tions were postponed until the fourth hos­
pital day or later had had cholecystography 
of some kind.
In Fig. 1 the surgeons have been ar-
increasing delay 
in operation
Fig. 1.—The effect of delaying operation.
ranged in rank order, from left to right, 
of mean duration of preoperative stay. The 
complication rate and the mean postopera­
tive stay (both indices of morbidity) did not 
seem to be worse among the patients of 
the surgeons who operated early; nor was 
the complication rate higher or the mean 
length of postoperative stay materially 
longer in the patients operated on early 
(Table II), although the mean leukocyte 
count and the proportion with gangrene 
were somewhat higher suggesting that in 
the patients operated on early the processes 
were more severe. Patients operated on at 
the eighth day or later may have had a 
higher complication rate, but this was prob­
ably because there was in this group a 
disproportionate number of complicated and 
unusual problems which militated against 
early operation and which were likely to be 
associated with postoperative complications. 
(Unfortunately there is no way of grading 
the severity of the disease or the associated 
conditions, but common experience sug­
gests that patients with severe disease or 
serious associated conditions are more like­
ly to be operated on either very early or 
very late.)
Ten patients only were subjected to 
cholecystostomy, five by one surgeon, while 
five other surgeons each performed this 
operation once. Obviously most of the 
surgeons found little place for cholecystos­
tomy. Other procedures performed at the 
time of cholecystectomy were: appendec­
tomy 81, choledochotomy 67, hiatus her­
niorrhaphy three, pyloroplasty two, lysis 
of adhesions two, and vagotomy and gastro­
jejunostomy, vagotomy and pyloroplasty, 
revision of gastrojejunostomy, excision of 
jejunal diverticulum, umbilical hernior-
TABLE’II.—Day of Operation and Morbidity
Days in hos­
pital before 
operation
No. of 
patients
Mean 
leukocyte 
count 
(cmm)
% with 
gangrene
% with 
postoperative 
complications
Mean post­
operative slay 
(days)
1 49 14,200 22 27 13 22 90 13,300 16 31 11 63 60 12,600 15 23 10 94 55 11,500 7 27 11 15 48 12,800 12 35 11 96 35 11,200 11 20 10 07 23 10,600 4 26 12 88 or more 87 12,200 7 36 15.5
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TABLE III.—M ean P ostoperative Days’ Stay TABLE V.—Blood B iochemistry T ests per 
for E ach Surgeon’s P atients P atient for E ach Surgeon
8.1 11.4 13.2
8.6 11.6 13.3
9.2 11.6 14.8
10.6 11.7 15.5
10.8 12.4 15.8
10.8 12.5 17.5
11.1 12.7 18.2
rh a p h y , b io p sy  o f  liv e r a n d b re a s t b io p sy
one each.
There was a remarkable spread in the 
mean number of postoperative days’ stay of 
the patients of the 21 surgeons (Table III). 
Two surgeons had discharged 70% of their 
patients by the eighth postoperative day, 
and two others 60%, while three surgeons 
did not discharge any patients in less than 
eight days.
Among 21 surgeons there was an un­
accountably wide range in the percentage 
of patients who were given preoperative 
(0 to 73%) and immediate postoperative 
(10% to 100%) antibiotics. The surgeons 
who were high preoperative or immediately 
postoperative users of antibiotics did not 
have lower complication rates or shorter 
mean postoperative stays.
There was also an unexplained wide 
variation in the use of operative cholan­
giography (Table IV).
TABLE IV.—Percentage of Patients Having 
Operative Cholangiography for E ach Surgeon
0 17 53
0 20 56
9 21 59
10 31 60
13 36 65
14 40 69
14 44 78
The incidence of common bile duct 
stones in this series was 7.5% which is 
comparable with the figures in other recent 
reports.1
There was also considerable variation 
in the number of estimations of blood bio­
chemistry per patient (Table V). In general 
those surgeons having frequent and regular 
contact with the intern and resident staff 
requested higher numbers of biochemical 
tests per patient. There was no evidence 
that the increased number of these tests 
was associated with lower complication rates
1.4 2.6 4.4
1.4 3.1 4.5
1.6 3.2 4.8
1.7 3.6 4.9
2.0 3.8 5.2
2.0 4.0 5.3
2.1 4.3 5.8
or shorter postoperative stays (i.e. lower 
morbidity) (Fig. 2).
There were six deaths. The age, post­
operative day of death, and cause of death 
for each patient were as follows: 80, first 
day, cerebrovascular accident; 75, second 
day, myocardial infarct; 65, eleventh day, 
aspiration and upper gastrointestinal hem­
orrhage; 87, twenty-eighth day, peritonitis; 
73, thirtieth day, metastatic carcinoma; 78, 
forty-third day, pneumonia. The first four 
of these patients were operated upon with­
in 48 hours of admission, three of them be­
cause of particularly severe disease. There 
was no evident reason to attribute death to 
the early operation. No surgeon had more 
than one death in the period reviewed.
D iscussion
This study has shown a wide variation 
in the behaviour of surgeons dealing with 
the same disease within a single institution. 
It identifies for each surgeon areas where 
improved performance is possible.
Fig. 2.—The effect on morbidity of increasing 
the number of blood chemistry tests.
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Since half the surgeons operated within 
four days of the patient’s admission it would 
seem that all could achieve this. Earlier op­
eration could be accomplished partly by less 
frequent or earlier ordering of cholecysto­
graphy. Postoperative morbidity is not af­
fected by early operation, so there is no 
need to incarcerate the patient in hospital 
unnecessarily and to deny the bed to 
others if delayed operation confers no 
benefit. On the other hand emergency oper­
ation on the day of admission puts an un­
desirable strain on the operating room staff 
and facilities which may exceed the benefit 
of the saved bed-days.
It is also clear that postoperative stay 
could be drastically shortened. After un­
complicated cholecystectomy patients can 
be discharged by the eighth day, as was 
the usual practice of four of the surgeons.
The use of antibiotics, either preoperative- 
ly or postoperatively could be reduced with 
a saving not only of patient discomfort but 
nursing, pharmacy and clerical time as well 
as the cost of the agents.
One-half of the surgeons did operative 
cholangiograms in less than one-third of 
their patients. Need it be done in a greater 
proportion when common duct stones were 
found in only 7.5% of the patients? The 
less the x-ray technician and her machine 
are used in the operating room, the more 
available she is elsewhere. The only known 
readmission for common bile duct stones 
was in a patient who had a choledocholitho- 
tomy, so that to date there have been no 
patients with stones missed because of con­
servatism in the use of operative cholangio­
graphy.
The remarkable variation in the number 
of blood biochemistry tests ordered is also 
unacceptable. No doubt some of the over­
ordering was by residents trying to impress 
their staffmen and vice versa, but the auto­
matic ordering of such tests, whether pre- 
operatively or postoperatively, cannot be 
condoned when there is no clinical reason 
to suspect an abnormality requiring treat­
ment. In this study the more frequent per­
formance of blood biochemistry tests did not 
produce better patient care as measured 
by postoperative complication rates or mean 
postoperative stay. However, the tests did 
consume much technical, clerical and nurs­
ing time (i.e. health dollars).
Unfortunately few of us really know 
what our individual parameters or per­
formance are. Studies such as this can be 
most revealing to oneself as was this one 
to the authors.
Conclusions
A peer review of 447 patients with acute 
cholecystitis has calculated the individual 
performance of the surgeons involved. Pa­
tients could have been safely operated upon 
earlier than they were, in general by the 
third day after admission. Some time could 
be saved by not performing so many chole- 
cystograms. Patients could be discharged 
sooner, by the eighth postoperative day in 
uncomplicated cases. Antibiotics, operative 
cholangiography and automated blood 
chemistry tests are overutilized.
Reference
1. Schein CJ: Acute Cholecystitis, Evanston,
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EPIDERMOID CYST OF BONE
ANTONI TRIAS, F.R.C.S.fC]* and GILLES BEAUREGARD, M.D.,
Sherbrooke, Que.
Summary: A case of epidermoid cyst of bone is 
reported and the preoperative features leading 
to a diagnosis are emphasized in order that un­
necessary amputations may be avoided.
Resume: Un cas de kyste epidermoide de I'os 
est rapporte avec discussion sur le diagnostique 
pre-operatoire afin d'eviter des amputations 
inutiles.
E p id e r m o id  cyst of bone is an uncommon 
lesion. About 95 cases have been described 
in the literature1' 2 most of them located in 
the terminal phalanges of the fingers; three 
cysts have been reported in the toes.2"4 A 
presumptive preoperative diagnosis is im­
portant to save the patient from unneces­
sarily extensive excision. Finger amputations 
have been carried out for this benign le­
sion2' 5"9 when curettage is curative.
C ase  R e p o r t
A 73-year-old man, under surveillance 
since 1970 for an adenocarcinoma of the 
prostate, presented with a progressive 
swelling of the distal part of the right 
thumb of three months’ duration. This was 
accompanied by pain and redness, assumed 
to be the result of penetration of a foreign 
body beneath the nail. Three weeks after 
the onset, the symptoms failed to subside 
in spite of subungual curettage and he was 
then referred to us at the University Hos­
pital, Sherbrooke. On physical examination 
the extremity of the right thumb was en­
larged, red and tender. An area of dark pig­
mentation was present near the nail.
Radiographs showed a round, well-cir­
cumscribed, osteolytic lesion (Fig. 1). Ede­
ma was noted in the soft tissues without 
periosteal reaction. The presumptive diag­
nosis was epidermoid cyst of bone but a 
malignant lesion could not be ruled out; 
because of the dark pigmentation a diag­
nosis of melanoma was possible and also 
metastatic disease had to be considered 
because of the patient’s previous history.
Biopsy was performed, including the area 
of pigmentation and part of the nail. The 
cystic lesion, easily peeled from the bone, 
consisted of a capsule containing caseous
*Professor and Chairman, Department of Ortho­
pedics, Centre Hospitalier Universitaire, Univer­
sity of Sherbrooke, Sherbrooke, Que.
Fig. 1.—Radiograph of the right thumb.
material. The bed of the lesion was sclerotic 
and this was curetted. The histopathology 
was that of a typical epidermoid cyst.
D isc u ssio n
Epidermoid cysts of bone occur almost 
solely in the terminal phalanges.1 They are 
twice as common in men as in women.10 Al­
though a case of an 8-year-old child11 and 
one of an 83-year-old man12 are reported, 
these cysts usually appear between the ages 
of 25 and 50. A definite history of trauma 
to the affected finger can often be elicited. 
The digits most affected are the thumb and 
the left middle finger.1
Clinically the lesion is characterized by 
swelling of the distal part of the finger, 
hyperemia of the overlying skin and inflam­
mation of the soft tissues. The pain is often 
constant but is sometimes intermittent.
Radiologically, a round, well-circum­
scribed osteolytic lesion without trabecular 
pattern is seen. Often a border of sclerosis
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Rig- 2.—Cross-section of an epidermoid cyst
surrounds the lesion. The cortex is some­
times expanded and thin and a pathologic 
fracture may be noted. Soft tissue edema is 
observed but periosteal reaction is never 
seen.
This unilocular cyst can measure up to 
2 cm in diameter and is surrounded by a 
limiting membrane composed of squamous 
malpighian epithelium with its usual three 
layers (Figs. 2 and 3). The cyst contains 
caseum-like material. Peripherally a granu­
lomatous reaction with a lymphoplasmocytic 
infiltrate often surrounds the lesion.
Of the bone tumours of the hand, enchon- 
droma is certainly the most frequent. The 
radiological picture is comparable to that 
of epidermoid cyst except for the presence
Fig. 3.—Wall of an epidermoid cyst (x 91).
of faint calcifications. In the absence of 
these calcifications it is impossible to dif­
ferentiate these two lesions. It is in this situa­
tion that the location of the tumour helps 
in the diagnosis. Enchondroma is most fre­
quent in the metacarpals and proximal 
phalanges, while epidermoid cysts are almost 
exclusively located in the distal phalanges. 
Therefore an expansive, well-circumscribed, 
osteolytic lesion is likely to be an enchon­
droma unless it is located in a distal pha­
lanx; in this case an epidermoid cyst should 
be the preferred diagnosis.
Epidermoid cyst is a benign lesion and 
simple excision of the cyst with curettage of 
the bony walls is curative. When the lesion 
is large the cavity can be filled with a bone 
graft. There are, in the literature, too many 
reported cases where the diagnosis was made 
only after amputation of such an essential 
digit as the thumb. It is therefore imperative 
to consider a presumptive diagnosis of an 
epidermoid cyst preoperatively.
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EPITHELIOID SARCOMA
THOMAS A. SEEMAYER, M.D., F.R.C.P.[C],‘ PAUL G. DIONNE, M.D.f and 
EDWARD J. TABAH, M.D. F.R.C.S.[C] ,% Montreal, Que.
Summary: Two cases of epithelioid sarcoma are 
presented and the world literature is reviewed 
and summarized. The authors conclude that 
epithelioid sarcoma is a deceptive soft tissue 
neoplasm, often misinterpreted and underesti­
mated by clinicians and pathologists alike. Early 
recognition combined with wide excision offer 
the greatest chance for survival.
Resume: Les auteurs presentent deux cas de 
sarcome epitheloide et, a cette occasion, pas- 
sent en revue et resument la litterature mondiale 
sur le sujet. Ils concluent que le sarcome epithe­
loide est un neoplasme decevant des tissus 
mous, trop souvent mal interprets et sous-esti- 
me par les cliniciens et aussi par les patholo- 
gistes. Ms estiment qu'un diagnostic precoce et 
une large excision chirurgicale offrent au patient 
les meilleures chances de survie.
T he purpose of this presentation is to ac­
quaint the clinical surgeon with a recently 
described entity, likely to be confused both 
clinically and pathologically with an in­
flammatory or benign neoplastic process, 
yet possessing a fully malignant capability 
from its inception. The longer it takes to 
appreciate the seriousness of the lesion, the 
smaller than chance that definitive surgery 
may effect cure. Through the discussion of 
these cases, with emphasis on their clas­
sical clinical presentation and development, 
and a review of the literature, it is hoped 
that the entity will be so characterized that 
other cases may be recognized early in their 
evolution.
Case R eports
Case 1.—A 49-year-old man first presented 
at another hospital in 1963 complaining of a 
palpable mass in the left politeal fossa. On
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•[Resident, Department of Pathology, Royal 
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examination a dermal and subcutaneous mass 
measuring 4 x 2 cm was found and subse­
quently removed. Histologically it was inter­
preted as representing “benign lymphocytoma 
cutis”, a variant of Speigler-Fendt sarcoid. Six 
months later the mass recurred and a second 
excisional biopsy was performed. The speci­
men consisted of three well-delineated nodules 
situated in the dermis and subcutis, ranging 
in size from 1 cm to 3 cm in dimension. The 
histological interpretation, again, was lym­
phocytoma cutis. Subsequently, the patient 
received a course of radiotherapy. Six months 
later he again noticed recurrence of the lesion.
He was admitted to the Royal Victoria 
Hospital, Montreal, for the first^time in 
February 1968 when a multinodular, firm, 
non-mobile mass was palpable in the lower 
posterior third of the left thigh extending 
inferiorly to just above the popliteal fossa. The 
mass measured 12 x 10 cm and was deeply 
situated, involving the fascia and underlying 
muscles. Preoperative investigation revealed a 
normal skeletal survey, chest radiograph, 
lymphangiogram, hemogram and routine bio­
chemical findings. A wide local excision with 
skin graft was performed. Histological exami­
nation identified a low-grade sarcoma, un- 
classifiable but probably an unusual variant 
of fibrosarcoma.
In May 1971 the patient again returned to 
the Hospital complaining of painful recurrence 
of the popliteal fossa mass and weight loss. 
The mass measured 10 cm in greatest dimension 
and was multinodular, firm, non-mobile and 
deeply situated. After clinical investigation 
failed to reveal metastases, a left hip disarticu­
lation was performed. Once more the diagnosis 
was an unclassifiable sarcoma, deeply involving 
the subcutis, fascia and contiguous muscle. 
Iliac lymph nodes were free of tumour. The 
tumour tissue was sent to a consultant whose 
diagnosis was “probable angiosarcoma”.
In December 1972 the patient returned 
complaining of shortness of breath and hemop­
tysis. Chest radiograph revealed a 2-cm tumour 
mass in the right upper pulmonary lobe. Al­
though bronchosqopy and mediastinoscopy 
were negative, cytological samples obtained 
at the time of bronchoscopy were positive for 
malignant cells. A right upper lobectomy 
was performed and metastatic sarcoma was 
found in the lung and in one contiguous hilar 
lymph node. Shortly after this operation signs 
of spinal cord compression developed and a
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lytic lesion was discovered in the dorsal spine. 
Bone scan detected probable metastases in the 
left pelvic region, right occipital region and 
lumbosacral spine. The patient underwent an 
emergency laminectomy of the upper thoracic 
spine and multiple fragments of firm, fibrous, 
extradural tumour were removed. The tumour 
was histologically comparable to all previously 
removed material. Radiation therapy was given 
to the vertebral column. The patient died 
seven months later. No autopsy was per­
formed.
Case 2 .—A 12-year-old boy presented in 
1971 with a painless soft tissue mass in the 
proximal part of the left forearm. This was 
associated with weakness in strength of the left 
thumb. The mass measured approximately 3 
cm in diameter and was deep to the sub­
cutaneous tissue. A biopsy was taken and a 
diagnosis of nodular fibromatosis was made.
He was seen at the Royal Victoria Hospital, 
Montreal, several months later with recur­
rence of the tumour. A biopsy was again in­
terpreted as fibromatosis. Over the next year 
there was a further recurrence and the diag­
nosis was not changed. Several months later 
the tumour again recurred and on this 
occasion produced ulceration of the overlying 
skin.
At this time the case was reviewed in its 
entirety and the diagnosis was amended to 
epithelioid sarcoma. This reinterpretation was 
confirmed at the Armed Forces Institute of 
Pathology, Soft Tissue Branch, in Washing­
ton. At the time of writing the child is alive 
but has recurrent tumour.
D iscussion
Epithelioid sarcoma was defined in 1970 
by Enzinger1 in a publication detailing 62 
cases accumulated from the files of the 
Armed Forces Institute of Pathology over 
a 25-year interval. The ability to simulate 
multiple benign and malignant entities was 
clearly demonstrated in the wide spectrum 
of designations recorded. Of the various 
benign classifications assigned, granuloma­
tous inflammation, nodular tenosynovitis, 
nodular fasciitis and chronic non-specific in­
flammation were most frequent. The most 
common malignant diagnoses included 
synovial sarcoma, fibrosarcoma, malignant 
melanoma, squamous cell carcinoma and 
angiosarcoma. Repeatedly the tumour was 
misinterpreted and its biological potential 
underestimated. In many instances, when
finally recognized as malignant, definitive 
curative surgery was precluded by general­
ized metastases.
Since the original description, others have 
been added in smaller series.2'10 In review­
ing the literature prior to Enzinger’s report 
other probable examples were discovered, 
n ,  12 o f  particular note is a Polish article 
written in 1961 and translated in 1971,13 
describing seven cases of an entity entitled 
“aponeurotic sarcoma” which appears to be 
identical with epithelioid sarcoma. There are 
now 104 acceptable reported cases (76 men 
and 28 women), which provide additional 
clinical and pathological documentation 
further supporting and amplifying the origi­
nal observations.
Epithelioid sarcoma is a neoplasm fea­
turing certain repetitive qualities. Generally 
it is a tumour of young adult males (in the 
104 cases the average age was 36 years with 
a range of 2.5 to 75), first noted in an 
extremity and most frequently on the volar 
surfaces of the fingers and palms and the 
extensor surface of the forearm (67 cases) 
and in the anterior tibial region (33 cases). 
Of these 104 cases only four have arisen 
in a site other than an extremity. The 
tumours may be situated either superficially 
or deeply, the former presenting usually in 
the dermis or subcutaneous tissue and, if 
present for some time, may result in super­
ficial epidermal ulceration. The deeper 
lesions are more likely to be fixed to super­
ficial fascia or tendons, are usually poorly 
defined, and insidiously infiltrate muscle, 
tendons, fascia and even bone.
Symptoms are usually limited to those 
of a palpable, slowly enlarging, painless 
mass, although occasionally the deeper 
lesions may produce mild pain. Through 
pressure on nerve trunks, rare sensory 
changes may be produced. The size of the 
mass is variable, ranging from 0.2 cm to 
5 cm at initial presentation. Radiographs 
of the mass reveal a soft tissue density. 
Rarely, particles of calcification may be 
identified within the mass and even cortical 
thickening may be present in contiguous 
bone.
Operation reveals a multinodular dermal 
or subcutaneous mass of firm consistence in 
most cases. The tumour is grey-white to 
grey-tan, and commonly has yellow or
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brown mottling on its surface. Histologically, 
the multinodular pattern is striking and 
frequently accentuated by central areas of 
necrosis. Tumour cells have a spindle as 
well as an epithelioid configuration, the lat­
ter featuring abundant eosinophilic cyto­
plasm. Irregular clefts or spaces are com­
monly formed, the result of poor cellular 
cohesion and probable fixation artefact. This 
may be so striking that it may simulate 
a vascular neoplasm. Cellular pleomorphism 
is variable although there is usually suffi­
cient variation in nuclear size, shape and 
chromatin pattern to arouse suspicion. 
Mitoses are usually readily found. A peculiar 
feature in many cases is the striking and 
often florid inflammatory reaction admixed 
with the tumour. In some areas it may be so 
intense as to mask and obliterate the un­
derlying neoplasm. Curiously, extracellular 
mucin, sensitive to hyaluronidase diges­
tion, may be found about but never within 
the tumour cells. In some areas the tumour 
is strikingly desmoplastic and therefore 
hypocellular, while in other regions it may 
be highly cellular. In general, metastases 
tend to be more cellular and show more 
necrosis than the primary tumour.
Electron microscopy of several tumours 
suggests either a synovial5' 14 or a fibrocytic 
origin.15 Ultrastructurally the tumour of 
our Case 1 would appear to have a synovial 
origin. Further study of the neoplasm will 
be necessary before its origin can be defi­
nitely delineated.
Behaviour of the tumour has been ade­
quately documented in 92 patients. The 
recurrence rate was 81%. Many of the 
recurrences were noted within six months 
of the original operation. It was not un­
common for patients to have multiple recur­
rences, in fact this was a rather constant 
feature. Ultimately the tumour demonstrated 
its true malignant potential by the appear­
ance of metastases in 35% of cases, usually 
within five years of diagnosis (Table I).
TABLE I.—Behaviour of T umour in 92 P atients 
W ith Available F ollow-up
Average duration of
follow-up Over 4 yrs (6 mos to 15 yrs)
Recurrences* 75 patients (81%)
Metastasis 31 patients (35%)
*Many recurrences after 6 mos of initial operation.
TABLE II .— C linical Condition of 92 P atients 
at E nd of Follow-Up  P eriod
Alive and well....................................
Alive with recurrence.......................
Alive with recurrence and/or
metastasis...........................................
Died from disease..............................
Died from intercurrent disease.......
44 (48%) 
14 (16%)
10 (11%) 
23 (24%) 
1 ( 1%)
TABLE III. R esults of Surgical P rocedure i n  
85 P atients in  W hom D ata are Available*
Patients Excision Amputation
Alive with or
without re- . „ „ ,
currence 56 (65%) 36 (64%) 20 (36%)
Alive with me­
tastasis or
died of _
disease 29 (35%) 15 (51%) 14 (49%)
* Average duration of follow-up was over 4 yrs; range 
6 mos to 15 yrs.
Metastases usually were manifest in lung, 
bone, pleura and, rarely, regional lymph 
nodes. Follow-up of these patients is sum­
marized in Table II.
The effects of various modes of therapy 
are not easily evaluated (Table III). While 
it might appear that the group alive with 
metastases or those dead of disease had 
more radical surgery only to experience 
poorer results, it is apparent that many of 
these patients had had multiple local recur­
rences and eventually developed uncontrol­
lable local disease necessitating amputation, 
frequently after the opportunity to effect 
cure had been lost.
The two cases presented typify the entity 
both clinically and pathologically and high­
light likely sources of misinterpretation in 
evaluating fully the potential of this tumour. 
The tumours presented as a painless soft 
tissue mass in the extremity of an adult 
male and child. Following biopsy, which 
was interpreted as benign, the tumours 
recurred only to be re-biopsied and again 
similarly interpreted. They slowly but in­
exorably recurred and several years later 
were finally interpreted as malignant. How­
ever, in Case 1 the malignant potential was 
still underestimated and fully three years 
elapsed before radical extirpation was per­
formed, only to be proved of little value, 
since shortly thereafter pulmonary and os­
seous metastases appeared.
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Fig. 1.—Case 1. Original biopsy showing dif­
fuse lymphoid infiltration masking the un­
derlying tumour (H & E x 250).
In reviewing the initial surgical material, 
it is readily appreciated why the first case 
was interpreted as an inflammatory-like 
lesion. Clusters of mature lymphocytes 
mixed with scattered histiocytes surround 
dermal vessels and appendages and blend 
together in a nodular pattern reminiscent 
of “sarcoid of Speigler-Fendt” (Fig. 1). 
However, admixed with these inflammatory 
cells are small numbers of pleomorphic 
spindle-shaped cells having cytological 
similarity to those which subsequently pre­
dominated in later biopsies. With successive 
biopsy review, these spindle-shaped cells 
become more dominant and striking. By 
1968 the lesion was an incontrovertible 
sarcoma. Yet the slow rate of growth, cou­
pled with minimal signs of local aggressive­
ness and probable reluctance on the part of 
the patient to accept radical surgery, con­
tributed to delay the amputation. By the 
time ablative surgery was performed, fully 
eight years had elapsed since the initial 
presentation (Figs. 2 and 3). Little more 
than a year later, generalized metastases 
were present (Fig. 4).
In reviewing the early surgical material
Fig. 2.—Case 1. Amputation specimen. The 
tumour is composed of plump spindle cells mixed 
with polygonal epithelioid cells. Note the small 
cell infiltration throughout the tumour (H & E 
x 250).
Fig. 3.—Case 1. Amputation specimen. The 
spindle cells (bottom) blend with the epithelioid 
cells (top). Note the scattered lymphoid-cell infil­
trate (H & E x 250).
*
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Fig. 4.—Case 1. Lung metastasis. The lung 
parenchyma (bottom) is invaded by spindle and 
polygonal cells. Note the prominent desmoplastic 
reaction to the tumour (H & E x 100).
Fig. 5.—Case 2. Original biopsy showing a 
nodular pattern of densely collagenized tissue. 
Note the central necrosis (H & E x 100).
of Case 2, the underestimation of the 
malignant potential of the tumour is easily 
appreciated. The tumour was composed of 
masses of hypocellular, densely collagenized 
nodules grouped together to form a multi­
nodular mass (Fig. 5). Individual nuclei 
appeared quite benign, and only on sub­
sequent biopsies did the cytological features 
become altered to produce a recognizable 
sarcoma. In retrospect, the only clue which, 
perhaps, indicated the true nature of the 
tumour was the presence of rare foci of 
necrosis within the nodules.
Clearly this is an entity deserving ack­
nowledgment and full respect from clini­
cians and pathologists alike. Slowly grow­
ing, recurrent, cutaneous, soft tissue masses 
presenting in extremities of young adults, 
characterized by a desmoplastic or inflam­
matory-like reactive tissue process deserve 
more than cursory analysis. Only clinical 
awareness of the entity and of the limita­
tions of microscopy, coupled with a mean­
ingful dialogue between clinicians and 
pathologists, will permit earlier recogni­
tion of this potentially curable, yet also 
potentially lethal tumour. The treatment of 
choice would appear to be the least radical 
operation necessary to remove the tumour 
completely. Chemotherapy and radiothera­
py, while possibly of palliative value, have 
not proved to be a substitute for proper 
surgical management.
We wish to thank Mrs. N. Vasudevan for 
secretarial assistance and Mr. H. Coletta for the 
photographs. The case material of both patients 
was reviewed and the diagnosis of epithelioid 
sarcoma was confirmed a t  the Soft Tissue 
Branch of the Armed Forces Institute of Patho­
logy, Washington, D.C.
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INTRATHORACIC VOLVULUS OF THE STOMACH: A LATE 
COMPLICATION OF DIAPHRAGMATIC COUNTERINCISION
N. PERERA, F.R.C.S.tEng. & C] and R. B. LYNN, M.D., F.R.C.S. (Eng. & Edin.),*
Kingston, Ont.
Summary: A 46-year-old man developed gan­
grene of the stomach secondary to volvulus after 
herniation through a dehisced counterincision of 
the diaphragm. This complication can be avoided 
by careful repair of the diaphragmatic incision.
Resume: II s'agit ici d'un homme de 46 ans qui 
avait presente une gangrene gastrique secon- 
daire a un volvulus provoque par une hernie au 
niveau d'une contre-incision rupturee du dia- 
phragme. II est certainement possible d'eviter 
cette complication en reparant soigneusement 
I'incision diaphragmatique.
The “Allison” technique for transthoraci' 
repair of a sliding hiatus hernia requires that 
a counterincision be made in the diaphragm 
to fix the phrenoesophageal reflexion intra- 
abdominally. It is not well known that late 
herniation of the stomach may result from 
dehiscence of the counterincision. We be­
lieve the following case merits recording be­
cause of the grave consequences of this 
complication if it remains unrecognized.
Case R eport Fig. 1.—Radiograph showing the incarcerated barium-filled stomach in the chest.
A 46-year-old labourer was admitted to 
a neighbouring’ hospital with a five-day 
history of epigastric pain which followed 
the consumption of a quantity of beer. Ra­
diographs after a barium meal were normal 
but two days later the pain recurred, ra­
diated to the left chest and was followed 
by vomiting, retching and finally aphagia. 
He was transferred to Kingston the next 
day.
He had had a cholecystectomy and repair 
of a hiatus hernia two years before and a 
transthoracic repair of a recurrence of the 
hiatus hernia by the Allison technique one 
year before the present admission. He looked 
ill and dehydrated. His pulse rate was 120/ 
min, blood pressure was 140/90 mm Hg and 
his respiratory rate was 30/min. The left 
chest moved poorly; air entry was re­
stricted and a pleural rub could be heard 
laterally. His abdomen was distended, 
tender and silent. The hemoglobin was 15.0 
g/100 ml, hematocrit 45% and leukocyte
♦From the Department of Surgery, Division of 
Cardiovascular Surgery, Queen’s University, 
Kingston, Ont.
count 14,100/cmm; serum electrolytes were 
essentially normal. A chest radiograph 
showed an air-fluid level in the left chest, 
and a barium swallow confirmed that this 
was stomach, although the esophagogastric 
junction was normal and below the dia­
phragm (Fig. 1). The patient was taken 
immediately to the operating room.
In spite of great care he aspirated fluid 
during induction of anesthesia. Broncho­
scopy and bronchial lavage were carried out 
and a laparotomy was done. It was impos­
sible to deliver the incarcerated stomach, so 
the incision was extended into the chest and 
the diaphragm incised down to the neck 
of the hernia. There was about one litre of 
serosanguineous fluid in the chest and the 
middle two-fourths of the stomach were 
gangrenous, the process being centred on 
the lesser curvature (Fig. 2). This seg­
ment was excised, continuity re-established 
and the diaphragm closed with interrupted 
silk sutures; the parietal incisions were 
closed in the routine manner. The postoper­
ative course was stormy because of an 
aspiration pneumonia for which the patient
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Fig. 2.—Intraoperative photograph of the gan­
grenous stomach and omentum.
required  a tracheostom y and resp irato ry  
support. He was finally discharged 23 days 
a fte r  adm ission when his chest radiograph 
and barium  meal exam ination were sa tis­
factory  (F ig . 3 ).
D iscussion
The incidence of herniation of the stomach 
through a dehisced diaphragmatic counter­
incision must be quite low, although it can­
not be known with certainty. Effler1 re­
ported six cases of his own and collected a 
further 16 from the literature; in only one 
of the series had gangrene of the stomach 
developed. Because of the possibility of such 
herniations Effler described a modification
Fig. 3.—Postoperative barium meal showing re­
latively normal gastric configuration.
of the Allison type of repair which omits the 
counterincision. It is not our intention to 
discuss the techniques of transthoracic re­
pair of hiatus hernias but to emphasize 
the importance of careful closure of any 
diaphragmatic incision with well-placed non­
absorbable suture material. If this is not 
done the patient may be exposed to the 
grave complication of herniation of the 
stomach into the chest with subsequent vol­
vulus and gangrene of the incarcerated seg­
ment.
R eference
1. Effler  DB: Allison’s repair of hiatal hernia: 
late complication of diaphragmatic coun­
terincision and technique to avoid it. J  
Thorac Cardiovasc Surg 49: 669, 1965
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DEXTRAN 75 IN THE PROPHYLAXIS OF DEEP VENOUS THROMBOSIS 
AND PULMONARY EMBOLISM*
J. H. WEDGE, M.D., W. H. KIRKALDY-WILLIS, M.A., M.D., F.R.C.S.[Edin. & C], 
F.A.C.S. and R. C. HAYTON, B.Sc., M.D., F.R.C.P.[C], Saskatoon, Sask.
Summary: To determine the effectiveness of 
dextran 75 in the prophylaxis of deep venous 
thrombosis and pulmonary embolism in patients 
with lower extremity fractures or after elective 
operations, we undertook a prospective double­
blind study in 242 patients over the age of 40 
years. The experimental solution was 6% dex­
tran 75 in water with 5% dextrose in water as 
the control solution.
Traditional prophylactic measures such as leg 
exercises, elastic bandaging and elevation of 
the foot of the bed were used in both groups of 
patients.
The diagnosis of deep venous thrombosis was 
made by clinical examination. There was no 
statistically significant difference in the inci­
dence of thromboembolic complications be­
tween the experimental and control groups. 
Therefore we conclude that dextran 75 as em­
ployed in this study is not an effective prophy­
lactic agent against deep venous thrombosis 
or pulmonary embolism.
Resume: En vue de determiner I'efficacite du 
dextran 75 comme prophylactique de la throm­
bose des veines profondes et de I'embolie pul- 
monaire chez des malades ayant subi des 
fractures des membres inferieurs ou apres des 
operations electives, nous avons entrepris une 
etude prospective doublement anonyme chez 
242 patients, tous ages de plus de 40 ans. 
La solution experimental choisie etait du dex­
tran 75 a 6% dans I'eau et la solution-temoin 
etait composee de 5% de dextrose dans I'eau.
Chez les deux groupes de malades, nous 
avons eu recours aux mesures prophylactiques 
ciasoiques, mouvements des jambes, port d'un 
bandage elastique et surelevation des pieds du 
lit.
Le diagnostic de thrombose des veines pro­
fondes a ete porte par examen clinique. Or, 
nous n'avons pas constate de difference nota­
ble, au point de vue statistique. dans la fre­
quence des complications thrombo-emboliques 
entre le groupe de malades traites et le groupe 
des temoins. Nous estimons done pouvoir con- 
clure que le dextran 75, dans les conditions ou
* From the Departments of Surgery (Orthopaedic) 
and Medicine, University Hospital, Saskatoon, 
Sask.
Presented at the Canadian Orthopaedic Association 
Meeting, Quebec City, Que., June 16, 1972.
nous I'avons employe ici, n’est pas un agent 
prophylactique efficace contre la thrombose 
veineuse profonde ou I'embolie pulmonaire.
O n the prophylaxis of thromboembolic phe­
nomena conflicting reports have been pub­
lished as to the efficacy and safety of war­
farin.1'3 Many studies have emphasized the 
high incidence of thromboembolic complica­
tions in operations on the lower extrem­
ity.1’ - •  4 6 In our own experience the risks 
of warfarin have outweighed its benefits. 
Other authors consider low-molecular-weight 
dextran to be a more effective and safer 
prophylactic agent.410
Dextrans are polymolecular polysaccha­
rides produced by the action of bacteria on 
a sucrose-containing medium. The “native” 
dextrans with very high molecular weights 
are split and separated by hydrolyzation and 
fractionation into the molecular weight 
ranges suitable for clinical use.
The mechanism of the antithrombotic ef­
fect of dextran is unknown. Table I lists the 
mechanisms postulated. The most widely ac­
cepted theory is that it decreases platelet 
adhesiveness.1113
Previous encouraging reports on dextran 
led us to undertake the study described be­
low.
M aterial and  M ethod
This double-blind study was carried out 
on the Orthopaedic Service of the Univer­
sity Hospital, Saskatoon, from December 1, 
1970 to November 30, 1971. Patients in­
cluded in the study were those over the age
TABLE I.—Postulated M echanisms of Anti­
thrombotic Effect of Dextran
1. Decrease in platelet adhesiveness (experimental­
ly, molecular weight of 77,500 has maximal 
effect)11
2. Decrease in blood viscosity
3. Increase in plasma volume
4. Increase in rate of blood flow
(a) by hemodilution
(b) by passive vasodilatation
5. Erythrocyte disaggregating effect (increased 
negative charge on surface membrane of red cell)
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TABLE II.—Age and Sex D istribution of 
P atients in the Study
Group
Control Dextran
Average age:
All patients..............
Patients with hip
63.0 yrs
fractures........
Sex distribution:
74.4 yrs
Male.................. 49
Female.............. . . .  72 69
of 40 years with either lower extremity frac­
tures or on whom elective operation of the 
lower extremity or lumbar spine had been 
performed. Patients who had been on anti­
coagulants in the preceding three months, 
those in congestive heart failure with pul­
monary edema and those with multiple in­
juries were excluded from the study. Table 
II presents the average age and sex distribu­
tion of the control and experimental groups.
The experimental solution was 6% dex­
tran 75 in water (Abbott). The control 
solution was 5% dextrose in water. The 
solutions were transferred under sterile 
conditions to bottles that were identical. 
They were coded by the Pharmacy Depart­
ment and the code was not broken until two 
months after the termination of the study.
The amount of the solution was that used 
by Lambie et at-* in their study using dex­
tran 70. Commencing immediately after the 
operation the dosage used was 7.0 ml/kg 
and on the first, second and third postoper­
ative days this was reduced to 3.5 ml/kg. 
The solutions were administered at the rate 
of 50 ml/hr.
The traditional methods for preventing 
deep venous thrombosis, namely leg eleva­
tion, elastic bandaging and vigorous leg exer­
cises, were employed in both the experi­
mental and control groups from the day of 
operation.
Criteria for Diagnosis
We admit the difficulties and inaccuracies 
of clinical diagnosis in deep venous throm­
bosis but this means of diagnosis appeared 
to be the only one that was practical in a 
large series of patients. We believed that in 
a carefully controlled series the errors in 
diagnosis would be comparable in both 
groups. Each patient was examined daily by
one of the authors. We also considered the 
use of venography and radioactive fibrinogen 
but thought them not practical in this study. 
While venography is a more accurate meth­
od of diagnosing deep venous thrombosis in 
individual cases, the time and morbidity in­
volved with the 242 patients in the series 
made it an unreasonable undertaking. We 
have utilized 1 - •’! and 131I fibrinogen with 
peripheral counts and leg scanning but have 
had problems in interpreting the results. 
Large drops occurred in the counts in the 
first 24 hours after operation, presumably 
because of loss into the wound hematoma 
and the urine. In our hands we still consider 
this an experimental method.
TABLE I I I —Criteria for D iagnosis of Deep 
Venous T hrombosis
L Increased warmth when compared with opposite 
extremity after 10 minutes’ exposure
2. Deep calf tenderness
3. Pitting edema
4. Increased circumference of more than 2 cm as 
compared with other leg
5. Erythema
6. PositiveHoman’ssign
The diagnosis was considered probable if 
either the first or second criterion listed in 
Table III was present, and definite if 
either of these was accompanied by any 
other sign.
The diagnosis of pulmonary embolism 
was not considered definite unless confirmed 
by a lung scan using macroaggregates of al­
bumin with a radioactive label.
TABLE IV.—T hromboembolic Complications
No. of patients
Complication
Control
group
(124 patients)
Dextran-
treated
group
(118 patients)
Deep venous thrombosis:
Probable............. 1 3
Definite.............. 12 12
Total................... 13 (10.4%) 15 (12.7%)
Pulmonary embolism:
Probable............. 1 1
Definite.............. 5 6
T otal................... 6 (4.8%) 7 (5.9%)
Total thrombo-
embolism.............. 17 (13.7%) 18 (15.3%)
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TABLE V.—Thromboembolic Complications in 
P atients With H ip F ractures
No. of patients
Dextran-
Control treated
group group
(36 patients) (34 patients)
Deep Venous 
thrombosis............. 7 5
Pulmonary em­
bolus........................ 5 3
Total thrombo­
embolism ................ 10 (27.8%) 7 (20.6%)
R esults
In the whole series, including controls, 
there were 242 patients. Thirty-five throm­
boembolic complications occurred, distri­
buted as indicated in Table IV.
Using chi-square analysis there was no 
significant statistical difference in the results 
in the two groups.
The results were further analyzed with 
reference to patients with hip fractures 
(Table V). The age distribution was the 
same in both these groups. Some patients 
had both complications. Again there was no 
statistically significant difference between 
these two groups.
Ninety-three of the patients in the whole 
series had fractures, 48 in the control group 
and 45 in the experimental group. Of those 
with fractures who had thromboembolic 
complications, 12 were in the control group 
and eight in the dextran-treated group.
The complications occurring in both 
groups are listed in Table VI. Two of these 
complications warrant discussion. A middle- 
aged woman developed a high fever, shak­
ing chills and diaphoresis several hours after
TABLE VI.—Complications
No. of complications
Dextran- 
Control treated 
Complication__________________ group group
Septicemia........................
Wound hematoma
(requiring drainage)........
Wound infection..............
Pneumonia.......................
Gastrointestinal hemor­
rhage....... .........................
Postoperative pulmonary
edema................................
Death................................
the daily dextran infusion was started. Sev­
eral blood cultures grew a species of Achro- 
mobacter: this peculiar gram-negative or­
ganism was thought to be a solution conta­
minant. In the second instance an elderly 
lady died on the tenth postoperative day af­
ter an episode of bronchospasm, anuria and 
hypotension. Postmortem examination re­
vealed no definite cause of death. Anaphy­
lactic shock due to delayed sensitivity to 
dextran was suspected.
There were five additional deaths. Four 
were from pneumonia in elderly patients, 
three of whom were in the dextran-treated 
group. One patient in the dextran group 
died of a suspected pulmonary embolus. 
This was the only death in the series in 
which permission for an autopsy was not 
obtained.
The results presented show that the in­
cidence of deep venous thrombosis and pul­
monary embolism was almost identical in 
both the experimental and control groups. 
Before deciding that dextran is not effect­
ive in preventing deep venous thrombosis 
and pulmonary embolism some possible 
sources of error are now considered.
It is possible that dextran 40 is a more ef­
fective prophylactic agent. There is, how­
ever, considerable overlap in the molecular 
weight ranges of dextrans 40 and 75 (Fig. 1) 
which presumably produces an overlap in
MOLECULAR W EIG H T IN 1,000’s
Fig. 1.—Molecular weight distribution of dextran 
40 and dextran 75.
0 1
4 3
4 2
1 5
1 1
3 0
1 5
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clinical effects. While some authors prefer 
dextran 40 to dextran 75 **•6 because of its 
fewer side effects, it is not possible to state 
at present which is the superior antithrom- 
bogenic agent.8
The dosage regimen and the time of ad­
ministration may be critical in obtaining the 
maximal antithrombogenic effect. Previous 
reports suggest that preoperative and intra­
operative infusion results in a lower inci­
dence of thrombosis. 6 The evidence for 
this is conflicting. Evarts and Feil5 were 
able to show a significant although less- 
marked reduction in thrombosis with post­
operative administration than with preoper­
ative and intraoperative infusion of dextran 
40. We have been unable to substantiate 
this claim in our study.
C onclusion
We therefore conclude that dextran 75 as 
employed in this study is not an effective 
prophylactic agent against deep venous 
thrombosis or pulmonary embolus. This was 
far from what we had anticipated. In re­
trospect this is the most cogent of reasons 
for undertaking a double-blind study.
Further work is necessary to determine 
the exact initiating event and the pathogene­
sis of deep venous thrombosis.14 Until that 
time it is unlikely that an effective and safe 
prophylactic agent will be found. Careful 
recognition of high-risk patients is essential 
to reduce mortality. Traditional prophylac­
tic measures must be employed.
We wish to thank Drs. J. E. Merriman of the 
Cardiopulmonary Laboratory and A. A. Wilkin­
son of the Department of Nuclear Medicine for 
their help and advice.
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EFFECT OF TRANSIENT BILIARY OBSTRUCTION ON LIVER FUNCTION
AND MORPHOLOGY*
SORIANO U. SO. M .D .f and G. F. BONDAR, M.D., C.M., M.Sc., F.R.C.S.[C], F.A.C.S.,
Edm onton, Alta.
Summary: Partial biliary obstruction was pro­
duced in 80 guinea pigs by partial ligation of the 
distal common bile duct and maintained from 
four to eight weeks. Partial biliary obstruction 
up to eight weeks produced marked hepatic 
changes. The significant functional changes 
were elevations of the serum alkaline phos­
phatase and serum glutamic oxaloacetic tran­
saminase and decrease of the serum albumin 
levels. Morphologically, the prominent changes 
were round cell infiltration, fibrosis and bile- 
duct proliferation with dilatation in the portal 
and interlobular areas, parenchymal cell atrophy 
and focal necrosis. Surgical relief of obstruction 
resulted in rapid recovery of liver function and 
restoration of normal morphology after eight- 
and 20-week periods. Therefore, partial biliary 
obstruction of up to eight weeks is reversible 
in the guinea pig.
Resume: Nous avons procede a une obstruction 
partielle des voies biliaires chez 80 cobayes par 
une ligature partielle de la portion distale du 
choledoque, ligature qui a ete maintenue pen­
dant une periode allant de quatre a huit semai- 
nes. Cette obstruction, apres huit semaines, a 
provoque de profondes modifications hepati- 
ques. Parmi les changements fonctionnels impor- 
tants, on pouvait noter une augmentation de la 
phosphatase alcaline du serum et de la S G O T  
et une diminution des concentrations de I'albu- 
mine serique. Au point de vue morphologique, 
les changements predominants etaient une in­
filtration cellulaire (cellules rondes), une fi­
brose et une proliferation du conduit biliaire 
avec dilatation au niveau de la region portale 
et des regions interlobulaires, une atrophie des 
cellules du parenchyme et une necrose focale. 
Des la levee de I'obstruction, on obtint un re- 
tablissement rapide de la fonction du foie et la 
restauration d'une morphologie normale apres 
une periode variant de huit a 20 semaines. 
Nous croyons pouvoir conclure que, chez le 
cobaye, une obstruction biliaire partielle jus- 
qu'au point de huit semainos est reversible.
*From the Surgical-Medical Research Institute 
and the Department of Surgery, The University of 
Alberta, Edmonton, Alta.
Supported by the University of Alberta Research 
Fund.
fSupported by the Edmonton Civic Employees 
Welfare Chest Fund.
P artial  biliary obstruction (PBO), in 
man and in the experimental animal, produ­
ces functional and morphological hepatic 
changes which may resolve or progress to 
cirrhosis depending upon the degree and 
duration of obstruction. These changes are 
usually evaluated by experimental ligation of 
the common bile duct (CBD). Most in­
vestigations of the pathological changes in 
the liver following biliary obstruction have 
been done following complete ligation of the 
distal CBD with or without dividing it.1"4 
Morphologically, the hepatic changes pro­
duced by experimental biliary obstruction 
simulate the changes that may occur clinic­
ally in man. Some workers have been able 
to correlate the biochemical changes and 
hepatic structural alterations following extra- 
hepatic biliary obstruction.n"8
In animals, several studies have noted the 
capacity of the obstructed liver to recover 
functionally and morphologically. Bell,9 in 
1926, ligated the CBD in dogs and demon­
strated regeneration of damaged hepatic 
parenchymal tissue after relief of the ob­
struction by cholecystogastrostomy. He noted 
that after relief of obstruction from two to 
four months would be required for the pro­
cess of regeneration, the time depending 
upon the amount of liver damage. In rats, 
the obstructed liver was noted to recover 
after spontaneous recanalization of the 
ligated CBD.10"1- In 1935, Cameron13 
noted slow regeneration of hepatic paren­
chymal cells in rats after relief of complete 
biliary obstruction of one week’s duration. 
He concluded that the longer the period of 
complete obstruction, the slower the return 
to normal growth capacity of the liver cells. 
Weinbren,14 in 1953, showed regeneration 
of rat liver cells 18 to 21 days after CBD 
ligation.
In the present work with guinea pigs a 
PBO was created by partial ligation of the 
distal CBD. The site and degree of biliary 
obstruction simulate closely the situation 
of chronic biliary obstruction due to stones 
or stricture which occurs clinically in man. 
This method of PBO allows a more pro-
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longed study of the hepatic changes caused 
by the obstruction.
At present there is lack of correlation be­
tween hepatic injury that is induced by vari­
able periods of PBO and the subsequent he­
patic recovery after the PBO is relieved. The 
study described herein was undertaken to 
determine the extent of liver damage which 
was induced by controlled periods of PBO, 
and to observe the subsequent hepatic re­
covery after surgical correction of the ob­
struction.
Materials and M ethods
One hundred and forty-seven healthy 
guinea pigs of both sexes weighing between 
300 and 500 g were used. Twenty served as 
biochemical and morphological normal con­
trols. Twenty-one were used as sham con­
trols since the ligature was too loose. Twen­
ty-six did not survive because the ligature 
was too tight. Eighty guinea pigs with sus­
tained PBO were used for the complete 
staged study. Food, in the form of standard 
guinea pig pellets, was given ad libitum. 
Preoperatively, weights were recorded and 
serial hemoglobin, serum bilirubin, alkaline 
phosphatase, serum glutamic oxaloacetic 
transaminase (SGOT), and proteins deter­
mined on blood obtained from the long 
saphenous vein. During operation the anim­
als were under Nembutal anesthesia (35 
mg/kg) given intraperitoneally. Liver biop­
sies were fixed in 10% formalin, subse­
quently embedded in paraffin and stained 
with hematoxylin and eosin, and Masson’s 
trichrome stain.
The experiment was divided into three 
stages (Table 1). Weekly clinical observa­
tions, weights and serial biochemistry were 
recorded. At laparotomy, liver biopsy, serial 
cholangiography, collection of gallbladder 
bile and measurement of CBD pressure and 
diameter were done. Stage I consisted of 
preoperative control studies in 80 guinea 
pigs and ended in laparotomy through an 
upper midline incision. The distal CBD was 
isolated and Stage II (PBO) commenced 
after the CBD was partially ligated with 
siliconized 0 silk, binding a 1-mm. stylet 
to the outside of the duct wall. The stylet 
was then slipped out slowly to avoid any 
significant trauma to the duct. The ab­
dominal incision was closed with chromic
TABLE I.—-Experimental Grouping and
Staging of 80 Guinea P igs During Stages of 
Control, PBO and Recovery
No. of
Stage Duration
guinea
pigs
I — Control............... 80
Partial................ (a) 4 wks 40
II — biliary.............. 40
obstruction
III —- Recovery . . . .
8 wks 20 (a) 
20 (b)
20 wks 20 (a)
20 (b)
catgut (000) in two layers, (a) the peri­
toneum and muscle and fascia with conti­
nuous sutures, and (b) the skin with inter­
rupted sutures. PBO was maintained for 
four weeks in 40 guinea pigs and for eight 
weeks in another 40 animals. At the termina­
tion of this stage serial hemoglobin was de­
termined and laparotomy performed. Stage 
HI (recovery) commenced after removal 
of the CBD ligature. After PBO of four or 
eight weeks in Stage II the guinea pigs were 
kept under surveillance for periods of eight 
and 20 weeks. At the end of Stage III the 
animals were sacrificed and a laparotomy 
was performed. Postmortem examination, 
which included renal biopsy, was done 
routinely. Blood was collected for hemoglo­
bin and biochemistry.
The animals that appeared moribund were 
sacrificed and an autopsy was performed on 
them and on any that died. A series of 
normal animals and a few from each stage 
were sacrificed to obtain the entire liver. The 
biliary tree was washed out, injected with 
vinyl and subsequently corroded with con­
centrated hydrochloric acid. The injection 
was carried out in all cases at a pressure of 
70 mm Hg, measured by means of a man­
ometer connected to a syringe-tubing set.
R esults
Of 147 healthy guinea pigs used in this in­
vestigation, 20 were studied to establish nor­
mal control values. The degree of biliary 
obstruction after partial ligation of the CBD 
was unsatisfactory in 47 animals.
In 26 guinea pigs the ligature had been 
too tightly applied and the animals died 
from complications including: (a) perfora­
tion of the gallbladder, CBD and/or a duo-
▼ ▼
V
*
TABLE II.—Averages of Laboratory and CBD Changes in Guinea Pigs W ith PBO of Four Weeks’ Duration
-----------------------------  1
Partial ligation
Preop-
Controls eratiue 1 week 2 weeks 3 weeks 4 weeks
Deligation
1 week 2 weeks 3 weeks 4 weeks 5 weeks 6 weeks 7 weeks 8 weeks
Hemoglobin (g/100 ml)
Average 15.8 15.7 13.2 
SD± 0.18 0.39 0.67 
P  NS10 S*«
15.0
0.69
NS10
Bilirubin (mg/100 ml)
Average 0.5 0.5 1.1 0.70 0.4 0.3 
SD± 0.21 0.16 0.9 0.23 0.26 0.19 
P NS- S S NS S
0 3 0.2 0.2 0.3 0.2 0.2 0.3 0.2 
0.22 0.17 0.15 0.18 0.15 0.19 0.19 0.15 
S S S S S  S S S
Alkaline phosphatase [Babson units)
Average 32.1 34 83.4 79.6 77.5 67.7 
SD± 5.0 4.03 18.16 16.17 20.22 20.64 
p NS S S S S
39.9 35.7 34.5 34.6 33.1 31.1 28.2 26.9 
10 04 9.42 9.73 9.60 8.11 7.75 7.21 5.0 
S NS NS NS NS NS <0.05 NS
SGOT [TransAc units) __
Average 31.3 28.3 193.3 107.8 123.22 73.1 
SD± 5.6 4.01 105.06 41.84 63.0 17.89 
p <0.05 S S S S
49 1 42.7 35.2 36.2 31.6 31.1 30.9 30.7 
15.36 11.55 10.29 10.22 6.14 5.37 5.13 6.24 
S S NS <0.05 NS NS NS NS
Albumin [g/100 ml)
Average 1.5 1.7 1.1 0.8 0.7 0.8 
SD± 0.27 0.26 0.51 0.23 0.16 0 14 
p <0.05 S S S S
1.0 0.9 0.9 1.0 1.2 1.3 1.3 1.4 
0 34 0.21 0.19 0.35 0.58 0.42 0.40 0.31 
S S S S <0.05 <0.05 <0.05 NS
Globulin [g/100 ml)
Average 4.3 4.3 5.1 4.4 4.2 4.1 
SD± 0 54 0.68 1.04 0.73 0.45 0.45 
P  NS S NS NS NS
4 2 4.1 4.1 4.5 4.1 4.1 3.8 3.8 
0.60 0.51 0.57 0.64 0.66 0.62 0.57 0.51 
NS NS NS NS NS NS S S
^ Average 1:2.9 1:2.6 1:5.3 1:5.6 1:6.3 1:5.0 
SD± 0.46 0.75 1.96 1.19 1.19 0.83 
p NS S S S S
1-5 0 1:4.6 1:5.0 1:4.7 1:4.3 1:3.4 1:3.3 1:2.8 
0.94 0.95 1.13 1.29 1.68 1.00 1.05 0.71 
S S S S S <0.05 NS NS
CBD (mm)
Average 2.1 2.1 4.5 
SD± 0.21 0.21 051 
P NS10 S
3.6
0.60
S
CBD pressure [mm bile)
Average 69 69 138 
SD± 7.44 7.44 37 5 
P NS8 S15
77.5
8.9
<0.0510
n = 20, except as indicated by small numbers; P values -  all compared with control group; S -  <0.01; NS -  >0.05.
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TABLE TIT.— Averages op Laboratory and CBD Changes in G uinea Pins W ith PBO op E ic.ht W ee ' s ' D uration
P a rtia l ligation D eliga tion
P re -
Controls operative 1 w eek 2 w eeks 3 w eeks It w eeks 5 w eeks 6 w eeks 7 w eeks 8 w eeks 1 week 2  w eeks 3 w eeks It w eeks 5 w eeks 6 weeks 7 w eeks 8 w eeks
H e  noglobin {g\100 m l)
Average 15.8 15.8 12.6 14.6
P D ±  0.18 0.32 0.72 1.11
P N S12 S >0 S
B iliru b in  {m g < 100 ml)
Average 0.5 0.4 1.2 0.7 0.5 0.3 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.3 0.2 0.2 0.2 0.3
S D i  0.21 0.13 1.00 0.29 0.18 0.15 0.18 0.18 0.14 0.10 0.20 0.18 0.20 0.19 0.14 0.14 0.16 0.26
P NS S <"0.05 NS s S S S S NS S NS S S S S <0.05
A lk a lin e  phosphatase {B abson  u n its )
Average 32.1 36.0 79.7 70.7 73.5 65.7 51.0 38 0 41.3 37.2 37.1 36.6 35.0 34.7 28.8 39.0 31.3 27.6
S D i  5.0 2.55 26.83 16.3 16 85 16 0 15.52 5.4! 10 32 9.99 9.55 8.64 8.74 8.22 5.48 4.42 6.53 6.39
P <^0 05 S S S S S s S <0.05 <0.05 NS NS NS NS NS NS <0.05
S C O T  ( T r a is A c  units)
Average 31.3 27.7 173.2 124.9 99.7 71.1 61.1 48.5 *2.0 44.7 57.7 34.9 37.8 38.7 34.4 34.6 36.1 31.1
S D i  5.6 3.28 81.67 84.74 44.27 18.76 18.85 14.07 17.40 13.56 16.55 9.63 14.3 9.67 7.57 6.63 6.96 6.96P <0.05 S S S S S S <0.05 S S NS NS S NS NS <  0.05 NS
A lbum in  (g 100  ml)
Average 1.5 1.6 1.4 0.84 0.7 0.62 1.0 0.74 0.92 0.83 0.7 0.9 0.9 0.7 0.9 0.9 1.2 1.5
S D i  0.27 0.41 0.50 0.22 0.22 0.22 0.23 0.32 0.30 0.21 0.27 0.21 0.18 0.35 0.19 0.23 0.31 0.34
P NS NS S S S S S S S S S S S S S S NS
G lobulin  (g :100  m l)
Average 4.3 4.0 4.5 4.6 4.7 4.20 4.7 4.2 4.0 4.5 4.1 3.9 3.9 4.2 4.0 3.9 3.8 3.7
S D i  0.54 0.64 0.91 0.77 0.67 0.51 0.65 0.46 0.59 0.71 0.59 0.37 0.53 0.68 0.43 0.39 0.48 0.46
P NS NS NS <0.05 NS <0.05 NS NS NS NS <0.05 <0.05 NS NS <0.05 S S
A l  G ratio ■
Average 1:2.9 1:2.8 1:3.5 1:5.7 1:7.4 1:7.0 1:5.0 1:6.0 1:4.9 1:5.6 1:5.8 1:4.5 1 4.5 1:6.4 1:4.7 1:4.5 1:3.3 1:2.7S D i  0.46 1.14 1.28 1.02 1.93 2.15 1.06 2.14 2.00 1.35 2.03 0.88 0.97 2.75 0.82 0.86 0.83 0.64
P NS <0.05 S S S S S S S S S S S S S <0.05 NS
C B D  (m m ) - --
Average 2.1 2.1 6.6
S D ±  0.21 0.21 0.93 0.73P N S10 S 17 S 16
C B D  pressure {m m  bile)
Average 69 69 163
S D i  7.44 7.44 40.92 9.61
P N S3 S s ‘<
15, except as indicated by small numbers; P =  values — all compared with control group; S =  < 0.01; NS =  >0.05.
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denal ulcer; (b) subphrenic abscess; and (c) 
adhesions affecting gallbladder, CBD, omen­
tum and loop of proximal small intestine 
together with complete biliary obstruction. 
The animals that died after seven or more 
days of total biliary obstruction showed 
marked pathologic changes in the liver.
In 21 guinea pigs the ligature was too 
loose and the animals had only transient or 
no clinical or laboratory changes. At lapa­
rotomy there were no significant mor­
phological changes in the liver or CBD. This 
group of animals was observed as sham- 
operated controls.
Eventually 80 animals were successfully 
operated on, ensuring sustained PBO for all 
stages of the controlled study.
During the first two to three days after 
partial ligation of the CBD the animals 
regularly lost 5 g to 8 g in weight because 
they could not eat well. In most guinea pigs 
clinical jaundice appeared within one week 
of PBO and remained for only a few days. 
A week or so after operation ascites gradual­
ly developed and was reflected in a sudden 
weight gain.
Tables II and III summarize the details of 
the laboratory and CBD changes in two 
series of guinea pigs. After four weeks of 
PBO serial hemoglobin averaged 13.2 g/ 
100 ml, while after eight weeks the average 
was 12.6 g/100 ml compared with the 
normal average of 15.8 g/100 ml. Serial 
serum bilirubin increased transiently to an 
average of 1.1 m g/100 ml during the first 
week of PBO from a normal average of 0.5 
m g/100 ml. During the four-week and eight- 
week periods of PBO the alkaline phos­
phatase increased to serial averages of 83.4 
units and 79.7 units respectively on the first 
week from a normal average of 32.1 Babson 
units. The SGOT increased to serial aver­
ages of 193.3 and 173.2 on the first week 
of PBO from a normal average of 31.3 
Trans Ac units. Thereafter, the values of al­
kaline phosphatase and SGOT gradually 
declined. The serum albumin decreased to a 
serial average of 0.7 g/100 ml on the third 
week of PBO from a normal average of 1.5 
g/100 ml. This change resulted in an altera­
tion of the albumin-globulin (A/G) ratio. 
There was no significant change in the serum 
globulin level. Thereafter, the depressed 
values of serum albumin slowly recovered.
Laparotomy after four and eight weeks of 
PBO invariably showed ascitic fluid a- 
mounting to 10 to 15 ml and 20 to 30 ml 
respectively. The liver was grossly enlarged, 
firm, yellowish brown, finely granular and 
offered resistance to cutting. In 32 out of 
80 animals there were focal 2- to 5-mm 
necrotic areas beneath the capsule. Serial 
liver weights expressed as a ratio to body 
weight ranged from 1:7.5 to 1:10.0 with 
an average of 1:8.7 compared with a normal 
average of 1:17.7. There was no significant 
difference between liver weights at four and 
eight weeks of PBO. The proximal CBD 
was dilated to an average width of 4.5 mm 
at four weeks of PBO and to an average 
width of 6.6 mm at eight weeks of PBO in 
contrast to a normal average width of 2.1 
mm. When the animals died from complete 
biliary obstruction the proximal CBD was 
much more dilated, in one instance to a width 
of 25 mm (Fig. 1). In 28 out of 40 animals 
small concretions up to 1 mm were noted 
in the dilated CBD after eight weeks of 
PBO. The gallbladder was greatly distended. 
Serial measurements of CBD pressure at
Fig. 1.—Photograph showing a markedly dilated 
CBD, distended gallbladder, and enlarged liver. 
The ligature around the distal CBD is held with 
a hemostat.
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Fig. 2.—Normal needle cholangiogram showing 
the normal calibre of the CBD and intrahepatic 
ducts with immediate passage of dye into the duo­
denum.
four weeks of PBO showed a range of 90 
to 210 mm, with an average of 138 mm of 
bile. After eight weeks of PBO the intra­
ductal pressure varied from 95 to 215, with 
an average of 163 mm of bile. The normal 
control value ranged from 60 to 80 and the 
average was 69 mm of bile. On serial cholan­
giography 30 minutes passed before the con­
trast medium (angio-conray 80% ) could be 
seen in the small bowel (Figs. 2 and 3). On 
culture, bile obtained from a series of normal 
animals and after four and eight weeks of 
PBO showed no pathogenic organisms. Mi­
croscopic study of liver biopsies (Figs. 4 and 
5) revealed portal and interlobular infiltra­
tion of lymphocytes, fibrosis and bile duct 
proliferation. These changes were invariably 
greater after eight weeks of PBO. Careful 
microscopic evaluation failed to show any 
plasma cells or eosinophils. The fibrous 
tissue proliferation caused rather marked 
distortion of the hepatic architecture with 
accentuation and elongation of the portal 
tract area. The connective tissue extended 
into the interlobular area as fibrous tissue 
septa showing reduplicated and dilated bile 
ducts. Sinusoidal dilatation and atrophy of 
liver cells were frequently encountered. Fat­
Fig. 3.—Needle cholangiogram after eight weeks 
of PBO showing a greatly dilated CBD with back- 
flow of dye into the dilated intrahepatic branches. 
Passage of dye into the duodenum was delayed 
for 30 minutes.
ty infiltration and centrolobular bile pigmen­
tation were evident in a few cases. A num­
ber of animals showed focal discrete areas 
of necrotic hepatic parenchymal cells at the 
periphery of the lobule. Sometimes the areas 
of necrosis were bordered by necrotic cellu­
lar debris and occasional leukocytes. Vinyl 
injection and subsequent acid corrosion of 
obstructed livers showed dilatation of the 
entire biliary system (Fig. 6). The degree of 
dilatation was more marked after longer 
periods of obstruction.
After biliary obstruction was relieved by 
removal of the constricting ligature, the 
ascites disappeared and the animals appeared 
healthy and regained normal weight. In the 
series of animals that had PBO for four 
weeks the elevated alkaline phosphatase 
decreased to a serial average of 26.9 Babson 
units and the elevated SGOT decreased to a 
serial average of 30.7 Trans Ac units eight 
weeks after relief of PBO. In the series of 
animals that had PBO for eight weeks the 
elevated alkaline phosphatase and SGOT 
decreased to serial averages of 27.6 Babson 
units and 31.1 Trans Ac units respectively 
by eight weeks after relief of PBO. The de­
creased serum albumin increased to a serial
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Fig. 4.—Photomicrograph of a normal liver sec­
tion showing normal lobular architecture (H & E 
x 120).
average of 1.4 g/100 ml, eight weeks after 
relief "of PBO. At sacrifice eight weeks after 
removal of the CBD ligature, the animals 
had a normal-looking liver with smooth sur­
face. The gallbladder was not distended. 
Serial liver weights expressed as a ratio to 
body weight showed a range of 1:23.3 to 
1:30.5 with an average of 1:26.9 compared 
with a normal average of 1:17.7. The CBD 
showed residual average dilatation to 4.0 
mm. Concretions up to 1 mm were noted 
in the CBD in 10 guinea pigs. There was 
apparent narrowing of the distal CBD at 
the site of the ligature. However, cholangio­
graphy and cross-section of the CBD showed 
that the relatively narrowed area was fully 
patent in all cases. Serial measurements of 
intraductal pressure showed an average of 
78.7 compared with a normal average of 69 
mm of bile. Bile cultures were negative for 
pathogenic organisms. Microscopic study 
(Fig. 7) of liver biopsies showed a well- 
preserved lobular pattern and regeneration 
of parenchymal cells. The fibrous connective 
tissue in the portal and interlobular areas 
had contracted and appeared much less in
Fig. 5.—Liver section after four weeks of PBO 
showing necrosis, fatty infiltration, portal fibrosis, 
round cell infiltration and bile duct proliferation. 
The gross lobular pattern is preserved (H & E 
x 35).
amount. A uniform reduction in the number 
of bile ducts was evident. A few remaining 
round cells were noted in the portal tract 
area. No plasma cells or eosinophils were 
seen in any of the biopsies studied. Recovery 
from hepatic damage was faster after four 
weeks than after eight weeks of PBO.
The guinea pigs that were studied up to 
20 weeks after PBO was relieved continued 
to show normal clinical progress and liver
Fig. 6.—Vinyl cast of a totally obstructed liver 
showing markedly dilated CBD and intrahepatic 
bile ducts.
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Fig. 7.—Liver section 20 weeks after relief of 
PBO showing the well-preserved lobular pattern 
with a decrease in portal fibrosis, round cell in­
filtration and bile duct proliferation with regenera­
tion of parenchymal cells (H & E x 120).
function tests relatively similar to those that 
were followed up for eight weeks. At the 
time of sacrifice there was no ascites and 
the liver appeared normal. Serial liver 
weights expressed as a ratio to body weight 
varied from 1:23.7 to 1:29.8 with an aver­
age of 1:26.3. The proximal CBD showed 
a residual average dilatation to 5.5 mm. 
Serial measurements of CBD pressure 
showed an average of 73.2 compared with 
a normal average of 69 mm of bile. His­
tological study of liver biopsies disclosed 
marked recovery from hepatocellular injury. 
Only a few reduplicated bile ducts were seen 
and the parenchymal cells had regenerated. 
A few fibrous connective-tissue strands in 
the portal and interlobular areas remained 
and appeared flattened and contracted. Re­
covery from liver damage was much greater 
in guinea pigs that were followed up for 20 
weeks than in those studied at eight weeks. 
Vinyl injection and acid corrosion of livers 
at sacrifice showed considerable diminution 
in size of the dilated biliary radicles. No
hepatic regeneration nodules were noted 
in any of the biopsies studied. None of the 
renal biopsies examined showed evidence 
of tubular degeneration of cholemic nephro­
sis.
The sham-operated control animals were 
studied for periods up to eight weeks and the 
findings were not significantly different from 
those of the normal and preoperative groups. 
Hemoglobin averaged 15.6 g/100 ml and 
the serum bilirubin averaged 0.4 m g/100 ml. 
The serum alkaline phosphatase and SGOT 
showed averages of 32.1 Babson units and 
30 TransAc units respectively. There were 
no significant changes in the serum albumin 
and globulin levels and therefore no altera­
tions of the A /G  ratio were noted. The 
CBD showed an average width of 2 mm 
and the average intraductal pressure was 73 
mm of bile. The liver weights averaged 24.2 
g. Histological study of liver sections failed 
to show any significant morphological alter­
ations from the normal.
D iscussion
This study showed that PBO induced by 
partial ligation of the distal CBD produces 
definite functional and morphological 
changes in the liver. The alterations that oc­
cur depend upon the degree and duration of 
obstruction and the amount of liver damage 
so produced.
In the test animals the serum bilirubin 
levels were never significantly elevated ex­
cept in a few cases, and in these only tran­
sient rises were noted during the first post­
operative week. Peak elevations of the 
serum alkaline phosphatase and SGOT were 
observed during the first week of PBO. 
Thereafter, the values gradually declined 
even before the PBO was relieved. This find­
ing parallels the observations of others.15 18 
The enzyme levels did not reach normal un­
til eight weeks after PBO was relieved. The 
constant decrease in the serum albumin with 
no significant increase in the globulin level 
persisted well beyond the relief of PBO. This 
change reduced the A /G  ratio. Later the 
ratio gradually rose to reach normal values 
when the serum albumin increased during 
the weeks following removal of the stenos- 
ing ligature.
After PBO of four and eight weeks, his­
tological study of liver biopsies invariably
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revealed lymphocytic infiltration, fibrosis and 
bile duct hyperplasia with dilatation in the 
portal and interlobular areas. These mor­
phological changes were more pronounced 
after longer periods of PBO. Although 
marked morphological changes, including 
fatty infiltration and hepatic parenchymal 
atrophy, disturbed normal hepatic pattern, 
the lobular architecture was usually well 
preserved. Forty per cent of all cases showed 
focal discrete areas of hepatocellular necrosis 
in the peripheral zone of the hepatic lobule.
In general, necrosis of hepatic cells did not 
transcend zonal boundaries, but remained 
focal and confined to the periphery of the 
lobule. When hepatocellular necrosis was 
extensive, adjacent hepatic lobules were 
noted to be involved. After relief of PBO 
there was constant recovery from hepatic 
injury. The morphological recovery from 
hepatic damage was faster and more pro­
found after four weeks than after eight weeks 
of PBO. Recovery was much more complete 
after follow-up of 20 weeks than of eight 
weeks after relief of PBO.
Vinyl injection and acid corrosion studies 
showed clearly generalized dilatation of the 
primary and secondary biliary radicles. At 
eight and 20 weeks after relief of PBO, con­
stant shrinkage of the dilated ducts was de­
monstrated.
The morphological changes in the liver 
following PBO induced by partial ligation 
of the distal CBD were impressive. His­
tologically, the damaged liver invariably 
showed profound widening and elongation 
of the portal tract area and the formation 
of interlobular fibrous tissue septa. Some­
times there was intralobular extension of 
fibrous tissue bands. There was absence of 
both solitary and multiple discrete nests of 
hepatic cells encapsulated by fibrous tissue; 
no so-called hepatic regeneration nodules 
were encountered in the biopsies studied.
In the pathogenesis of biliary cirrhosis, 
infection may be imposed on PBO. From 
a study of this combination of factors in 
man, Judd and Counseller19 concluded that 
chronic partial obstruction by stones or 
stricture must be accompanied by cholangitis 
to produce biliary cirrhosis. Cameron and 
Muzaffar Hasan20 emphasized that infection 
was the deciding factor in the development of 
biliary cirrhosis. However, this study shows
that obstruction alone can produce severe 
morphological hepatic changes and the 
results of this experiment agree with those of 
others.21'-'3 Serial bile cultures did not grow 
any pathogenic organisms and histological 
examination of the CBD showed no evi­
dence of inflammation. Liver biopsies 
showed only lymphocytic infiltration lim­
ited to the portal and interlobular areas and 
no polymorphonuclear leukocytes.
MacMahon, Lawrence and Maddock24 
and Stewart and Lieber25 emphasized the 
role played by increased intraductal pressure 
in biliary cirrhosis. Counseller and Mcln- 
doe26 believed that increased intraductal 
pressure was important in hydrohepatosis. 
Certainly with biliary tract obstruction the 
intraductal pressure rises. This study would 
indicate that a rise in intraductal pressure 
contributes to the production of marked he­
patic structural injury. Peak elevations of 
CBD pressure after four and eight weeks of 
PBO were noted, at the times when signif­
icant morphological changes occurred in the 
liver.
Although there was apparent narrowing 
of the distal CBD at the point of application 
of the ligature, no evidence of functional 
stenosis was noted. Cholangiography and 
easy insertion of a 2-mm probe into the re­
latively narrowed area revealed full luminal 
patency.
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EXPERIENCE WITH THE HARKEN PROSTHESIS FOR 
AORTIC VALVE REPLACEMENT*
p RFDARD M D FRCS.[C], W. J. KEON, M.D., F.R.C.S.[C], A. KENYON, M.B. P. BEDARD, p  BERj^MAjsj M.D., M.Sc., F.R.C.P.[C],
Ottawa, Ont.
Summary: Seventy-two patients underwent
aortic valve replacement at the Ottawa Civic 
Hospital during the period April 1969 to 
September 1971. In 40 patients in whom such 
replacement was the sole procedure necessary, 
the Harken valve was used. Preoperatively four 
of these patients belonged to NYHA Class II, 
31 to Class III and five to Class IV. There were 
no deaths within three weeks of operation; 
there were five late deaths. Thirty-five (88%) 
of these 40 patients are alive and their condi­
tion is improved by the operation; all but four 
are now considered to be in Class I. Morbidity 
associated with this operation has also been re­
viewed and it is believed that aortic valve re­
placement with the Harken prosthesis is a re­
latively safe procedure producing a good func­
tional result.
Resume: On proceda a un remplacement val- 
vulaire aortique chez 72 patients a I hopital 
Civic d'Ottawa, d'avril 1969 a septembre 1971. 
Quarante de ces patients n'eurent que ce rem­
placement, et on s'est servi de la prothese de 
Harken. Quatre etaient de la Class II NYHA, 
31 de la Classe III et cinq de la Classe IV 
avant I'operation. II n'y eut aucun deces ope- 
ratoire (trois semaines). II y eut cinq deces 
tardifs. Trente-cinq (88%) de ces 40 patients 
sont done vivants et ameliores par I'operation. 
A I'exception de quatre patients, tous sont de 
la Classe I apres I'operation. On a passe en 
revue la morbidite associee a cette operation 
et Ton croit que le remplacement valvulaire 
aortique avec la prothese de Harken est rela- 
tivement sur et que les resultats obtenus sont 
hbmodynamiquement satisfaisants.
The management of patients who require 
isolated aortic valve replacement has im­
proved greatly during the past decade. 
Numerous prostheses, both biological and
*From the University of Ottawa Cardiac Unit, 
Ottawa Civic Hospital, Ottawa, Ont.
Presented at the Annual Meeting of the Royal 
College of Physicians and Surgeons of Canada, 
Toronto, Ont., January 1972.
This work was supported by the Ontario Heart 
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Reprint requests to: Dr. Pierre Bedard, Cardiac 
Surgical Office, Ottawa Civic Hospital, 1053 Car­
ling Avenue, Ottawa, Ont. K1Y 4E9.
artificial, are available. We here present 
our experience with the first 40 patients 
who had an isolated valve replacement using 
a Harken prosthesis at the University of 
Ottawa Cardiac Unit at the Ottawa Civic 
Hospital.
Material and Methods
Between April 1969 and September 1971 
72 patients had diseased aortic valves re­
placed using the Harken aortic prosthesis. 
Forty of these had isolated aortic valve 
disease necessitating 41 aortic valve replace­
ments. Fifteen had predominant aortic 
stenosis, 17 had predominant incompetence, 
eight had combined aortic stenosis and in­
sufficiency and one had a ball variance of a 
Starr-Edwards prosthesis inserted else­
where. Patients’ ages ranged from 26 to 71 
years. According to the NYHA classifica­
tion four were in Class II, 31 in Class III 
and five in Class IV.
Operation is performed through a midline 
sternotomy incision. Cardiopulmonary by­
pass is established at normothermia using a 
Bentley oxygenator and with hemodilution 
and high flow. The aorta is cross-clamped, 
a left ventricular vent inserted and a trans­
verse aortotomy done, extending down into 
the non-coronary sinus of Valsalva. The 
diseased aortic valve is completely removed. 
The internal aortic annulus is measured with 
a Harken obturator and the appropriately 
sized valve is immersed in a solution con­
taining penicillin, ampicillin, oxacillin and 
amphotericin B for two minutes. The valve 
is sutured into place using interrupted 
figure-of-eight 00 Tevdek interlocking 
sutures on the valve ring. The aortotomy is 
closed in two layers with continuous 000 
silk. Air is removed and the aortic cross­
clamp is released. Cardiac anoxia ranged 
from 33 to 56 minutes with an average of 
44 minutes. An extra-large valve was in­
serted in five patients, a large size in 20, 
a medium size in 15 and a small-sized valve 
in one patient. Postoperatively the patient
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is kept intubated and ventilated for ap­
proximately 20 hours. Blood is administered 
to maintain atrial and arterial pressures 
within established limits. Warfarin or di­
pyridamole and acetylsalicylic acid are 
started on the third postoperative day.
An evaluation of the late postoperative 
results was made after an interval of four 
to 32 months (average 16 months). Thirty- 
one patients were examined by us person­
ally. On the same occasion a chest radio­
graph and electrocardiogram were taken 
and the hemoglobin, reticulocyte count and 
lactic dehydrogenase level were determined. 
Four patients were assessed by their private 
physicians.
TABLE I.—F atalities 
Early..................................................
Late
Dehiscence of aortotomy...........................  1
Cerebral hemorrhage. ........................ ’ i
Myocardial infarction.............................. ’ 2
Cardiac arrest (? arrhythmia)................. 1
TABLEilL—F unctional Results of Survivors
n y h a
classification Preoperalive Postoperative
Class I ..................... 0 31
Class II ................... 4 4
Class I I I ................. 27 0
Class IV.................. 4 0
R e su l t s
Deaths may be considered as “early 
deaths” (postoperative period of less than 
three weeks) and “late deaths” occurring 
after three weeks. AH five deaths in this 
series were in the latter category (Table I).
Of the 35 patients who survived (Table 
II), 34 admitted to great subjective impro­
vement while one was unchanged. Of the 
five patients assigned preoperatively to 
Class IV, one died and four were re­
classified as belonging to Class I. Of the 31 
Class III patients, four died, 23 were ad­
vanced to Class I and four to Class II. Four 
patients in Class II preoperatively were all 
later assigned to Class I. In summary, all 
but four of the surviving patients are in 
Class I on the NYHA scale.
TABLE III.—Complications
Complication Not fatal Fatal
Embolism............... 3 o
Hemorrhage due to 
anticoagulation.............. 2 1
Subacute bacterial 
endocarditis............ 3 1
Regurgitant leaks......... 4 0
1 requires operation
2 asymptomatic
1 shows signs of congestive cardiac failure
The occurrence of thromboembolic 
phenomena is related to the type of Harken 
valve used and to the use of anticoagula­
tion therapy. Three demonstrable throm­
boembolic episodes were identified (Ta­
ble III). One patient suffered a mesenteric 
artery embolism 19 months after the opera­
tion. The other two, three and six months 
postoperatively, had a cerebral embolus 
resulting in transient cerebral ischemia. Of 
13 patients receiving warfarin, one suffered 
an upper gastrointestinal hemorrhage and 
one died of cerebral hemorrhage.
Subacute bacterial endocarditis devel­
oped in three patients (Table III). One died 
from a coincident cerebral hemorrhage. One 
has developed regurgitation.
Regurgitation (leak) has become evident 
in four of the 40 patients (Table III). One 
required a second operation because of 
excessive hemolysis and resultant anemia 
and is now well. Two are clinically well 
and the fourth shows signs of congestive 
heart failure.
Hematological investigation disclosed a 
raised lactic dehydrogenase level in all 
cases, ranging from 250 to 1,575 units/1 
(normal 250 units) with an average of 495 
units. This increase is attributable to some 
degree of erythrocyte damage by the 
prosthesis. Hemoglobin averaged 13.6 
g/100 ml but was less than 12 g/100 ml
TABLE IV.—Investigations at F ollow-Up
Lactic acid dehydrogenase 
Hemoglobin
Reticulocytes
Cardiothoracic ratio
Electrocardiogram
Elevated in all patients 
Less than 12 g/100 ml 
in five patients 
Over 3% in seven 
patients
Decreased from pre­
operative ratio in all 
except four patients 
Decrease in left ven­
tricular hypertrophy in 
all except four patients.
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in five cases. Reticulocytes averaged 2.6% 
but were over the 3% upper limit of normal 
in seven of 28 patients studied (Table IV ).
In the seven cases in which the lactic dehy­
drogenase was over 600 units, the reti­
culocytes were over 3 % and the hemo­
globin was below 12 g/100 ml in five, sug­
gesting hemolysis. In only two of these 
seven was evidence of regurgitation present.
The cardiothoracic ratio decreased 
notably in all except four patients by an 
average of 3% (Table IV ). In some 
instances the decrease was over 10%, from 
the region of 60% to within the normal 
range of less than 50%. All Class IV  pa­
tients dramatically improved with regard to 
this parameter. The four exceptions, where 
the cardiothoracic ratio increased, included 
two patients with long-standing hyperten­
sion and one in whom there was regurgita­
tion.
Preoperative and postoperative electro­
cardiograms were analyzed in 29 patients by 
measuring the S wave in V j and the R  
wave in V 3 and V c as other measurements 
appeared to be unsatisfactory. In the 24 
patients who showed evidence of left ven­
tricular hypertrophy before operation, its 
reduction at the postoperative follow-up 
examination was demonstrated in 20 (Table 
IV ). The four patients who showed an in­
crease in this parameter all belong to Class 
I; no significant reduction in heart size was 
evident in three in whom chest radiographs 
were obtained.
One patient has intermittent claudication 
secondary to left femoral artery stenosis.
D iscussion
The absence of early postoperative deaths 
can be attributed to recent improvements 
of techniques, including normothermia, 
hemodilution and high-flow bypass, the 
correct selection of valve and avoidance of 
cardiac anoxia for longer than 45 minutes. 
Two of the late deaths were directly related 
to operation. In one, the aortotomy wound 
developed a defect at the twenty-third day 
resulting in tamponade; in the other an 
error in dosage of anticoagulants lowered 
the prothrombin time to 60 seconds and the 
patient had a cerebral hemorrhage (this 
patient also had bacterial endocarditis). The
other three deaths were not related to oper­
ation. Two were owing to myocardial in­
farcts and one to cardiac arrest probably 
related to an acute arrhythmia. This late 
mortality of 12.5% approximates what is 
reported by others.1- 2
The improvement in cardiac function as 
shown by the transfer to more favourable 
groups in the N Y H A  classification is 
gratifying. A ll except four were transferred 
to Class I including four Class IV  patients. 
Three of the four patients who are in Class 
II at present are over 65 years of age. The 
fourth has a significant leak and will need 
a further operation; he is the only patient 
who does not admit to any improvement.
It is our opinion that the clinical improve­
ment noted is related to the design o f the 
valve prosthesis which, in the large and 
extra-large sizes, offers virtually no gradient. 
With the small and medium-sized valve we 
have found a gradient between 10 and 20 
mm Hg at rest.
One embolus occurred in a patient who 
had discontinued anticoagulants of his own 
volition. Two others occurred in patients 
who were on aspirin and dipyridamole. Two 
patients treated with warfarin suffered 
serious complications, one a fatal cerebral 
hemorrhage and the other serious upper 
gastrointestinal bleeding.
Two types of Harken aortic valve have 
been produced, one completely covered by 
cloth and, more recently introduced, one 
with a plastic ring on which the metallic 
ball seats. We have found no significant 
difference between those two types of valve 
in regard to the frequency of thrombo­
embolism but we prefer the old type lest the 
plastic interface favour thrombosis. Our 
incidence of thromboembolism is 7.5% 
which is in accord with the experience o f 
others, although Smeloff3 and Blood well 
et a l4 report a 2.5% to 5%  incidence with 
the use of the Smeloff-Cutter prosthesis. 
Recently Starr5 has reported an even lower 
incidence using the new 2310 Starr model. 
Caution should be taken if a prothrombin- 
depressing medication is stopped because of 
the rebound hypercoagulation noted.6
Three of our patients developed subacute 
bacterial endocarditis despite immersion of 
the valve in a solution of antibiotics and 
postoperative antibiotic theraby. In larger
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series, with the use of routine antistaphyl- 
ococcal prophylaxis, the reported incidence 
of endocarditis after aortic valve replace­
ment has been as low as 1% to 4 % .1- *■ 7
Parabasilar leak may be a consequence 
of prosthetic valvular infection or may 
actually cause it.s Out of the 41 operations, 
regurgitation developed in four patients. 
Two of these are asymptomatic but it must 
be noted that they have not been assessed 
by angiography and the parabasilar leak 
may not be significant. In the experience of 
Bloodwell et al4 the incidence of para­
basilar leak has been 5 %.
T he rise in lactic acid dehydrogenase cor­
relates well with the degree of red cell 
survival time.” Although it is difficult to 
know the exact incidence of hemolysis, this 
has been reported by Walsh, Starr and 
Ritzmann9 as 15%.
No correlation could be obtained be­
tween the size of the valve used and the 
radiographic a n d  electrocardiographic 
changes.
C o n c l u s io n
Replacement by the Harken prosthesis 
of the diseased aortic valve when this is 
the sole lesion present is a relatively safe 
procedure. In the series of cases we present
the operation produced good functional 
results and was associated with relatively 
low morbidity. We believe it compares 
favourably with other methods currently 
in use.
The least dramatic results are obtained 
in the elderly in whom an earlier surgical 
approach to the disease is recommended.
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SUBCUTANEOUS MASTECTOMY AND IMMEDIATE PROSTHETIC 
IMPLANTATION AS AN ALTERNATIVE 
TO SIMPLE MASTECTOMY*
F. G. INGLIS, M.D., F.R.C.S.[C] and R. D. MIDGLEY, M.D.. F.R.C.S.[C],
Montreal, Que.
Summary: The recent development of a satis­
factory breast prosthesis by Cronin has led to 
a reassessment of the role of standard simple 
mastectomy in the treatment of breast disorders. 
There are circumstances when subcutaneous 
mastectomy with immediate implantation of a 
prosthesis is a suitable alternative. The case 
reports of five patients (on whom seven opera­
tions were performed) are presented. Indications 
for the operation included lobular carcinoma 
in situ, diffuse fibrocystic disease, and recurrent 
benign disease in the remaining breast after 
previous radical mastectomy for cancer. The 
technical aspects of the procedure requiring 
emphasis include sharp dissection, meticulous 
hemostasis and the selection of an appropriate 
prosthesis. It is recommended that this opera­
tion be given consideration when a simple 
mastectomy would be otherwise indicated.
Resume: La mise au point recente par Cronin 
d'une prothese mammaire satisfaisante nous a 
incite a reevaiuer le role de la mastectomie 
simple classiquement pratiquee dans !e traite- 
ment des pathologies mammaires. II arrive qu'on 
rencontre des circonstances ou on peut envi- 
sager une mastectomie sous-cutanee suivie de 
I'implantation immediate d'une prothese pour 
remplacer la mastectomie simple. Nous presen- 
tons ici les cas de cinq patientes (chez lesquelles 
on avait deja pratique sept interventions). Parmi 
les indications de 1'operation en question figu- 
raient un epitheliome lobulaire in situ, un cas 
de maladie fibrokystique diffuse et une tumeur 
benigne r6cidivante dans le sein restant apres 
une mastectomie radicals anterieurement prati­
quee pour cancer. Parmi les aspects techniques 
de 1'operation qui doivent etre mis en evidence, 
on peut citer une dissection precise, une hemos- 
tase meticuleuse et le choix de la prothese 
appropriee. II nous semble judicieux d'envisager 
de pratiquer cette operation dans les cas ou 
une mastectomie simple serait, sinon, indiquee.
Subcutaneous mastectomy has been pro­
posed as an alternative to simple mas­
tectomy in the management of certain dis-
*From the Department of Surgery, University 
Hospital, Saskatoon, Sask. and the Division of 
Plastic Surgery, Royal Victoria Hospital, Montreal, 
Que.
Presented to the Canadian Society of Clinical 
Surgeons, Western Division, Saskatoon, Sask. 
March, 1972.
orders of the breast. It offers the advan­
tage that the nipple is left intact, thereby 
reducing the deformity inflicted by simple 
mastectomy. However, unless the configu­
ration of the breast remains, little is 
achieved from the cosmetic standpoint. To 
overcome this deficiency, subcutaneous mas­
tectomy with immediate prosthetic implan­
tation has been advocated, performed by 
a general surgeon and a plastic surgeon 
working as a team. The following case 
histories illustrate the indications for the 
operation and what results may be expected.
Case Reports
Lobular Carcinoma In Situ
Case 1 —When this 40-year-old woman 
was first seen in November 1965 physical 
examination revealed a nodular area in the 
left breast which was thought to be fibrocystic 
disease. Mammograms confirmed the clinical 
impression that there was no evidence of a 
malignant lesion. She was re-examined at 
regular intervals and mammograms showed 
no change in the lesion. In August 1968, 
although no change was observed, she was 
concerned by the presence of this lump and 
an excisional biopsy was performed. The 
diagnosis from a frozen section was gross 
adenosis but a definite diagnosis was with­
held until the paraffin sections were ex­
amined. The incision was closed and the 
patient returned to her room.
From the paraffin sections a diagnosis of 
intraductal and lobular carcinoma in situ was 
made. The patient was considering remarriage 
and was most reluctant to accept the recom­
mendation of a left simple mastectomy. Fol­
lowing discussion, she agreed to a subcutane­
ous mastectomy with prosthetic implantation. 
Six days after the first procedure a left sub­
cutaneous mastectomy was carried out and an 
Arion prosthesis was implanted. The incisions 
healed well. The skin and nipple areas re­
mained well vascularized and she was dis­
charged on the eighth postoperative day.
The patient was re-examined at regular in­
tervals, and although there was no evidence 
of recurrence, the originally placed prosthesis 
had leaked and become wrinkled so that the
64 THE CANADIAN JOURNAL OF SURGERY Vol. 17
cosmetic result was less than satisfactory. 
Meanwhile, she developed a tender nodule in 
the right breast and mammography revealed 
the possibility of fibrocystic disease or lobular 
carcinoma in situ. Accordingly, she was read­
mitted in February 1970 and an excisional 
biopsy of the suspicious area of the right 
breast was carried out. Final histological ex­
amination indicated sclerosing adenosis with 
fibrocystic disease and no evidence of lobular 
carcinoma. At the same time the wrinkled 
prosthesis was removed and replaced by a 
Cronin prosthesis. The cosmetic result was 
very satisfactory and she was discharged on 
the seventh postoperative day.
The nature of her condition was explained 
to her and the fact that she was in a high-risk 
group amplified. In the absence of a histologic­
al diagnosis of carcinoma, she was reluctant to 
undergo an excision of the right breast tissue. 
She has been followed up at regular intervals 
by mammograms and, to date, there has been 
no further evidence of disease in the right 
breast and the cosmetic result in the left breast 
remains satisfactory.
Case 2 .—The patient, aged 48 years, was 
referred for surgical opinion by her gynecolo­
gist in May 1968. A nodular lesion, firm and 
discrete from the surrounding tissue was found 
in the left breast from which no fluid could be 
aspirated. A mammogram showed a fairly 
well-defined density which was thought to be 
a cyst or fibroadenoma. She was reluctant to 
undergo a biopsy and was therefore re­
examined at regular intervals. In August 1968 
a repeat mammogram disclosed another nodule 
beneath the nipple of the right breast and 
small benign calcifications of the left breast. 
There was no indication of malignancy. At 
this point the patient agreed to biopsy. Ex­
amination of frozen sections revealed benign 
cystic disease of both breasts and in the left 
an area thought to resemble intralobular 
carcinoma in situ. Serial sections subsequently 
revealed that this area was only one of many 
areas showing the same features. In the right 
breast only a very small focus of non-infiltrat­
ing intraductal carcinoma was identified.
Bilateral subcutaneous mastectomy with im­
plantation of an Arion prosthesis was carried 
out. Multicentric lobular carcinoma in situ 
was confirmed in the left breast and in one 
area of the right breast an infiltrating intra­
ductal carcinoma was found.
It was therefore decided to give three-port 
radiotherapy to the mediastinum, right supra­
clavicular and axillary areas. She received a 
total of 3,500 rads to the mediastinal area.
The prosthesis was left in situ until, despite 
conscientious skin care, a small area of in­
flammation developed. Under local anesthesia 
the prosthesis was removed and the skin healed 
satisfactorily. The patient was readmitted in 
May 1971, when a Cronin-type prosthesis was 
placed on the right side and substituted for the 
Arion prosthesis on the left. No skin necrosis 
or inflammation followed these procedures 
and the patient now has a satisfactory cosmetic 
result with no sign of recurrence of tumour 
51 months later.
Case 3. This 33-year-old Jamaican woman 
noticed a small painless lump in the right 
breast three weeks prior to admission in June 
1969. Examination showed a hard nodule, 
less than 1 cm in diameter, very close to the 
nipple. There was no lymphadenopathy and 
the left breast was normal to clinical examina­
tion. Mammography confirmed the clinical 
impression of a benign lesion. An excisional 
biopsy was carried out. Examination of the 
frozen sections suggested the diagnosis of 
lobular carcinoma. The paraffin sections con­
firmed this impression of lobular carcinoma 
in situ, and therefore a right subcutaneous 
mastectomy with Cronin prosthetic reconstruc­
tion was performed (Fig. 1). The wound healed
Fig. 1.—Cronin prosthesis. Note the Teflon 
patches on the undersurface.
satisfactorily and the nipple and skin circula­
tion remained healthy. Follow-up examination 
and mammography revealed no evidence of 
disease in the left breast and the cosmetic 
result remained satisfactory (Fig. 2). It is 
now 42 months since her operation and there 
is no evidence of recurrence.
Recurrent Fibrocystic Disease in the Op­
posite Breast Following Radical Mas­
tectomy
Case 4.—In November 1967 this white 
married woman, aged 50 years, underwent a
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Fig. 2a Fig. 2b
Fie 2 -C ase 3 (a) Frontal and (b) right lateral views after insertion of the prosthesis. Note 
the extent'of’the submammary incision in both views. The circumareolar biopsy incision may be seen 
on the right breast.
right radical mastectomy for carcinoma whose 
presence had been suspected from mammo­
graphy. The left breast was normal. The pa­
tient was followed up at regular intervals. In 
November 1969 she was admitted for biopsy 
of a lesion in the left breast which, by mammo­
graphy, was suspicious for carcinoma. Histo­
logical examination diagnosed fibrocystic 
disease. The patient remained well until Janu­
ary 1971, when a second lesion was found in 
the left breast. No fluid could be aspirated 
from it. The radiologist again suspected from 
the mammogram that the lesion was malignant.
The patient was reluctant to lose a second 
breast because she was feeling well and en­
joyed outdoor activities. However, she agreed 
to a subcutaneous mastectomy with insertion 
of a Cronin prosthesis. This was carried out 
without incident in February 1971. Serial 
sections of the operative specimen did not 
reveal any carcinoma. She has remained well 
for 414 years following her initial radical 
mastectomy and the prosthesis provides her 
with a good cosmetic result and an “anchor” 
for her right silicone prosthesis.
Diffuse Fibrocystic Disease
Case 5.—This 47-year-old woman had 
severe fibrocystic disease for many years and 
several biopsies had been performed. She was 
seen in January 1971 after noticing a new 
lump and was extremely worried because 
there was a history of cancer of the breast in 
her mother’s family. She requested bilateral 
simple mastectomy. After examination, which 
confirmed the presence of fibrocystic disease, 
it was agreed that a bilateral subcutaneous 
mastectomy with insertion of a Cronin pro­
sthesis should be carried out. The second side 
was dealt with six days after the first. Both in­
cisions healed satsfactorily and the blood 
supply to the skin and nipples remained in­
tact. The cosmetic result was entirely ac­
ceptable. Serial slicing and selective sectioning 
of the mastectomy specimens by the patholo­
gist revealed only fibrocystic disease.
T echnique
The operation must be carried out care­
fully if the skin and nipple are to remain
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viable. A generous submammary incision is 
made, making certain that it extends far 
enough laterally to allow excision of the 
axillary tail of the breast. The skin is re­
flected upwards and the plane of dissection 
in the subcutaneous tissues entered. The in­
ferior hemisphere of the breast is freed up 
to, but not including, the nipple. Skin re­
traction must be gentle using skin hooks 
initially and, subsequently, rounded right- 
angled retractors. Scrupulous care is taken 
to secure all bleeding points with plain 
catgut ligatures or minimal electrocautery. 
The plane of dissection between the breast 
and the fascia of the pectoralis major is 
developed by sharp and blunt dissection. 
Special care should be taken with the medial 
portion of the breast. It is here that one 
may easily leave residual breast tissue, or, 
if the flaps are trimmed too thinly, necrosis 
may ensue. The entire breast is elevated 
from the muscle, and perforating branches 
from the internal mammary vessels are 
secured with hemostats as they are en­
countered. The dissection of the skin over 
the upper half of the breast is then com­
pleted using sharp scissor dissection. The 
nipple is freed by knife dissection. At this 
point, the axillary tail is the only re­
maining attachment. By extending the 
original incision in an upward direction, it 
is possible to excise the entire axillary tail 
without placing undue traction on the skin 
flaps. It is important that hemostasis be 
meticulous. This is achieved by confining 
the dissection to the natural planes of 
cleavage whenever possible, by carefully 
ligating all bleeding vessels and by the cau­
tious use of electrocautery to control any 
minor oozing.
Following removal of the breast, the area 
is irrigated with Ringer’s lactate or saline so­
lution and any further bleeding points are 
carefully secured. A persistent ooze can be 
controlled by manual pressure with warm, 
moist sponges against the pectoral muscle 
for five minutes. The colour of the skin 
and nipple is then checked and if, follow­
ing pressure-blanching, there is a healthy 
inflow, the decision to proceed with the in­
troduction of the Cronin prosthesis is made.
A suitable “petite” or “small-sized” pros­
thesis (Fig. 1) is gently inserted beneath the 
skin flap after removing all clots and fatty
debris by saline irrigation. As a consequence 
of meticulous hemostasis, it has not been 
necessary to use drains. A few subcutaneous 
catgut sutures are placed to observe the 
tension on the prosthesis. If satisfactory, 
closure is continued using 000 plain catgut 
and 4-0 nylon simple sutures on the skin. 
A bulky gauze-elastoplast dressing is ap­
plied with the nipple exposed to allow daily 
inspection of its viability.
The patient remains in bed in a semi- 
recumbent position for two days; the 
dressing is then removed and the skin 
inspected. If skin viability is doubtful, the 
prosthesis should be removed and reinserted 
in three months. The bulky supportive dress­
ing is then reapplied for another seven to 10 
days. Subsequently the sutures are removed, 
and the patient is allowed to resume her 
normal activities, wearing her own brassiere 
for support.
D iscussion
The indications for subcutaneous mas­
tectomy with immediate plastic reconstruc­
tion appear to be generally acceptable for 
non-malignant breast disease such as pain­
ful fibrocystic breasts or the other condi­
tions illustrated by the case reports. How­
ever, its applications to the treatment of 
malignant breast disease are certain to be 
controversial. Infiltrating lesions are best 
treated by the procedures used for carci­
noma of the breast—-radical mastectomy, 
modified radical mastectomy, or simple 
mastectomy with or without radiation 
therapy.
The management of non-infiltrating ma­
lignant lesions such as lobular carcinoma 
in situ includes radical mastectomy,1 mo­
dified radical mastectomy,2 simple mas­
tectomy,3- 4 simple mastectomy with con­
tralateral prophylactic mastectomy,3 mas­
tectomy with biopsy of the outer quadrant 
of the contralateral breast,3 and Haagen- 
sen’s approach of simple excision with 
regular follow-up.1 ln the latter report, a 
23% incidence of the later development 
of cancer in the same breast has been re­
ported.
Since the original description of this 
lesion by Foote and Stewart in 1941,3 
there have been extensive reviews of the
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subject of lobular carcinoma in the litera­
ture.6' 811 The incidence of lobular carci­
noma reported by various authors has 
ranged from 0.6% to 10%.8 This variation 
reflects the diagnostic problems which this 
lesion presents to the pathologist. It would, 
therefore, be appropriate for surgeons deal­
ing with breast lesions to acquaint themselves 
with the views of their own pathologist con­
cerning this particular lesion. Long-term 
follow-up by several authors1' 7 would 
suggest that lobular carcinoma in situ is a 
preliminary stage to invasive carcinoma. It 
is also true that this lesion may be associ­
ated with an invasive breast cancer at the 
time of its discovery. That the invasive 
cancer may invariably have been preceded 
by lobular carcinoma is conjectural. How­
ever, all authors agree that this tumour has 
a high incidence of multicentricity and 
Warner,8 after compiling all reported cases, 
reports an overall incidence of bilaterality 
in lobular carcinoma of not less than 15%. 
In view of these characteristics it would 
appear that simple mastectomy is the proper 
treatment of lobular carcinoma in situ 
(lobular neoplasia), and if one considers 
the undesirable psychological effects of mas­
tectomy,12 consideration should be given 
to preserving the natural form of the breast 
by implanting a suitable prosthesis follow­
ing subcutaneous mastectomy. Further, in 
view of the high incidence of bilateral 
disease, a second mastectomy may be sub­
sequently required. Appearances are im­
portant when considering the relatively 
young age of these patients. Therefore, if 
the surgeon selects simple mastectomy as
the treatment for lobular carcinoma in situ 
and other non-malignant disease of the 
breast, the authors recommend that con­
sideration be given to subcutaneous mas­
tectomy with prosthetic implantation.
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B O O K  R E V I E W S
DIGESTIVE SURGERY. Proceedings of 1st 
World Congress of Collegium Internationale 
Chirurgiae Digestivae Held in San Remo, 
May 1971. Edited by G. Grassi and G. 
D ’Onofrio. 1096 pp. Illust. Piccin Medical 
Books, Padua and London, 1973. L. 35,000. 
$60.85 (approx.).
This book is a collection of papers by world 
experts on selected topics rather than a co­
ordinated textbook.
The subjects included are of current in­
terest and include reconstruction of the eso­
phagus, precancerous lesions of the rectum 
and colon, chronic vascular mesenteric insuf­
ficiency, acute pancreatitis, liver tumours, liver 
transplants, hydatid cysts, peptic ulcer and the 
teaching of digestive surgery.
The format of this book is excellent with 
good headings and subtitles. Illustrations are 
used effectively in some sections. A few of the 
presentations are in French, the remainder in 
English. This book is a good reference for 
specific topics for experienced surgeons.
S. E. Carroll
St. Joseph’s Hospital,
London, Ont.
PALLIATIV-CHIRURGISCHE EINGRIFFE 
BEI MALIGNEN TUMOREN. Edited by 
Klaus Schultis, Hermann Ecke and Hans 
Schoen. 197 pp. Illust. Intercontinental 
Medical Book Corp., New York; Georg 
Thieme Verlag, Stuttgart, 1973. DM 69,00. 
$28.55 (approx.).
This monograph is a well-organized review of 
the malignant tumour processes in the various 
organs and systems of the body. It is divided 
into 25 chapters, written by a large group of 
co-authors.
The similar structural make-up of each 
chapter makes the orientation of the large 
supply of material and the reading easy. The 
work covers all clinical situations in which the 
only form of treatment is palliative surgical 
intervention. The authors define clearly the 
stages of the malignant processes, giving brief­
ly the classification and the pathological-ana­
tomical character of the tumour under discus­
sion, as well as the operative findings.
The postoperative complications, the results 
and the prognosis of the treatment are im­
portant sections of each chapter. They allow 
the reader to form an opinion of the true value 
of the non-radical surgery in the treatment of 
malignant tumours, when radical operations 
are contraindicated. The final goal is achieved 
when the patient’s general status is improved 
and his life prolonged, even if for a short.
L. G. Farkas
The Hospital for Sick Children,
Toronto, Ont.
RECENT ADVANCES IN OTOLARYNGO­
LOGY. 4th ed. Edited by Joselen Ransome, 
H. Holden and T. R. Bull. 461 pp. Illust. 
Churchill Livingstone, Edinburgh; Longman 
Canada Limited, Toronto, 1973. $23.50.
There are some advantages to be gained when 
15 years elapse between editions. The many 
advances that occur in this time demand al­
most complete revision. This is the case with 
the fourth edition of “Recent Advances in Oto­
laryngology”.
This is essentially a British book; the only 
one of its 29 chapters by an American author 
is concerned with aerospace and its relation 
to the ear, nose and throat. Each chapter is 
devoted to a different aspect of the specialty 
and is written by a different author. Partic­
ularly well done is the chapter on acoustic im­
pedance. Sadly lacking, however, is a section 
dealing with the nose. Perhaps the explanation 
is that rhinoplasty belongs to a specialty other 
than otolaryngology, a situation that is grad­
ually being reversed in North America.
Special techniques such as microlaryngeal 
surgery and cryosurgery are dealt with. In the 
section devoted to related subjects are included 
hematology, virus infections, antibiotics and 
anesthesia. With the constant advances in these 
fields, their inclusion is not only in order, but 
most helpful.
This book is not a reference book but should 
be most useful to the specialist resident and an 
excellent addition to the otologist’s library.
V. de C. Magian
The Winnipeg Clinic,
Winnipeg, Man.
SURGERY ANNUAL. Volume 4. 1972. 
Series Editors: Phillip Cooper and Lloyd 
M. Nyhus. 445 pp. Illust. Appleton- 
Century-Crofts, Educational Division, 
Meredith Corporation, New York, 1972. 
$17.50.
The “Surgery Annual” 1972 is an attractive 
review of many important areas of clinical 
surgery. In slightly over 400 pages the 
editors and their advisory board have chosen 
discriminately from the copious surgical 
literature of 1972 and produced a volume 
of interest to general surgeons and sub­
specialists alike.
The contents have been well balanced 
between operative techniques and their 
refinem ents and conceptual aspects of sur­
gical pathophysiology and non-operative 
treatm ent. There are critical reviews of 
assisted circulation with emphasis on 
counterpulsation, of shock, and gastric mu- 
(Continued on page XXVIII)
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Fight infection, help wounds heal with—
Furacin
•  Broad, stable antibacterial range. More than 
80.000,000 courses of topical therapy with Furacin 
have scarcely changed its wide antibacterial range.
•  Non-antibiotic Non-Systemic. Furacin is used 
only topically. There is no development of 
cross-resistance or cross-sensitization with 
antibiotics or sulfonamides, hence no interference 
with any planned systemic therapy.
•  Effective in pus, serum and other wound fluids.
Unlike certain antibiotics, sulfonamides and other 
antibacterials, Furacin is not bound, inactivated or 
destroyed by body secretions or exudates.
•  Non-toxic to healing tissue. Freedom from 
cytotoxicity facilitates tissue regeneration and take of 
skin grafts.
•  Non-macerating. Water-solubility of the Furacin 
carrier, the unique, non-lipid Solubase ensure 
tissue and fluid compatibility.
•  Low incidence of sensitization. Rarely seen in 
burns and surgical practice, the reported overall 
incidence of sensitization to Furacin is about 1.2%.
•  Limited development of resistance. There has 
been no emergence of clinically significant resistant
bacterial mutants in over 20 years of clinical use. 
Furacin continues to destroy pathogens that have 
long since grown resistant to some other 
antimicrobials.
•  Increased patient comfort. Furacin topical therapy 
minimizes malodor and does not interfere with 
drainage
•  Versatile and widely useful. Furacin is available in 
many forms to treat a wide variety of conditions— 
Furacin Sterile Gauze and Batiste Rolls and Pads, the 
exceptionally useful Furacin Sterile Stretch Gauze, 
and also Furacin Soluble Dressing, Soluble Powder, 
Solution and Topical Cream.
•  Ready to use. No time or labor wasted in preparing 
impregnated dressings and in sterilization. Furacin 
impregnated rolls and pads are supplied sterile and 
ready for immediate use, as is the Furacin Stretch 
Gauze.
•  Non-staining. Furacin does not stain skin, clothing 
or bedding as sometimes happens with iodophors or 
the older medicinal dyes.
•  Economical therapy. Saves time and money in the 
hospital, in the office, and on prescription.
The first family of ready-to-use antibacterial dressings.
versatile / economical 
exclusively topical
Furacin* (nitrofurazone)
F u r a c i n  P r o d u c t  I n f o r m a t i o n
FURACIN STERILE STRETCH GAUZE:
A sterile  prepacked bactericidal wet dressing that con fo rm s 
and c lings com fortab ly to body contours and hard to  dress 
wounds. It is im pregnated w ith a water-m iscib le 0 2% F ura ­
cin so lu tion . If a continuously wet dressing is desired, it may 
be m oistened as required w ith Furacin So lution d ilu ted 1.1
w ith  sterile  water.
FURACIN STERILE ROLLS:
Rolls o f sterile  co tton  gauze o r sterile  co tton batiste im p re g ­
nated w ith Furacin Soluble D ressing conta in ing  0.2% F ura ­
cin in w a ter-so lub le  S o lubase ;.
FURACIN STERILE PADS:
Ind iv idua l fo il envelopes conta in a sterile co tton  gauze pad 
or sterile  co tton  batiste pad 3 "  x 3 "  (opens to 3 "  x 9 "). Each 
pad is im pregnated with Furacin Soluble Dressing c o n ta in ­
ing 0 2% Furacin in water-solub le Solubase 
Also availab le: Furacin Soluble Dressing, Furacin S o lub le  
Powder, Furacin Solution, and Furacin Top ica l Cream.
Additional information available on request
§ Originators and Developers of the N itrofurans EATON LABORATORIESDivision of Norw ich Pharmacal Company Ltd. PARIS, CANADA
sis Furacin and Solubase are registered Trade Marks
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cosal integrity as a factor in ulceration. 
Trauma is dealt with in terms of injury to 
both chest and the spinal cord. There is an 
equally excellent chapter on the short-gut 
syndrome, and the physiologic and clinical 
significance of ileal rejection from the 
viewpoint of bypass procedures. There 
follows an excellent review of improvements 
in metabolic and diagnostic assessments of 
human renal allotransplants; this will be of 
interest to students, residents and their pro­
fessors from the viewpoint of lecture con­
tent, as well as to those who are more inti­
mately concerned with this particular aspect 
of therapy. There are two chapters dealing 
with pediatric surgery.
This book is excellent and the quality of 
both diagrams and reproduced radiographs 
is well above standard. All chapters are 
well referenced; the index is accurate.
The book will be of great value to senior 
medical students who may be preparing 
subject matter for seminars and confer­
ences; for residents who are preparing for 
examinations in surgery; and for all those 
who wish to update and review many basic 
concepts of modalities of treatment. Al­
though the price may seem high for a book
ROYAL VICTORIA HOSPITAL
PROBLEMS IN 
GENERAL SURGERY
May 8 - 9 - 1 0 ,  1974
This Course is designed for the 
surgeon in active practice. Sessions 
will include general surgery, com­
mon peripheral vascular surgery and 
coverage of pre- and post-operative 
care. Teaching methods to be uti­
lized are ward rounds, case presen­
tations, operative clinics, seminars 
and lectures. Recent advances will 
be emphasized.
For further information, write to: 
The Secretary, 
Post-Graduate Board,
ROYAL VICTORIA HOSPITAL,
Montreal, Quebec H3A 1A1.
Fee: $100.00
of little over 400 pages, it is money well 
spent in these days of inflation.
I. W. D. Henderson
Department of Surgery,
Ottawa General Hospital,
Ottawa, Ont.
SURGICAL ANATOMY FOR CLINICAL 
EXAMINATION. Andrew W. Munster and 
George J. Thomas. 129 pp. Illust. McGraw- 
Hill Ryerson Limited, Toronto; Charles C 
Thomas, Publisher, Springfield, 111., 1973. 
$10.75.
This is an example of the new type of anatomy 
textbook that is short, concise and easy to read. 
It covers all regions of the body and includes 
more than surface anatomy, yet not enough for 
operative procedures. As the title indicates, 
the book describes the anatomy pertinent to 
physical examination and indicates the signif­
icance of many anatomical details. The many 
illustrations are clear and effective.
Medical students and interns will find this 
book useful and instructive. It might find a 
place in a family practitioner’s office, but does 
not provide enough depth or detail for the 
planning of operations.
S. E. Carroll
St. Joseph’s Hospital,
London, Ont.
SURGICAL PEDIATRICS. Edited by Stephen 
L. Gans. 337 pp. Illust. Grune & Stratton, 
Inc., New York; Longman Canada Limited, 
Toronto, 1972. $22.50.
This unique 337-page volume is devoted ex­
clusively to the preoperative and postoperative 
care of children. Surgical procedures and tech­
nical aspects are not discussed. The 19 chap­
ters have been written by 22 experts in their 
respective fields.
Section I, entitled “External Influences”, 
deals with emotional, psychological and spi­
ritual aspects of hospitalization and treatment 
of the child. These chapters are particularly 
helpful to the young doctor dealing with the 
seriously ill or dying child.
In this age of referral to specialized centres 
and hospital-oriented treatment a chapter on 
transportation of sick and injured children 
is not only appropriate but also essential in 
improving the standards of ambulance services. 
The special needs of the neonate are stressed, 
i.e. temperature control, prevention of sepsis, 
maintenance of airway and circulation, and 
proper communication and consultation before 
transport.
An informative chapter on genetic coun­
selling completes the first section.
Section II, devoted to critical care, covers 
the problems peculiar to the pediatric patient, 
namely temperature control, respiratory care, 
(Continued on page XXXI)
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fluid and electrolytes and physiological 
monitoring. This section also deals with pre­
operative evaluation, blood component trans­
fusion therapy, and cardiopulmonary resusci­
tation. Peritoneal lavage using a catheter is 
more reliable and safe than the recommended 
four quadrant taps. There is no mention of 
angiography as a definitive method of assessing 
intra-abdominal injuries short of laparotomy.
The chapters dealing with the responsibility 
of the anesthesiologist, and postoperative 
respiratory care are repetitive. Alterations in 
ventilation-perfusion ratios, alveolar arteriolar 
oxygen gradients, physiological shunting and 
alterations of compliance are not discussed.
The problems of monitoring the small in­
fant are clearly outlined in a well-written, well- 
illustrated chapter. The author rightly points 
out the hazards of umbilical artery catheter 
infusions. Monitoring of muscle pH is refer­
red to as routinely possible and perfected, 
whereas a reliable, safe pH probe has yet to 
be developed.
In the discussion of fluid electrolytes and 
intravenous nutrition the calculation of main­
tenance fluids is on the basis of 75 m l/kg/ 
day. This results in too little fluid in the small 
patient and overhydration in the older patient. 
Calculations on the basis of surface area are 
more accurate and a simple formula using this 
principle is given elsewhere in the book.
In describing the preparation of intravenous 
hyperalimentation fluids the author leaves the 
impression that these fluids are mixed on the 
ward. To assure safety and sterility, all such 
procedures must be performed in the pharmacy 
under laminar flow hood. Complications of 
intravenous hyperalimentation are stressed. 
Management of the central venous catheter is 
outlined in detail.
The excellent comprehensive chapter on 
blood transfusion therapy serves to emphasize 
the importance of blood transfusions to meet 
specific needs, rather than indiscriminate use 
of whole blood transfusions.
Section III deals with infections in the sur­
gical patient.
In Section IV, dealing with special problems, 
there is a good review of normal coagulation 
mechanisms and the management of coagulo­
pathy. The child with diabetes mellitus and the 
allergic child are the subjects of special chap­
ters.
This textbook is simply written and there­
fore easy to read. Conflicting viewpoints are 
occasionally unavoidable when there are many 
contributors. Unfortunately, except for four 
chapters, this text has very few illustrations, 
tables, or graphic illustrations to aid the reader.
“Surgical Pediatrics” is an important book 
for those caring for pediatric surgical patients.
R. P ostum a
Health Sciences Children’s Centre,
Winnipeg, Man.
SYSTEMATIC ENDOCRINOLOGY. Edited
by Calvin Ezrin, John O. Godden, Robert
Volpe and Richard Wilson, 509 pp. Illust.
Harper & Row, Publishers, Inc., Hagers­
town, Md., 1973. $22.50.
In the preface to this book the editor has in­
dicated that the authors have set out to write 
a book containing “important facts, duly ar­
ranged and reasoned upon with care”. After 
close scrutiny of this textbook it is obvious that 
the authors and editors have succeeded admir­
ably in their task. It is an impressive volume. 
All of the facts are here, recorded in proper 
perspective, and the recent advances in knowl­
edge and technology, which are many, have 
been included, providing a comprehensive, in­
tegrated and up-to-date survey of the endo­
crine literature. The care with which the book 
was conceived and executed is demonstrated 
by the uniformly excellent quality of each 
chapter.
The success of the venture probably reflects 
the choice of authors. Each chapter was writ­
ten by an endocrinologist involved in research, 
practice and teaching of this discipline. Each 
of the authors is a recognized expert in his 
field (some with international stature) and has 
made impressive and important contributions 
to the field of endocrinology. It is a “Cana­
dian” contribution but one whose interest and 
usefulness will not know national boundaries.
This is not a textbook directed at surgeons, 
which does not necessarily preclude it as rec­
ommended reading for our surgical colleagues. 
It is a good source for basic as well as recent 
information. Surgery in patients with endo­
crine disorders requires a co-ordination of 
surgical technique with knowledge of meta­
bolic and endocrine disturbances if morbidity 
and mortality are to be minimized. Although 
there may be more basic inforrmation than 
is required, this book is recommended for 
surgeons interested and involved in endocrine 
and metabolic problems.
The book arose out of a need to provide 
material for a system-based curriculum for se­
nior medical students at the University of To­
ronto. While it would be admirable for the 
medical student to digest and integrate the 
total contents of this textbook, the contents 
provide more than what constitutes, in terms 
of current jargon, “core material”. It is diffi­
cult to fault the authors on their enthusiasm 
and comprehensiveness, and this reviewer 
would rather suggest that this book is admir­
ably suited to the needs of a student of endo­
crinology, whatever his level of training may 
be.
Of special interest to readers is that one of 
the editors of this text, John O. Godden, was 
the faithful and efficient editor of the Cana­
dian Journal of Surgery for many years. The 
hand of the experienced editor is clearly visi­
ble. He has managed to extract from each 
author a clear and careful representation of 
the current state of endocrinology.
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Colon and Rectal Surgery. Continuing Educa­
tion Review. Eric J. Lazaro. 214 pp. Med­
ical Examination Publishing Co., Inc., 
Flushing, N.Y., 1973. $10.00. Paperbound.
Coronary Angiography. Harold A. Baltaxe, 
Kurt Amplatz and David C. Levin. 239 pp. 
Illust. McGraw-Hill Ryerson Limited, To­
ronto; Charles C Thomas, Publisher, 
Springfield, 111., 1973. $22.50.
Flexible Implant Resection Arthroplastry in 
the Hand and Extremities. Alfred B. Swan­
son. 352 pp. Illust. The C. V. Mosby Com­
pany, St. Louis, 1973. $39.40.
The Hip. Proceedings of the First Open Sci­
entific Meeting of The Hip Society. Pro­
gram Chairman: Augusto Sarmiento. 173 
pp. Illust. The C. V. Mosby Company, 1973. 
$22.05.
Hyperparathyroidism. Edward Paloyan, Ann 
M. Lawrence and Francis H. Straus. 222 
pp. Illust. Grune & Stratton, Inc., New 
York; Longman Canada Limited, Toronto, 
1973. $18.50.
Organ Preservation. A Symposium Held at 
the Clinical Research Centre, Northwick 
Park Hospital, Harrow. Edited by David 
E. Pegg. 286 pp. Illust. Churchill Living­
stone, Edinburgh; Longman Canada Lim­
ited, Toronto, 1973. $18.00.
Outpatient Surgery. Edited by George J. Hill, 
II. 1079 pp. Illust. W. B. Saunders Com­
pany, Philadelphia; W. B. Saunders Com­
pany Canada Limited, Toronto, 1973. 
$28.85.
Pathology Annual. Volume 8, 1973. Edited by 
Sheldon C. Sommers, 479 pp. Illust. Apple- 
ton-Century-Crofts, Educational Division, 
Meredith Corporation, New York, 1973. 
$18.50.
Postoperative Disorders of the Gastrointesti­
nal Tract. Hastings K. Wright and M. David 
Tilson. 204 pp. Illust. Grune & Stratton, 
Inc., New York; Longman Canada Limited, 
Toronto, 1973. $16.75.
Recent Advances In Surgery. Number Eight. 
Edited by Selwyn Taylor. 485 pp. Illust. 
Churchill Livingstone, Edinburgh; Longman 
Canada Limited, Toronto, 1973. $19.75.
Reoperative Gastrointestinal Surgery. Thomas 
Taylor White and R. Cameron Harrison. 304 
pp. Illust. Little, Brown and Company, 
Boston, 1973. $25.00.
Stroke. Diagnosis and Management. Current Pro­
cedures and Equipment. Edited by William S. 
Fields and John Moossy. 298 pp. Illust. Warren 
H. Green, Inc., St. Louis, 1973. $15.50.
